data_1apo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1apo _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 1.396 ' NE2' HE21 ' A' ' 49' ' ' GLN . 52.5 mm-40 . . . . . 0 C--O 1.213 -0.816 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 89.2 m -110.74 19.92 18.12 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 114.126 -3.03 . . . . 0.0 107.631 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.64 142.88 44.51 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 115.201 -2.599 . . . . 0.0 110.048 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.714 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 76.04 47.75 10.85 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 115.172 -3.394 . . . . 0.0 110.161 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.714 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.5 m80 9.25 91.99 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 118.161 -1.416 . . . . 0.0 111.616 173.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -91.75 -43.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.627 0.804 . . . . 0.0 110.65 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.205 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 77.2 m -77.76 151.88 33.86 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 115.611 -2.435 . . . . 0.0 110.349 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.55 ' CD1' HD21 ' A' ' 80' ' ' ASN . 74.0 mt -101.67 173.47 6.4 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.596 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 47.69 64.69 1.51 Allowed 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 117.415 -1.714 . . . . 0.0 111.688 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 46.83 26.86 0.62 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.081 -1.448 . . . . 0.0 111.497 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.36 132.49 12.69 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 113.95 -3.976 . . . . 0.0 110.155 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -77.86 167.93 20.73 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.345 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.5 p -147.62 123.61 10.71 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 115.75 -2.38 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.0 -141.6 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 115.345 -2.542 . . . . 0.0 108.611 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -144.47 161.64 38.54 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 115.894 -2.322 . . . . 0.0 109.168 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -166.9 173.5 42.2 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 115.092 -3.433 . . . . 0.0 109.917 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.76 30.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 116.274 -2.17 . . . . 0.0 108.612 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.66 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 176.16 80.7 0.05 OUTLIER Glycine 0 C--N 1.279 -2.612 0 C-N-CA 115.614 -3.184 . . . . 0.0 108.298 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.66 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 42.3 m-20 73.81 137.21 0.05 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 116.527 -2.069 . . . . 0.0 109.355 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -78.25 -165.16 0.63 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 116.501 -2.08 . . . . 0.0 109.491 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -133.68 143.8 48.77 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.975 -2.29 . . . . 0.0 109.67 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.205 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 44.4 m -90.03 144.14 26.16 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 115.647 -2.421 . . . . 0.0 110.001 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.6 m -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 116.789 -1.964 . . . . 0.0 108.246 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 8.2 m -79.44 141.14 37.07 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 115.836 -2.346 . . . . 0.0 109.689 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.85 164.84 18.79 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 115.462 -2.495 . . . . 0.0 109.479 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.88 115.15 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.174 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.63 12.85 13.81 Favored Glycine 0 C--N 1.357 1.722 0 C-N-CA 115.068 -3.444 . . . . 0.0 112.08 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.4 m-85 -141.62 153.52 44.82 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 115.059 -2.656 . . . . 0.0 109.638 174.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.6 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -155.03 -146.31 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 115.379 -2.528 . . . . 0.0 108.914 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.918 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 87.58 168.89 45.04 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 114.285 -3.817 . . . . 0.0 107.917 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -58.32 -29.9 66.27 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 115.14 -2.624 . . . . 0.0 110.213 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.55 HD21 ' CD1' ' A' ' 56' ' ' LEU . 19.9 m-20 -108.64 19.62 19.5 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 116.225 -2.19 . . . . 0.0 111.242 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 56.0 m 60.11 27.52 16.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 115.102 -2.639 . . . . 0.0 106.945 -162.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.692 ' N ' ' O ' ' A' ' 77' ' ' GLU . 7.7 tt0 -61.61 -47.8 83.8 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 117.595 -1.642 . . . . 0.0 112.643 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 1.6 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -98.75 134.18 42.01 Favored 'General case' 0 N--CA 1.404 -2.771 0 C-N-CA 112.533 -3.667 . . . . 0.0 113.169 -152.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.3 p -79.49 106.03 11.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 115.676 -2.409 . . . . 0.0 109.748 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.452 HG23 ' CD ' ' A' ' 77' ' ' GLU . 69.6 p -46.46 -43.53 16.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 116.269 -2.172 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 . . . . . 0 C--O 1.21 -1.0 0 C-N-CA 115.278 -2.569 . . . . 0.0 110.775 -179.542 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 14.2 mp0 . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.9 t -143.22 19.88 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 115.681 -2.408 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -81.88 -1.96 49.5 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 115.758 -2.377 . . . . 0.0 110.912 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.13 18.67 5.53 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 114.446 -3.74 . . . . 0.0 110.882 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.9 t60 51.29 90.33 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.797 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -98.92 -26.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.28 1.32 . . . . 0.0 110.041 -174.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.159 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 65.7 m -78.07 141.31 38.91 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 115.663 -2.415 . . . . 0.0 110.061 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HG ' HD21 ' A' ' 80' ' ' ASN . 54.6 mt -88.09 177.42 6.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 117.433 -1.707 . . . . 0.0 110.216 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 81' ' ' CYS . 5.4 p30 43.67 56.88 4.28 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.891 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 57' ' ' ASN . 6.6 tt0 49.73 29.2 3.04 Favored 'General case' 0 N--CA 1.397 -3.097 0 C-N-CA 116.503 -2.079 . . . . 0.0 112.268 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.83 -176.33 16.78 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 114.815 -3.564 . . . . 0.0 111.334 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 61.0 t-80 -109.87 147.14 33.9 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 116.71 -1.996 . . . . 0.0 109.236 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.2 p -128.26 107.84 10.11 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.057 -2.257 . . . . 0.0 108.774 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -91.97 121.76 33.85 Favored 'General case' 0 C--O 1.258 1.502 0 C-N-CA 115.553 -2.459 . . . . 0.0 109.173 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.0 153.14 29.06 Favored 'General case' 0 C--O 1.255 1.37 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.934 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.32 -92.71 0.08 OUTLIER Glycine 0 CA--C 1.547 2.05 0 C-N-CA 116.64 -2.695 . . . . 0.0 109.405 174.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 66' ' ' GLY . 83.9 mt -65.22 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.587 0 C-N-CA 116.836 -1.946 . . . . 0.0 110.462 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.578 ' N ' HG23 ' A' ' 65' ' ' ILE . . . -52.85 -22.31 11.88 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.267 -4.301 . . . . 0.0 111.394 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' N ' ' C ' ' A' ' 65' ' ' ILE . 31.5 m-20 -107.18 135.58 48.46 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 115.965 -2.294 . . . . 0.0 108.991 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 16.4 p90 -77.4 -166.19 0.71 Allowed 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 116.243 -2.183 . . . . 0.0 109.177 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.67 133.99 38.72 Favored 'General case' 0 C--O 1.255 1.36 0 C-N-CA 113.256 -3.378 . . . . 0.0 108.646 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.159 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 7.4 m -90.95 110.97 22.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 115.535 -2.466 . . . . 0.0 108.965 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 98.1 m -96.8 119.32 35.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.832 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 61.6 m -88.28 156.93 18.93 Favored 'General case' 0 C--O 1.276 2.457 0 C-N-CA 114.256 -2.977 . . . . 0.0 109.342 -173.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 176.11 10.0 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 115.236 -2.586 . . . . 0.0 110.392 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.02 134.02 56.62 Favored 'General case' 0 C--O 1.266 1.941 0 C-N-CA 115.954 -2.298 . . . . 0.0 110.047 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.788 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.59 24.67 60.12 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 115.522 -3.228 . . . . 0.0 110.39 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.8 m-85 -141.95 140.94 32.89 Favored 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 115.455 -2.498 . . . . 0.0 108.704 171.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -144.57 -172.42 3.81 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 116.167 -2.213 . . . . 0.0 108.728 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.72 172.56 46.55 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 115.638 -3.172 . . . . 0.0 110.79 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -64.89 -47.0 79.37 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 115.658 -2.417 . . . . 0.0 109.594 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.772 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 13.3 m120 -79.67 -17.26 54.1 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 115.741 -2.384 . . . . 0.0 109.979 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.7 m 86.48 18.67 0.09 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 115.574 -2.45 . . . . 0.0 107.616 -164.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -55.95 -29.55 60.35 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.003 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 65.5 m-85 -78.92 162.56 25.92 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 115.032 -2.667 . . . . 0.0 110.066 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.788 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 35.7 t -121.85 29.54 7.07 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 115.243 -2.583 . . . . 0.0 107.949 170.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.521 ' OG1' ' O ' ' A' ' 84' ' ' SER . 26.3 p 43.87 19.95 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.153 0 C-N-CA 117.311 -1.755 . . . . 0.0 111.178 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' H ' ' C ' ' A' ' 84' ' ' SER . 45.2 ttt85 . . . . . 0 C--N 1.287 -2.119 0 C-N-CA 116.527 -2.069 . . . . 0.0 111.013 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.573 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -109.94 -14.33 14.28 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 114.846 -2.742 . . . . 0.0 109.967 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -74.96 144.72 43.06 Favored 'General case' 0 C--O 1.268 2.057 0 C-N-CA 114.945 -2.702 . . . . 0.0 108.965 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.762 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 87.28 43.13 5.99 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 114.666 -3.635 . . . . 0.0 110.495 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.762 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER 10.61 92.63 0.04 OUTLIER Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 112.46 -1.87 . . . . 0.0 110.506 175.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.78 -40.22 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.136 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.149 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 83.8 m -74.63 150.01 39.79 Favored 'General case' 0 C--O 1.256 1.439 0 C-N-CA 113.82 -3.152 . . . . 0.0 109.762 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.432 HD11 HD21 ' A' ' 80' ' ' ASN . 17.6 mt -88.63 -178.55 5.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.118 -2.233 . . . . 0.0 109.888 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.552 HD22 ' HB2' ' A' ' 81' ' ' CYS . 6.7 p30 41.72 38.97 1.06 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.879 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 54.55 26.5 7.34 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.541 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 177.23 6.12 Favored Glycine 0 C--N 1.282 -2.462 0 C-N-CA 114.161 -3.876 . . . . 0.0 108.124 171.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -106.71 154.27 21.2 Favored 'General case' 0 C--N 1.278 -2.516 0 C-N-CA 116.229 -2.188 . . . . 0.0 108.492 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 31.4 p -133.53 93.72 3.19 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 115.658 -2.417 . . . . 0.0 108.48 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -76.99 147.41 36.85 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.117 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.58 158.53 15.41 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 116.182 -2.207 . . . . 0.0 110.025 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.4 -100.66 0.14 Allowed Glycine 0 C--O 1.24 0.517 0 C-N-CA 115.261 -3.352 . . . . 0.0 109.309 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.435 ' C ' ' N ' ' A' ' 67' ' ' ASP . 63.2 mt -62.77 170.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 115.584 -2.447 . . . . 0.0 108.462 173.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.432 ' N ' HG21 ' A' ' 65' ' ' ILE . . . -53.83 -19.18 9.73 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 114.46 -3.733 . . . . 0.0 110.401 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' C ' ' A' ' 65' ' ' ILE . 9.1 t70 -101.95 139.45 37.57 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.651 -1.62 . . . . 0.0 107.222 169.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.578 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -83.98 -162.12 0.61 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 116.923 -1.911 . . . . 0.0 107.296 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -141.05 141.99 34.24 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.265 -2.174 . . . . 0.0 108.594 173.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.149 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 95.1 m -94.7 114.44 26.36 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 116.131 -2.228 . . . . 0.0 110.274 -173.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 m -98.62 120.18 38.61 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 115.528 -2.469 . . . . 0.0 108.171 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 41.3 m -93.89 147.21 23.29 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 114.855 -2.738 . . . . 0.0 109.086 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.52 24.68 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 114.483 -2.887 . . . . 0.0 109.004 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.14 134.72 49.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 115.959 -2.296 . . . . 0.0 108.372 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 99.34 -13.05 61.74 Favored Glycine 0 CA--C 1.489 -1.588 0 C-N-CA 114.585 -3.674 . . . . 0.0 110.85 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.67 ' HB3' ' HB3' ' A' ' 81' ' ' CYS . 85.4 m-85 -126.95 147.94 50.09 Favored 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 114.051 -3.06 . . . . 0.0 109.436 167.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.1 170.68 19.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 114.517 -2.873 . . . . 0.0 110.652 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.47 -175.67 19.02 Favored Glycine 0 N--CA 1.434 -1.474 1 C-N-CA 113.035 -4.412 . . . . 0.0 111.343 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -74.31 -61.64 1.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 C-N-CA 113.807 -3.157 . . . . 0.0 109.394 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 46.6 m-20 -76.56 -5.14 46.38 Favored 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 114.776 -2.77 . . . . 0.0 111.711 175.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.1 m 82.51 17.44 0.34 Allowed 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 116.539 -2.065 . . . . 0.0 107.698 -169.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.75 -22.32 5.13 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 116.281 -2.168 . . . . 0.0 112.573 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.27 153.2 30.08 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 114.834 -2.747 . . . . 0.0 109.597 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 39.1 m -120.44 42.86 2.88 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 114.602 -2.839 . . . . 0.0 106.457 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 71.1 p 41.41 47.42 3.12 Favored 'General case' 0 N--CA 1.512 2.665 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.833 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 85' ' ' THR . 34.6 mtm-85 . . . . . 0 C--N 1.277 -2.579 0 C-N-CA 115.262 -2.575 . . . . 0.0 109.099 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 CA--C 1.565 1.538 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 24.2 t -148.63 68.38 1.07 Allowed 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 113.618 -3.233 . . . . 0.0 108.606 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' A' ' 53' ' ' HIS . 8.1 tt0 -65.31 179.3 0.77 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 115.384 -2.526 . . . . 0.0 108.631 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 4.0 4.71 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 114.718 -3.611 . . . . 0.0 111.576 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' GLU . 11.0 t-160 -173.12 96.67 0.35 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 116.14 -2.224 . . . . 0.0 109.058 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -111.92 -46.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 108.049 -1.558 . . . . 0.0 108.049 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.5 m -81.19 157.11 25.36 Favored 'General case' 0 C--O 1.253 1.241 0 C-N-CA 114.863 -2.735 . . . . 0.0 108.923 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.452 ' CD1' HD21 ' A' ' 80' ' ' ASN . 80.9 mt -90.25 175.95 6.93 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 115.964 -2.294 . . . . 0.0 108.682 -177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 56.37 43.13 26.71 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.174 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 45.66 33.38 1.42 Allowed 'General case' 0 N--CA 1.407 -2.616 0 C-N-CA 117.068 -1.853 . . . . 0.0 112.793 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.94 -170.03 1.74 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 114.77 -3.586 . . . . 0.0 109.635 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 24.2 t-80 -107.78 163.55 13.01 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 115.665 -2.414 . . . . 0.0 109.564 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 10.8 t -143.19 143.05 31.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 115.204 -2.598 . . . . 0.0 108.295 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -123.3 -144.35 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.539 -2.065 . . . . 0.0 108.114 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -140.53 152.38 45.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 114.469 -2.892 . . . . 0.0 110.315 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.95 149.55 12.02 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 115.084 -3.436 . . . . 0.0 110.026 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.532 ' C ' ' H ' ' A' ' 67' ' ' ASP . 39.4 mt -62.57 138.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.303 -176.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.6 -28.89 1.51 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 116.299 -2.857 . . . . 0.0 111.436 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 65' ' ' ILE . 34.3 t70 -176.58 141.14 0.38 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 116.521 -2.072 . . . . 0.0 110.152 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.747 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 17.9 p90 -81.48 -165.6 0.99 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 116.424 -2.111 . . . . 0.0 108.068 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -131.99 136.46 47.31 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 115.41 -2.516 . . . . 0.0 110.507 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.747 ' SG ' ' HE2' ' A' ' 68' ' ' TYR . 93.2 m -94.3 142.39 27.47 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 115.268 -2.573 . . . . 0.0 109.475 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 82.2 m -125.53 108.32 11.48 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 115.282 -2.567 . . . . 0.0 107.647 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.182 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.0 m -82.42 142.89 31.58 Favored 'General case' 0 C--O 1.259 1.559 0 C-N-CA 116.325 -2.15 . . . . 0.0 108.716 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 165.59 24.76 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.936 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -50.36 143.13 9.23 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.185 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 80.83 12.94 82.15 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 114.889 -3.529 . . . . 0.0 110.426 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 98.1 m-85 -140.25 143.64 36.07 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.382 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -145.56 -174.34 4.37 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 116.128 -2.229 . . . . 0.0 109.622 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.43 173.42 48.3 Favored Glycine 0 C--O 1.236 0.261 0 C-N-CA 114.636 -3.65 . . . . 0.0 109.658 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -71.15 -42.18 69.48 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 115.456 -2.498 . . . . 0.0 110.38 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.624 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 41.2 m-20 -83.65 -4.7 58.81 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 116.795 -1.962 . . . . 0.0 110.152 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.182 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 70.91 25.66 3.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 114.322 -2.951 . . . . 0.0 108.219 -165.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.58 -25.03 68.05 Favored 'General case' 0 C--N 1.368 1.394 0 C-N-CA 116.155 -2.218 . . . . 0.0 110.057 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -79.16 175.65 10.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 115.892 -2.323 . . . . 0.0 109.234 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 23.4 p -139.97 28.45 2.12 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 116.768 -1.973 . . . . 0.0 108.246 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p 41.92 30.07 0.15 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.4 -1.72 . . . . 0.0 110.405 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 84' ' ' SER . 48.1 ttp180 . . . . . 0 C--N 1.3 -1.557 0 C-N-CA 116.426 -2.11 . . . . 0.0 109.764 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.466 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.1 mp0 . . . . . 0 C--O 1.239 0.543 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.5 t -137.32 64.41 1.53 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 115.04 -2.664 . . . . 0.0 110.132 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' C ' ' N ' ' A' ' 53' ' ' HIS . 9.1 tt0 -57.48 164.76 1.78 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 115.668 -2.413 . . . . 0.0 109.311 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.22 -12.74 8.48 Favored Glycine 0 CA--C 1.529 0.959 1 C-N-CA 113.853 -4.022 . . . . 0.0 111.448 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.422 ' N ' ' C ' ' A' ' 51' ' ' GLU . 21.1 t-160 -172.3 94.48 0.39 Allowed Pre-proline 0 CA--C 1.577 1.989 0 C-N-CA 116.323 -2.151 . . . . 0.0 109.403 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -97.34 -37.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.481 0.765 0 O-C-N 123.422 1.222 . . . . 0.0 110.668 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 79.7 m -98.54 154.75 17.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 115.235 -2.586 . . . . 0.0 108.755 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.503 ' CD1' HD21 ' A' ' 80' ' ' ASN . 58.0 mt -73.84 176.93 5.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 115.483 -2.487 . . . . 0.0 111.662 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 56' ' ' LEU . 3.6 p30 46.2 53.44 9.39 Favored 'General case' 0 C--O 1.269 2.081 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.781 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 1.282 ' NE2' HE21 ' A' ' 58' ' ' GLN . 47.1 mt-30 50.94 25.07 2.05 Favored 'General case' 0 N--CA 1.396 -3.166 0 C-N-CA 116.981 -1.888 . . . . 0.0 110.26 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.09 130.44 38.69 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 115.666 -3.159 . . . . 0.0 108.252 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -80.03 174.64 11.39 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.348 -174.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 19.4 p -139.96 116.55 10.78 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 114.407 -2.917 . . . . 0.0 108.435 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -90.38 119.72 30.91 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 115.406 -2.518 . . . . 0.0 107.338 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.3 157.56 27.69 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 116.524 -2.07 . . . . 0.0 110.02 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.16 -87.11 0.07 OUTLIER Glycine 0 C--O 1.198 -2.114 0 C-N-CA 114.23 -3.843 . . . . 0.0 108.226 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CG2' ' H ' ' A' ' 66' ' ' GLY . 50.4 mt -71.04 -176.42 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.263 1.778 0 C-N-CA 116.533 -2.067 . . . . 0.0 110.231 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' H ' ' CG2' ' A' ' 65' ' ' ILE . . . -58.65 -13.19 16.59 Favored Glycine 0 N--CA 1.486 2.002 0 C-N-CA 116.407 -2.806 . . . . 0.0 109.878 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.6 p-10 -120.62 144.88 47.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 115.931 -2.308 . . . . 0.0 106.118 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.418 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 21.1 p90 -84.91 -161.3 0.56 Allowed 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 115.858 -2.337 . . . . 0.0 108.94 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -140.14 136.94 34.02 Favored 'General case' 0 C--O 1.204 -1.314 0 C-N-CA 116.34 -2.144 . . . . 0.0 109.098 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.3 m -78.15 137.25 38.08 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 115.283 -2.567 . . . . 0.0 108.611 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.8 m -120.67 115.22 22.92 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 116.774 -1.97 . . . . 0.0 107.754 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.2 m -84.52 139.72 31.95 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 114.886 -2.726 . . . . 0.0 110.014 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.9 168.89 5.76 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.367 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.08 120.0 6.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.166 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 98.44 23.45 12.48 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 115.016 -3.469 . . . . 0.0 111.617 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 83.8 m-85 -146.37 149.71 34.29 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 115.412 -2.515 . . . . 0.0 110.554 172.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.252 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -155.84 -146.72 0.18 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 115.314 -2.554 . . . . 0.0 109.657 173.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.847 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 86.68 168.43 44.82 Favored Glycine 1 N--CA 1.52 4.263 0 C-N-CA 114.739 -3.6 . . . . 0.0 109.165 177.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -54.7 -37.25 65.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 116.254 -2.179 . . . . 0.0 109.008 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.503 HD21 ' CD1' ' A' ' 56' ' ' LEU . 75.1 m-20 -102.19 29.93 4.82 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 116.105 -2.238 . . . . 0.0 111.676 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 73.6 m 50.84 25.01 1.97 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 115.232 -2.587 . . . . 0.0 106.786 -163.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.815 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.2 tp10 -55.22 -55.03 35.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.455 -1.698 . . . . 0.0 113.022 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 1.252 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -90.1 139.1 30.95 Favored 'General case' 0 N--CA 1.387 -3.582 0 C-N-CA 113.445 -3.302 . . . . 0.0 112.098 -148.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 22.8 t -86.15 58.47 5.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 115.992 -2.283 . . . . 0.0 110.734 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.2 p 37.14 28.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 116.051 -2.26 . . . . 0.0 112.051 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' N ' ' C ' ' A' ' 84' ' ' SER . 71.4 mtp85 . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 115.941 -1.98 . . . . 0.0 108.762 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.13 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 74.2 m -117.32 -0.66 11.95 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.425 -2.11 . . . . 0.0 108.98 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 115.059 -2.657 . . . . 0.0 109.85 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -95.55 18.13 57.98 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 114.903 -3.522 . . . . 0.0 111.01 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' GLY . 16.4 t-160 44.48 84.2 0.19 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 116.239 -2.185 . . . . 0.0 110.161 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -97.13 -38.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 O-C-N 123.667 1.351 . . . . 0.0 111.096 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 61.2 m -96.42 151.02 19.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 115.677 -2.409 . . . . 0.0 110.423 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.462 ' CD1' HD21 ' A' ' 80' ' ' ASN . 86.2 mt -103.78 176.39 5.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 116.128 -2.229 . . . . 0.0 110.034 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 56.75 47.77 17.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 117.218 -1.793 . . . . 0.0 111.755 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 1.415 ' NE2' HE21 ' A' ' 58' ' ' GLN . 43.5 tt0 49.52 35.12 7.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.174 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.75 -161.39 4.88 Favored Glycine 0 C--N 1.363 2.05 0 C-N-CA 114.051 -3.928 . . . . 0.0 110.468 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 9.0 t-160 -135.68 175.03 9.97 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 115.208 -2.597 . . . . 0.0 109.697 -176.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.13 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 14.3 p -153.13 138.14 17.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 114.374 -2.93 . . . . 0.0 108.702 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -115.82 133.28 56.19 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 116.124 -2.23 . . . . 0.0 109.237 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.14 159.3 29.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 116.083 -2.247 . . . . 0.0 108.607 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 66' ' ' GLY . . . -152.21 38.29 0.79 Allowed Glycine 0 N--CA 1.504 3.178 0 C-N-CA 114.471 -3.728 . . . . 0.0 110.367 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 65' ' ' ILE . 81.4 mt 36.27 36.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 116.784 -1.966 . . . . 0.0 110.037 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 162.22 85.62 0.06 OUTLIER Glycine 0 C--N 1.288 -2.101 0 C-N-CA 115.471 -3.252 . . . . 0.0 109.825 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.2 m-20 67.57 116.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 116.656 -2.017 . . . . 0.0 109.007 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.492 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 24.6 p90 -76.7 -169.9 1.4 Allowed 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.278 -2.569 . . . . 0.0 108.363 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 p -139.43 132.8 30.07 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 115.789 -2.364 . . . . 0.0 108.831 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 61.4 m -81.68 128.46 33.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.38 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 88.8 m -108.04 109.65 21.15 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 114.739 -2.785 . . . . 0.0 108.435 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.14 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.9 m -86.46 143.41 27.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 115.57 -2.452 . . . . 0.0 109.648 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.71 171.44 13.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 116.935 -1.906 . . . . 0.0 109.711 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -52.4 126.88 20.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 115.705 -2.398 . . . . 0.0 110.039 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.6 19.46 44.48 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.769 -3.586 . . . . 0.0 110.235 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 99.9 m-85 -140.49 145.99 37.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.287 -2.565 . . . . 0.0 108.538 165.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 46.2 mm-40 -146.31 -166.97 2.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 116.086 -2.245 . . . . 0.0 109.083 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.54 168.27 35.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 114.296 -3.811 . . . . 0.0 109.261 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -68.54 -37.09 79.68 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 114.58 -2.848 . . . . 0.0 109.904 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 39.9 m-20 -80.72 -16.01 55.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.16 -1.816 . . . . 0.0 111.762 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.14 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.2 m 77.98 18.67 1.16 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.16 -2.616 . . . . 0.0 107.331 -162.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.74 -31.16 69.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 117.498 -1.681 . . . . 0.0 110.211 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 49.5 m-85 -78.82 160.71 27.23 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 115.362 -2.535 . . . . 0.0 110.502 -176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.569 ' C ' ' N ' ' A' ' 86' ' ' ARG . 19.2 t -123.58 38.08 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 115.564 -2.455 . . . . 0.0 108.221 170.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p 40.03 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.324 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.569 ' N ' ' C ' ' A' ' 84' ' ' SER . 78.0 ttt-85 . . . . . 0 C--N 1.308 -1.231 0 C-N-CA 115.936 -2.306 . . . . 0.0 110.202 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.4 t -127.19 -22.8 3.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 114.906 -2.718 . . . . 0.0 111.532 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.3 -17.41 64.77 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 114.311 -2.956 . . . . 0.0 110.122 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -88.88 36.36 3.48 Favored Glycine 0 C--O 1.259 1.657 0 C-N-CA 115.872 -3.061 . . . . 0.0 110.993 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.72 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.7 m-70 13.98 88.47 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 117.843 -1.543 . . . . 0.0 110.678 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -89.98 -42.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.974 1.782 . . . . 0.0 109.746 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 38.7 m -81.97 113.42 19.86 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 116.12 -2.232 . . . . 0.0 110.969 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.461 ' CD1' HD21 ' A' ' 80' ' ' ASN . 81.2 mt -74.82 175.93 7.55 Favored 'General case' 0 CA--C 1.58 2.126 0 C-N-CA 115.023 -2.671 . . . . 0.0 110.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 62.11 50.44 4.0 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 117.146 -1.821 . . . . 0.0 109.972 168.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 53.39 27.79 6.74 Favored 'General case' 0 C--O 1.281 2.711 0 C-N-CA 116.7 -2.0 . . . . 0.0 111.389 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.18 -150.46 3.86 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 114.081 -3.914 . . . . 0.0 110.44 175.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -141.07 135.13 30.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 114.606 -2.838 . . . . 0.0 108.308 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.7 p -113.93 128.11 56.26 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 116.051 -2.26 . . . . 0.0 110.032 176.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -97.78 -165.24 1.23 Allowed 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.599 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -151.81 138.03 18.37 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 115.945 -2.302 . . . . 0.0 109.26 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.29 -95.96 0.1 Allowed Glycine 0 C--O 1.247 0.959 0 C-N-CA 114.49 -3.719 . . . . 0.0 109.766 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 66' ' ' GLY . 71.6 mt -62.82 177.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 116.007 -2.277 . . . . 0.0 110.833 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.524 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.32 -18.76 5.22 Favored Glycine 0 CA--C 1.549 2.205 0 C-N-CA 114.772 -3.585 . . . . 0.0 111.067 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' C ' ' A' ' 65' ' ' ILE . 3.3 p-10 -112.81 146.56 38.64 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 116.005 -2.278 . . . . 0.0 108.014 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.539 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -83.89 -166.03 1.3 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 116.762 -1.975 . . . . 0.0 108.604 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.87 136.15 36.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 114.985 -2.686 . . . . 0.0 108.542 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 8.6 m -95.88 155.33 16.8 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 114.676 -2.81 . . . . 0.0 110.937 -174.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -135.49 131.04 35.61 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 115.506 -2.478 . . . . 0.0 109.0 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.6 m -107.51 142.45 37.37 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 114.697 -2.801 . . . . 0.0 108.503 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.87 172.71 10.36 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 116.233 -2.187 . . . . 0.0 109.319 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -55.85 146.21 22.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.863 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.743 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.23 8.73 87.62 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 114.487 -3.721 . . . . 0.0 110.994 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 92.4 m-85 -136.82 140.74 42.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 114.506 -2.878 . . . . 0.0 109.998 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -147.08 -166.75 2.59 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 116.197 -2.201 . . . . 0.0 107.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.56 167.06 38.06 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 114.383 -3.77 . . . . 0.0 109.501 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -67.8 -34.44 76.75 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 116.375 -2.13 . . . . 0.0 108.391 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.59 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.4 m-20 -89.71 -4.74 57.57 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 116.35 -2.14 . . . . 0.0 111.933 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.8 m 71.66 17.48 5.53 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 114.484 -2.886 . . . . 0.0 107.452 -166.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.28 -31.12 68.82 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 118.021 -1.472 . . . . 0.0 109.406 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -79.74 165.01 23.24 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 115.517 -2.473 . . . . 0.0 111.296 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.5 t -127.29 38.67 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.53 -2.468 . . . . 0.0 107.898 173.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 84' ' ' SER . 24.6 p 46.1 22.95 0.16 Allowed 'General case' 0 N--CA 1.511 2.588 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.836 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' N ' ' C ' ' A' ' 84' ' ' SER . 8.8 mmm180 . . . . . 0 N--CA 1.514 2.732 0 CA-C-O 115.702 -2.094 . . . . 0.0 108.135 176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.439 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 85.9 mm-40 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 122.552 1.168 . . . . 0.0 111.732 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 50.1 t -112.53 54.97 0.7 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 115.101 -2.639 . . . . 0.0 109.513 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' CYS . 16.9 tt0 -40.61 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 115.669 -2.412 . . . . 0.0 111.204 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.6 -14.01 8.77 Favored Glycine 0 CA--C 1.559 2.832 0 C-N-CA 114.488 -3.72 . . . . 0.0 112.115 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -174.26 93.03 0.32 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 115.191 -2.604 . . . . 0.0 109.888 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -99.74 -41.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.823 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.213 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -81.72 169.39 17.01 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 115.926 -2.31 . . . . 0.0 109.122 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.44 ' CD1' HD21 ' A' ' 80' ' ' ASN . 73.8 mt -98.91 176.88 5.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 115.181 -2.608 . . . . 0.0 109.784 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 56.52 44.13 24.67 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.029 -1.869 . . . . 0.0 110.356 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 50.49 29.29 3.87 Favored 'General case' 0 N--CA 1.385 -3.693 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.14 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.45 -166.99 7.9 Favored Glycine 0 N--CA 1.475 1.277 1 C-N-CA 113.099 -4.382 . . . . 0.0 111.48 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -120.13 166.08 13.9 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 116.179 -2.208 . . . . 0.0 110.089 -173.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 20.2 p -144.87 130.12 18.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 115.355 -2.538 . . . . 0.0 108.576 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -103.29 -132.75 0.3 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 115.241 -2.584 . . . . 0.0 108.188 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -144.84 156.04 43.81 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 115.227 -2.589 . . . . 0.0 110.19 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.37 141.47 4.81 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 114.849 -3.548 . . . . 0.0 108.804 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 67' ' ' ASP . 11.1 mt -59.65 137.19 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 113.047 -3.461 . . . . 0.0 110.769 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.99 -38.32 2.97 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 115.176 -3.392 . . . . 0.0 110.236 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.9 147.23 5.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 116.124 -2.23 . . . . 0.0 108.997 -174.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.458 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.7 p90 -86.13 -166.59 1.58 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 116.237 -2.185 . . . . 0.0 108.001 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -134.36 142.67 47.28 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 114.297 -2.961 . . . . 0.0 108.936 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.213 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 97.3 m -90.64 145.86 24.5 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 115.182 -2.607 . . . . 0.0 110.05 -176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.1 m -126.8 116.83 21.49 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 116.15 -2.22 . . . . 0.0 107.848 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.158 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.3 m -90.05 143.88 26.39 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 116.049 -2.26 . . . . 0.0 109.745 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.48 171.57 12.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 116.313 -2.155 . . . . 0.0 110.468 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.82 137.96 43.71 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.179 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.15 16.28 69.91 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 115.447 -3.263 . . . . 0.0 111.121 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.8 m-85 -144.2 145.07 31.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.807 -2.357 . . . . 0.0 108.878 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 5.0 mt-10 -147.63 -178.95 6.53 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.488 -2.085 . . . . 0.0 109.555 -176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.7 174.66 39.88 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 114.859 -3.543 . . . . 0.0 109.762 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.34 -48.33 56.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 115.577 -2.449 . . . . 0.0 109.725 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 37.7 m-20 -82.08 -5.0 58.07 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 116.741 -1.984 . . . . 0.0 110.622 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.158 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 74.25 27.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 115.159 -2.617 . . . . 0.0 108.922 -165.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.9 -22.59 65.7 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 117.38 -1.728 . . . . 0.0 110.076 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -85.04 165.26 17.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 114.82 -2.752 . . . . 0.0 109.177 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.8 t -128.49 35.81 4.34 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 115.713 -2.395 . . . . 0.0 107.695 169.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.557 ' OG1' ' O ' ' A' ' 84' ' ' SER . 20.7 p 44.29 16.15 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 117.439 -1.704 . . . . 0.0 111.39 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 84' ' ' SER . 15.6 ptm180 . . . . . 0 C--O 1.196 -1.76 0 C-N-CA 114.938 -2.705 . . . . 0.0 108.949 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 2.3 mp0 . . . . . 0 CA--C 1.575 1.908 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 49' ' ' GLN . 59.1 m -163.87 14.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 116.191 -2.204 . . . . 0.0 109.47 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -78.67 -14.09 59.48 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 114.965 -2.694 . . . . 0.0 108.437 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -117.04 26.0 8.53 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 114.986 -3.483 . . . . 0.0 110.327 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' GLY . 13.2 t-160 39.65 91.5 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 116.066 -2.254 . . . . 0.0 110.788 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -91.68 -31.95 0.09 OUTLIER 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 121.339 1.36 . . . . 0.0 109.878 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 60' ' ' HIS . 15.7 m -75.83 124.38 27.22 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.696 -2.401 . . . . 0.0 110.598 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.508 ' CD1' HD21 ' A' ' 80' ' ' ASN . 46.9 mt -77.07 176.44 8.68 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 116.476 -2.09 . . . . 0.0 109.404 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 63.36 40.33 8.6 Favored 'General case' 0 C--O 1.29 3.202 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.895 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 46.5 35.88 3.19 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 115.266 -2.574 . . . . 0.0 110.35 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.11 -134.82 0.05 OUTLIER Glycine 0 CA--C 1.563 3.042 1 C-N-CA 113.141 -4.361 . . . . 0.0 110.2 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.424 ' O ' ' SG ' ' A' ' 55' ' ' CYS . 2.0 t-160 -159.17 -175.46 5.27 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 114.64 -2.824 . . . . 0.0 109.003 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.5 t -155.46 128.94 8.39 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 114.429 -2.908 . . . . 0.0 108.36 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -89.43 -20.97 23.28 Favored 'General case' 0 C--O 1.256 1.418 0 C-N-CA 114.629 -2.828 . . . . 0.0 110.301 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 63.22 146.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 117.59 -1.644 . . . . 0.0 110.443 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 -100.91 0.14 Allowed Glycine 0 C--O 1.211 -1.282 0 C-N-CA 114.81 -3.567 . . . . 0.0 109.417 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.428 ' C ' ' N ' ' A' ' 67' ' ' ASP . 4.6 mm -69.4 178.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 116.081 -2.248 . . . . 0.0 110.713 172.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' ' CG2' ' A' ' 65' ' ' ILE . . . -49.92 -23.39 5.3 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 115.561 -3.209 . . . . 0.0 110.192 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.428 ' N ' ' C ' ' A' ' 65' ' ' ILE . 6.0 m-20 -98.27 132.05 44.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 116.569 -2.052 . . . . 0.0 108.669 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 17.9 p90 -90.65 -173.81 3.87 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 115.256 -2.578 . . . . 0.0 109.941 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 p -123.95 133.79 53.63 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 115.95 -2.3 . . . . 0.0 108.942 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.83 128.96 49.37 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 115.584 -2.446 . . . . 0.0 109.614 -171.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.9 m -99.26 170.03 8.95 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 115.441 -2.504 . . . . 0.0 106.636 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.0 m -122.09 -45.05 2.26 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 114.276 -2.97 . . . . 0.0 110.897 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 72' ' ' CYS . . . 115.88 162.28 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.99 119.35 5.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 115.58 -2.448 . . . . 0.0 110.943 -175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.2 29.94 32.36 Favored Glycine 0 N--CA 1.504 3.218 0 C-N-CA 114.156 -3.878 . . . . 0.0 111.839 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.665 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 88.5 m-85 -142.96 152.1 41.63 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 114.088 -3.045 . . . . 0.0 108.943 170.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 6.5 mt-10 -153.32 -176.68 5.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 115.336 -2.546 . . . . 0.0 108.442 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.74 176.32 28.27 Favored Glycine 0 C--N 1.361 1.919 0 C-N-CA 114.315 -3.802 . . . . 0.0 110.568 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -58.01 -63.18 1.35 Allowed 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 116.463 -2.095 . . . . 0.0 110.568 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.825 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 22.9 m-20 -78.85 -21.0 48.23 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 116.15 -2.22 . . . . 0.0 110.713 177.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 19.5 m 94.1 26.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 116.647 -2.021 . . . . 0.0 107.671 -168.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.76 -19.91 65.34 Favored 'General case' 0 CA--C 1.6 2.897 0 C-N-CA 117.078 -1.849 . . . . 0.0 109.274 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 27.5 m-85 -78.14 176.2 9.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.764 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.721 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 80.5 p -133.97 28.4 3.84 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 116.12 -2.232 . . . . 0.0 108.278 172.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 84' ' ' SER . 41.0 p 47.54 5.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 117.54 -1.664 . . . . 0.0 111.148 -172.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.709 ' H ' ' C ' ' A' ' 84' ' ' SER . 16.1 tpt180 . . . . . 0 CA--C 1.572 1.815 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.83 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 1.429 ' NE2' HE21 ' A' ' 49' ' ' GLN . 8.8 mp0 . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.0 m -145.23 -22.75 0.49 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 115.416 -2.514 . . . . 0.0 109.563 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -78.58 -15.67 58.28 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 116.349 -2.14 . . . . 0.0 108.748 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -87.8 13.37 61.11 Favored Glycine 0 C--O 1.215 -1.057 0 C-N-CA 114.817 -3.563 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.6 t-160 44.3 82.18 0.24 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 116.485 -2.086 . . . . 0.0 110.018 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -95.69 -42.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.029 1.153 . . . . 0.0 110.606 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.175 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 72.4 m -77.74 160.42 28.42 Favored 'General case' 0 C--O 1.253 1.258 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.713 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.438 ' CD1' HD21 ' A' ' 80' ' ' ASN . 82.7 mt -101.99 175.86 5.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 116.038 -2.265 . . . . 0.0 110.989 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 55.43 38.9 30.94 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 117.458 -1.697 . . . . 0.0 110.319 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 56.79 25.95 10.91 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.827 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.16 136.6 32.63 Favored Glycine 0 N--CA 1.424 -2.16 0 C-N-CA 114.723 -3.608 . . . . 0.0 108.864 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -78.47 179.37 7.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.725 -2.237 . . . . 0.0 108.725 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 11.1 p -154.61 137.49 15.39 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.661 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -102.35 128.32 48.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 115.76 -2.376 . . . . 0.0 108.855 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.4 149.39 42.52 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 115.681 -2.407 . . . . 0.0 109.878 -173.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.55 161.99 35.79 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 115.469 -3.253 . . . . 0.0 108.356 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.74 144.0 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 116.195 -2.202 . . . . 0.0 109.16 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 68.8 69.56 1.36 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 114.728 -3.606 . . . . 0.0 111.802 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 32.4 m-20 68.08 153.51 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.95 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -82.75 -164.47 0.86 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 118.045 -1.462 . . . . 0.0 107.239 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 17.6 p -135.16 152.11 51.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 116.218 -2.193 . . . . 0.0 108.797 171.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.175 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.0 m -96.22 154.03 17.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 115.738 -2.385 . . . . 0.0 110.802 -174.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.2 m -142.24 113.73 7.81 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 115.27 -2.572 . . . . 0.0 108.147 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.127 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 22.2 m -89.67 140.63 29.38 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 115.141 -2.624 . . . . 0.0 108.846 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.2 169.72 15.55 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.583 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 127.76 28.42 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 116.259 -2.177 . . . . 0.0 110.196 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.17 18.59 49.44 Favored Glycine 0 N--CA 1.48 1.57 1 C-N-CA 113.714 -4.089 . . . . 0.0 111.209 -178.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.65 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 92.9 m-85 -140.63 142.15 35.03 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 115.298 -2.561 . . . . 0.0 111.322 161.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.374 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -143.2 -145.86 0.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.341 -2.544 . . . . 0.0 109.719 169.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.994 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 82.13 164.25 33.87 Favored Glycine 1 N--CA 1.519 4.207 0 C-N-CA 114.229 -3.844 . . . . 0.0 107.067 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.08 -50.74 70.18 Favored 'General case' 0 N--CA 1.511 2.625 0 C-N-CA 115.063 -2.655 . . . . 0.0 110.869 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.571 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 29.3 m-20 -90.13 29.04 1.28 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.408 -1.717 . . . . 0.0 110.348 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.127 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 47.8 m 57.07 20.78 5.76 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 113.943 -3.103 . . . . 0.0 106.678 -164.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 80' ' ' ASN . 9.3 tp10 -49.08 -52.47 25.56 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 117.528 -1.669 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 1.374 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.93 174.85 6.96 Favored 'General case' 1 N--CA 1.365 -4.683 0 C-N-CA 112.977 -3.489 . . . . 0.0 109.311 -165.768 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.957 ' O ' HG21 ' A' ' 85' ' ' THR . 22.9 p -88.69 -68.67 0.75 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.004 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.957 HG21 ' O ' ' A' ' 84' ' ' SER . 0.9 OUTLIER -178.29 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 CA--C 1.553 1.07 0 CA-C-O 113.404 -3.188 . . . . 0.0 108.399 -179.848 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 . . . . . 0 CA--C 1.566 1.582 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.3 t -122.98 -3.98 8.57 Favored 'General case' 0 C--O 1.256 1.426 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.733 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.2 -21.98 58.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 114.395 -2.922 . . . . 0.0 109.458 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.07 7.6 81.79 Favored Glycine 0 CA--C 1.558 2.732 0 C-N-CA 114.242 -3.837 . . . . 0.0 112.019 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.52 86.13 0.16 Allowed Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 116.478 -2.089 . . . . 0.0 110.187 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -97.95 -46.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 109.88 -0.854 . . . . 0.0 109.88 -171.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.141 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -75.28 165.07 25.76 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.446 -170.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.478 ' CD1' HD21 ' A' ' 80' ' ' ASN . 58.7 mt -103.32 174.83 5.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 116.645 -2.022 . . . . 0.0 111.293 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 51.02 52.4 15.08 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.206 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 53.29 26.36 5.16 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 117.999 -1.48 . . . . 0.0 110.571 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.73 127.41 25.48 Favored Glycine 0 N--CA 1.465 0.602 0 C-N-CA 115.087 -3.435 . . . . 0.0 110.514 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -81.32 102.64 10.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.005 -2.098 . . . . 0.0 109.817 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 p -78.71 123.3 27.02 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 115.955 -2.298 . . . . 0.0 109.909 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -92.73 152.84 19.27 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 114.92 -2.712 . . . . 0.0 108.302 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -83.45 141.76 31.46 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 115.721 -2.391 . . . . 0.0 110.782 -170.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.68 161.31 28.79 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 115.166 -3.397 . . . . 0.0 108.903 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 67' ' ' ASP . 8.6 mt -66.7 138.5 22.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 114.982 -2.687 . . . . 0.0 109.327 -172.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.72 -37.74 1.89 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.57 -3.681 . . . . 0.0 112.135 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 65' ' ' ILE . 21.9 m-20 -162.84 139.19 7.35 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 116.53 -2.068 . . . . 0.0 109.484 -169.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 27.0 p90 -78.56 -164.71 0.6 Allowed 'General case' 0 C--O 1.259 1.557 0 C-N-CA 116.153 -2.219 . . . . 0.0 108.458 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 p -137.16 140.5 41.87 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 115.399 -2.52 . . . . 0.0 109.35 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.141 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 99.5 m -85.67 128.47 34.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.717 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -117.35 108.75 15.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 114.608 -2.837 . . . . 0.0 107.786 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.122 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 11.6 m -80.98 140.39 35.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 115.067 -2.653 . . . . 0.0 108.994 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 74' ' ' GLU . . . -74.5 159.67 31.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 73' ' ' ALA . 41.7 tt0 -47.07 116.58 1.42 Allowed 'General case' 0 C--O 1.258 1.514 0 C-N-CA 115.671 -2.412 . . . . 0.0 111.012 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 113.05 7.05 21.96 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 114.418 -3.753 . . . . 0.0 110.724 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.6 m-85 -139.01 152.52 47.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 C-N-CA 116.257 -2.177 . . . . 0.0 108.617 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.464 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.1 pt-20 -154.73 -151.95 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 115.9 -2.32 . . . . 0.0 109.234 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.838 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 91.76 174.28 42.78 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 115.13 -3.414 . . . . 0.0 108.754 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -61.57 -38.22 86.7 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 115.703 -2.399 . . . . 0.0 110.52 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 10.8 m-20 -102.47 26.23 8.11 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 117.513 -1.675 . . . . 0.0 111.175 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.122 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 55.5 m 57.24 30.19 18.0 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 114.17 -3.012 . . . . 0.0 107.905 -165.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.3 tp10 -63.84 -50.4 69.01 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 116.86 -1.936 . . . . 0.0 112.405 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 1.464 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.51 135.5 35.88 Favored 'General case' 0 N--CA 1.382 -3.832 0 C-N-CA 113.477 -3.289 . . . . 0.0 110.728 -149.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 36.2 p -76.12 94.82 3.54 Favored 'General case' 0 C--O 1.251 1.159 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.878 -177.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.612 ' HB ' ' CD ' ' A' ' 77' ' ' GLU . 1.1 t -73.09 -25.78 61.01 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 115.869 -2.333 . . . . 0.0 109.47 -177.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 . . . . . 0 C--O 1.202 -1.395 0 C-N-CA 115.543 -2.463 . . . . 0.0 110.847 177.665 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.501 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 89.9 mm-40 . . . . . 0 CA--C 1.559 1.311 0 CA-C-O 121.034 0.445 . . . . 0.0 111.885 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 46.2 t -116.16 4.76 13.64 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.473 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -73.26 143.91 46.87 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 116.109 -2.236 . . . . 0.0 109.423 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.68 75.67 Favored Glycine 0 CA--C 1.541 1.716 0 C-N-CA 114.072 -3.918 . . . . 0.0 111.266 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.1 t60 48.08 90.74 0.07 OUTLIER Pre-proline 0 C--N 1.36 1.045 0 C-N-CA 115.65 -2.42 . . . . 0.0 109.179 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -93.32 -35.31 0.04 OUTLIER 'Trans proline' 0 C--O 1.249 1.047 0 C-N-CA 121.116 1.21 . . . . 0.0 110.228 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.111 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 88.7 m -81.76 146.94 29.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 114.883 -2.727 . . . . 0.0 109.19 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.56 ' CD1' HD21 ' A' ' 80' ' ' ASN . 74.2 mt -96.96 175.26 6.4 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 116.147 -2.221 . . . . 0.0 109.553 -174.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 57.46 46.81 17.41 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.085 -1.871 . . . . 0.0 107.02 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 50.69 33.48 8.35 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.871 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.66 -168.72 5.26 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 113.976 -3.964 . . . . 0.0 109.839 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -130.7 120.26 23.61 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.311 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.3 p -104.9 117.35 33.81 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 115.175 -2.61 . . . . 0.0 109.036 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -98.82 148.71 23.63 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 116.0 -2.28 . . . . 0.0 107.304 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.03 149.55 21.14 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 115.419 -2.512 . . . . 0.0 108.587 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.67 0.1 OUTLIER Glycine 0 C--O 1.255 1.458 0 C-N-CA 114.947 -3.501 . . . . 0.0 109.671 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.659 ' CG2' ' H ' ' A' ' 66' ' ' GLY . 5.6 mm -70.32 -173.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.288 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.659 ' H ' ' CG2' ' A' ' 65' ' ' ILE . . . -62.79 -4.95 7.89 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 114.244 -3.836 . . . . 0.0 110.774 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.3 p30 -123.67 146.91 47.87 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.787 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.0 p90 -84.76 -164.5 0.98 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 115.306 -2.558 . . . . 0.0 107.82 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.6 135.35 40.19 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.362 171.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.111 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 57.0 m -86.65 140.08 30.17 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 115.594 -2.442 . . . . 0.0 107.931 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -122.5 110.79 16.02 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 115.963 -2.295 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 1.129 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 6.9 m -83.08 140.53 32.61 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 115.464 -2.495 . . . . 0.0 109.432 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.66 164.23 22.03 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 115.416 -2.514 . . . . 0.0 110.191 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -50.62 109.85 0.35 Allowed 'General case' 0 C--O 1.215 -0.741 0 C-N-CA 115.277 -2.569 . . . . 0.0 109.519 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 115.88 15.13 7.5 Favored Glycine 0 CA--C 1.551 2.323 0 C-N-CA 114.984 -3.484 . . . . 0.0 112.299 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.0 m-85 -146.0 153.77 41.13 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 115.143 -2.623 . . . . 0.0 109.015 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.573 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.6 pt-20 -157.15 -145.52 0.15 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 114.593 -2.843 . . . . 0.0 107.846 177.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.896 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 84.49 176.09 50.93 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 115.089 -3.434 . . . . 0.0 108.085 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.38 -36.68 71.55 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 115.342 -2.543 . . . . 0.0 111.115 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.674 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 55.2 m-20 -107.56 21.61 17.2 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.436 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 1.129 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 62.3 m 62.02 24.52 14.61 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 114.963 -2.695 . . . . 0.0 107.278 -160.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.736 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.8 tp10 -58.7 -53.76 54.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 116.115 -2.234 . . . . 0.0 112.197 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 1.573 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.44 129.85 41.04 Favored 'General case' 0 N--CA 1.394 -3.236 0 C-N-CA 111.82 -3.952 . . . . 0.0 111.97 -149.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 20.4 p -74.29 102.5 4.37 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 115.507 -2.477 . . . . 0.0 109.664 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.454 HG22 ' CD ' ' A' ' 77' ' ' GLU . 76.2 p -44.64 -43.11 8.01 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 114.888 -2.725 . . . . 0.0 110.877 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 . . . . . 0 N--CA 1.433 -1.301 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.027 -176.44 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 C--O 1.238 0.47 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 1.13 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 15.0 p -154.69 23.07 0.46 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 115.918 -2.313 . . . . 0.0 110.064 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.22 -14.52 61.36 Favored 'General case' 0 C--O 1.197 -1.674 0 C-N-CA 115.697 -2.401 . . . . 0.0 110.351 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.62 20.19 36.37 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 114.734 -3.603 . . . . 0.0 110.853 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 49.84 83.12 0.23 Allowed Pre-proline 0 C--O 1.254 1.34 0 C-N-CA 116.639 -2.024 . . . . 0.0 109.944 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -88.95 -37.53 0.06 OUTLIER 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 121.434 1.423 . . . . 0.0 110.666 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.074 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 56.6 m -72.94 127.19 31.83 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 115.108 -2.637 . . . . 0.0 110.43 -176.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 80' ' ' ASN . 82.2 mt -83.32 175.04 10.18 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 116.137 -2.225 . . . . 0.0 109.873 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.43 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 60.9 m-80 64.94 50.81 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.986 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 51.28 22.85 1.48 Allowed 'General case' 0 C--O 1.253 1.241 0 C-N-CA 115.518 -2.473 . . . . 0.0 113.374 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.95 -142.65 0.38 Allowed Glycine 0 N--CA 1.499 2.85 1 C-N-CA 113.677 -4.106 . . . . 0.0 110.05 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -153.13 164.42 38.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 114.974 -2.69 . . . . 0.0 109.005 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.13 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 25.0 p -141.11 150.33 42.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 114.842 -2.743 . . . . 0.0 109.747 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -138.27 134.76 34.75 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 108.295 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.06 151.98 33.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 116.022 -2.271 . . . . 0.0 111.578 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -142.44 -176.28 16.44 Favored Glycine 0 CA--C 1.544 1.901 1 C-N-CA 113.743 -4.075 . . . . 0.0 109.216 178.106 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 65' ' ' ILE . 48.5 mt -84.93 29.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.278 -1.769 . . . . 0.0 109.297 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . 165.09 86.88 0.06 OUTLIER Glycine 0 C--N 1.262 -3.542 0 C-N-CA 115.417 -3.278 . . . . 0.0 109.849 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 73.13 134.62 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 116.174 -2.21 . . . . 0.0 109.306 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.453 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -77.89 -170.86 2.05 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 117.844 -1.542 . . . . 0.0 108.62 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -130.77 136.53 48.81 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 116.607 -2.037 . . . . 0.0 109.659 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 1.074 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -103.47 129.31 50.59 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 113.448 -3.301 . . . . 0.0 110.238 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 m -104.28 173.11 6.44 Favored 'General case' 0 C--O 1.25 1.105 0 C-N-CA 115.814 -2.355 . . . . 0.0 107.844 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.835 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 47.8 m -123.56 -48.96 1.91 Allowed 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 115.997 -2.281 . . . . 0.0 110.007 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 72' ' ' CYS . . . 119.75 165.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.858 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -57.3 122.21 11.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 115.375 -2.53 . . . . 0.0 111.145 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 76.95 34.91 40.81 Favored Glycine 0 N--CA 1.47 0.956 0 C-N-CA 115.114 -3.422 . . . . 0.0 111.502 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 82.7 m-85 -143.58 150.38 38.75 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.036 167.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 2.4 mt-10 -155.83 178.43 10.27 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 115.721 -2.391 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.1 179.09 21.39 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 114.72 -3.609 . . . . 0.0 110.036 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.86 -61.0 2.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 115.222 -2.591 . . . . 0.0 108.092 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.783 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 16.0 m-20 -78.91 -20.91 48.21 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 116.633 -2.027 . . . . 0.0 111.156 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.783 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 12.5 m 92.18 27.25 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 116.394 -2.123 . . . . 0.0 108.383 -164.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.25 -19.77 56.12 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 116.005 -2.278 . . . . 0.0 110.547 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.499 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 35.4 m-85 -81.16 177.48 9.0 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.825 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.9 m -136.24 39.85 2.68 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.503 166.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 84' ' ' SER . 35.2 p 43.5 30.26 0.32 Allowed 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.964 -1.894 . . . . 0.0 109.932 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 85' ' ' THR . 31.7 tpt180 . . . . . 0 C--N 1.298 -1.657 0 CA-C-O 115.888 -2.006 . . . . 0.0 109.254 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp . . . . . 0 N--CA 1.424 -1.757 0 CA-C-O 113.279 -3.248 . . . . 0.0 115.607 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -114.71 -45.66 2.98 Favored 'General case' 0 C--O 1.268 2.039 2 C-N-CA 111.238 -4.185 . . . . 0.0 110.433 -173.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.29 98.07 0.13 Allowed Glycine 0 CA--C 1.472 -2.606 0 C-N-CA 114.574 -3.679 . . . . 0.0 108.866 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.707 ' C ' ' H ' ' A' ' 50' ' ' CYS . 3.7 p-10 -104.39 -10.76 17.52 Favored 'General case' 0 CA--C 1.581 2.15 0 C-N-CA 114.294 -2.962 . . . . 0.0 109.065 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.396 ' NE2' HE21 ' A' ' 49' ' ' GLN . 52.5 mm-40 46.53 7.05 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.846 175.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 89.2 m -110.74 19.92 18.12 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 114.126 -3.03 . . . . 0.0 107.631 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.64 142.88 44.51 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 115.201 -2.599 . . . . 0.0 110.048 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.714 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 76.04 47.75 10.85 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 115.172 -3.394 . . . . 0.0 110.161 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.714 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.5 m80 9.25 91.99 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 118.161 -1.416 . . . . 0.0 111.616 173.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -91.75 -43.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.627 0.804 . . . . 0.0 110.65 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.205 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 77.2 m -77.76 151.88 33.86 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 115.611 -2.435 . . . . 0.0 110.349 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.55 ' CD1' HD21 ' A' ' 80' ' ' ASN . 74.0 mt -101.67 173.47 6.4 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.596 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 47.69 64.69 1.51 Allowed 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 117.415 -1.714 . . . . 0.0 111.688 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 46.83 26.86 0.62 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.081 -1.448 . . . . 0.0 111.497 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.36 132.49 12.69 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 113.95 -3.976 . . . . 0.0 110.155 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -77.86 167.93 20.73 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.345 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.5 p -147.62 123.61 10.71 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 115.75 -2.38 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.0 -141.6 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 115.345 -2.542 . . . . 0.0 108.611 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -144.47 161.64 38.54 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 115.894 -2.322 . . . . 0.0 109.168 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -166.9 173.5 42.2 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 115.092 -3.433 . . . . 0.0 109.917 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.76 30.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 116.274 -2.17 . . . . 0.0 108.612 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.66 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 176.16 80.7 0.05 OUTLIER Glycine 0 C--N 1.279 -2.612 0 C-N-CA 115.614 -3.184 . . . . 0.0 108.298 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.66 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 42.3 m-20 73.81 137.21 0.05 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 116.527 -2.069 . . . . 0.0 109.355 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -78.25 -165.16 0.63 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 116.501 -2.08 . . . . 0.0 109.491 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -133.68 143.8 48.77 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.975 -2.29 . . . . 0.0 109.67 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.205 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 44.4 m -90.03 144.14 26.16 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 115.647 -2.421 . . . . 0.0 110.001 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.6 m -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 116.789 -1.964 . . . . 0.0 108.246 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 8.2 m -79.44 141.14 37.07 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 115.836 -2.346 . . . . 0.0 109.689 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.85 164.84 18.79 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 115.462 -2.495 . . . . 0.0 109.479 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.88 115.15 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.174 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.63 12.85 13.81 Favored Glycine 0 C--N 1.357 1.722 0 C-N-CA 115.068 -3.444 . . . . 0.0 112.08 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.4 m-85 -141.62 153.52 44.82 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 115.059 -2.656 . . . . 0.0 109.638 174.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.6 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -155.03 -146.31 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 115.379 -2.528 . . . . 0.0 108.914 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.918 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 87.58 168.89 45.04 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 114.285 -3.817 . . . . 0.0 107.917 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -58.32 -29.9 66.27 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 115.14 -2.624 . . . . 0.0 110.213 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.55 HD21 ' CD1' ' A' ' 56' ' ' LEU . 19.9 m-20 -108.64 19.62 19.5 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 116.225 -2.19 . . . . 0.0 111.242 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.096 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 56.0 m 60.11 27.52 16.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 115.102 -2.639 . . . . 0.0 106.945 -162.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.692 ' N ' ' O ' ' A' ' 77' ' ' GLU . 7.7 tt0 -61.61 -47.8 83.8 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 117.595 -1.642 . . . . 0.0 112.643 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 1.6 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -98.75 134.18 42.01 Favored 'General case' 0 N--CA 1.404 -2.771 0 C-N-CA 112.533 -3.667 . . . . 0.0 113.169 -152.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.3 p -79.49 106.03 11.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 115.676 -2.409 . . . . 0.0 109.748 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.452 HG23 ' CD ' ' A' ' 77' ' ' GLU . 69.6 p -46.46 -43.53 16.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 116.269 -2.172 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 . . . . . 0 C--O 1.21 -1.0 0 C-N-CA 115.278 -2.569 . . . . 0.0 110.775 -179.542 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 1 N--CA 1.548 4.464 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -121.01 -27.54 4.94 Favored 'General case' 0 C--O 1.274 2.374 0 C-N-CA 114.492 -2.883 . . . . 0.0 110.962 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.36 105.45 0.19 Allowed Glycine 0 C--O 1.265 2.078 0 C-N-CA 113.955 -3.974 . . . . 0.0 107.54 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -97.15 52.56 1.14 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 116.874 -1.93 . . . . 0.0 112.072 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 14.2 mp0 -84.43 -25.72 28.79 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 115.928 -2.309 . . . . 0.0 109.517 -175.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.9 t -143.22 19.88 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 115.681 -2.408 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -81.88 -1.96 49.5 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 115.758 -2.377 . . . . 0.0 110.912 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.13 18.67 5.53 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 114.446 -3.74 . . . . 0.0 110.882 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.9 t60 51.29 90.33 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.797 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -98.92 -26.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.28 1.32 . . . . 0.0 110.041 -174.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.159 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 65.7 m -78.07 141.31 38.91 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 115.663 -2.415 . . . . 0.0 110.061 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.449 ' HG ' HD21 ' A' ' 80' ' ' ASN . 54.6 mt -88.09 177.42 6.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 117.433 -1.707 . . . . 0.0 110.216 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 81' ' ' CYS . 5.4 p30 43.67 56.88 4.28 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.891 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 57' ' ' ASN . 6.6 tt0 49.73 29.2 3.04 Favored 'General case' 0 N--CA 1.397 -3.097 0 C-N-CA 116.503 -2.079 . . . . 0.0 112.268 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.83 -176.33 16.78 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 114.815 -3.564 . . . . 0.0 111.334 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 61.0 t-80 -109.87 147.14 33.9 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 116.71 -1.996 . . . . 0.0 109.236 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.2 p -128.26 107.84 10.11 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.057 -2.257 . . . . 0.0 108.774 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -91.97 121.76 33.85 Favored 'General case' 0 C--O 1.258 1.502 0 C-N-CA 115.553 -2.459 . . . . 0.0 109.173 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.0 153.14 29.06 Favored 'General case' 0 C--O 1.255 1.37 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.934 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.32 -92.71 0.08 OUTLIER Glycine 0 CA--C 1.547 2.05 0 C-N-CA 116.64 -2.695 . . . . 0.0 109.405 174.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 66' ' ' GLY . 83.9 mt -65.22 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.587 0 C-N-CA 116.836 -1.946 . . . . 0.0 110.462 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.578 ' N ' HG23 ' A' ' 65' ' ' ILE . . . -52.85 -22.31 11.88 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.267 -4.301 . . . . 0.0 111.394 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' N ' ' C ' ' A' ' 65' ' ' ILE . 31.5 m-20 -107.18 135.58 48.46 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 115.965 -2.294 . . . . 0.0 108.991 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 16.4 p90 -77.4 -166.19 0.71 Allowed 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 116.243 -2.183 . . . . 0.0 109.177 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.67 133.99 38.72 Favored 'General case' 0 C--O 1.255 1.36 0 C-N-CA 113.256 -3.378 . . . . 0.0 108.646 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.159 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 7.4 m -90.95 110.97 22.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 115.535 -2.466 . . . . 0.0 108.965 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 98.1 m -96.8 119.32 35.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.832 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 61.6 m -88.28 156.93 18.93 Favored 'General case' 0 C--O 1.276 2.457 0 C-N-CA 114.256 -2.977 . . . . 0.0 109.342 -173.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 176.11 10.0 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 115.236 -2.586 . . . . 0.0 110.392 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.02 134.02 56.62 Favored 'General case' 0 C--O 1.266 1.941 0 C-N-CA 115.954 -2.298 . . . . 0.0 110.047 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.788 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.59 24.67 60.12 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 115.522 -3.228 . . . . 0.0 110.39 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.8 m-85 -141.95 140.94 32.89 Favored 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 115.455 -2.498 . . . . 0.0 108.704 171.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -144.57 -172.42 3.81 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 116.167 -2.213 . . . . 0.0 108.728 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.72 172.56 46.55 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 115.638 -3.172 . . . . 0.0 110.79 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -64.89 -47.0 79.37 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 115.658 -2.417 . . . . 0.0 109.594 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.772 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 13.3 m120 -79.67 -17.26 54.1 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 115.741 -2.384 . . . . 0.0 109.979 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.193 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.7 m 86.48 18.67 0.09 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 115.574 -2.45 . . . . 0.0 107.616 -164.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -55.95 -29.55 60.35 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.003 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 65.5 m-85 -78.92 162.56 25.92 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 115.032 -2.667 . . . . 0.0 110.066 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.788 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 35.7 t -121.85 29.54 7.07 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 115.243 -2.583 . . . . 0.0 107.949 170.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.521 ' OG1' ' O ' ' A' ' 84' ' ' SER . 26.3 p 43.87 19.95 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.153 0 C-N-CA 117.311 -1.755 . . . . 0.0 111.178 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' H ' ' C ' ' A' ' 84' ' ' SER . 45.2 ttt85 . . . . . 0 C--N 1.287 -2.119 0 C-N-CA 116.527 -2.069 . . . . 0.0 111.013 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.5 tttp . . . . . 0 N--CA 1.395 -3.224 0 CA-C-O 124.831 2.253 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -154.03 108.44 3.05 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 110.956 -2.838 . . . . 0.0 110.732 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.46 94.33 0.62 Allowed Glycine 0 C--O 1.206 -1.646 1 C-N-CA 113.306 -4.283 . . . . 0.0 110.393 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -110.64 58.73 0.61 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 114.912 -2.715 . . . . 0.0 107.779 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.573 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -71.46 -36.2 71.13 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 115.033 -2.667 . . . . 0.0 109.645 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -109.94 -14.33 14.28 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 114.846 -2.742 . . . . 0.0 109.967 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -74.96 144.72 43.06 Favored 'General case' 0 C--O 1.268 2.057 0 C-N-CA 114.945 -2.702 . . . . 0.0 108.965 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.762 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 87.28 43.13 5.99 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 114.666 -3.635 . . . . 0.0 110.495 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.762 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER 10.61 92.63 0.04 OUTLIER Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 112.46 -1.87 . . . . 0.0 110.506 175.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.78 -40.22 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.136 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.149 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 83.8 m -74.63 150.01 39.79 Favored 'General case' 0 C--O 1.256 1.439 0 C-N-CA 113.82 -3.152 . . . . 0.0 109.762 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.432 HD11 HD21 ' A' ' 80' ' ' ASN . 17.6 mt -88.63 -178.55 5.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.118 -2.233 . . . . 0.0 109.888 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.552 HD22 ' HB2' ' A' ' 81' ' ' CYS . 6.7 p30 41.72 38.97 1.06 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.879 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 54.55 26.5 7.34 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.541 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 177.23 6.12 Favored Glycine 0 C--N 1.282 -2.462 0 C-N-CA 114.161 -3.876 . . . . 0.0 108.124 171.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -106.71 154.27 21.2 Favored 'General case' 0 C--N 1.278 -2.516 0 C-N-CA 116.229 -2.188 . . . . 0.0 108.492 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 31.4 p -133.53 93.72 3.19 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 115.658 -2.417 . . . . 0.0 108.48 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -76.99 147.41 36.85 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.117 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.58 158.53 15.41 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 116.182 -2.207 . . . . 0.0 110.025 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.4 -100.66 0.14 Allowed Glycine 0 C--O 1.24 0.517 0 C-N-CA 115.261 -3.352 . . . . 0.0 109.309 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.435 ' C ' ' N ' ' A' ' 67' ' ' ASP . 63.2 mt -62.77 170.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 115.584 -2.447 . . . . 0.0 108.462 173.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' N ' HG21 ' A' ' 65' ' ' ILE . . . -53.83 -19.18 9.73 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 114.46 -3.733 . . . . 0.0 110.401 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' C ' ' A' ' 65' ' ' ILE . 9.1 t70 -101.95 139.45 37.57 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.651 -1.62 . . . . 0.0 107.222 169.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.578 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -83.98 -162.12 0.61 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 116.923 -1.911 . . . . 0.0 107.296 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -141.05 141.99 34.24 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.265 -2.174 . . . . 0.0 108.594 173.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.149 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 95.1 m -94.7 114.44 26.36 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 116.131 -2.228 . . . . 0.0 110.274 -173.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 m -98.62 120.18 38.61 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 115.528 -2.469 . . . . 0.0 108.171 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 41.3 m -93.89 147.21 23.29 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 114.855 -2.738 . . . . 0.0 109.086 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.52 24.68 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 114.483 -2.887 . . . . 0.0 109.004 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.14 134.72 49.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 115.959 -2.296 . . . . 0.0 108.372 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 99.34 -13.05 61.74 Favored Glycine 0 CA--C 1.489 -1.588 0 C-N-CA 114.585 -3.674 . . . . 0.0 110.85 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.67 ' HB3' ' HB3' ' A' ' 81' ' ' CYS . 85.4 m-85 -126.95 147.94 50.09 Favored 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 114.051 -3.06 . . . . 0.0 109.436 167.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.1 170.68 19.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 114.517 -2.873 . . . . 0.0 110.652 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.47 -175.67 19.02 Favored Glycine 0 N--CA 1.434 -1.474 1 C-N-CA 113.035 -4.412 . . . . 0.0 111.343 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -74.31 -61.64 1.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 C-N-CA 113.807 -3.157 . . . . 0.0 109.394 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 46.6 m-20 -76.56 -5.14 46.38 Favored 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 114.776 -2.77 . . . . 0.0 111.711 175.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.1 m 82.51 17.44 0.34 Allowed 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 116.539 -2.065 . . . . 0.0 107.698 -169.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.75 -22.32 5.13 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 116.281 -2.168 . . . . 0.0 112.573 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.27 153.2 30.08 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 114.834 -2.747 . . . . 0.0 109.597 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 39.1 m -120.44 42.86 2.88 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 114.602 -2.839 . . . . 0.0 106.457 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 71.1 p 41.41 47.42 3.12 Favored 'General case' 0 N--CA 1.512 2.665 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.833 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 85' ' ' THR . 34.6 mtm-85 . . . . . 0 C--N 1.277 -2.579 0 C-N-CA 115.262 -2.575 . . . . 0.0 109.099 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm . . . . . 0 N--CA 1.526 3.365 0 CA-C-O 124.398 2.047 . . . . 0.0 107.345 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -67.96 170.56 8.05 Favored 'General case' 1 C--N 1.434 4.265 0 CA-C-N 111.616 -2.538 . . . . 0.0 109.035 -175.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.09 -124.35 1.43 Allowed Glycine 0 N--CA 1.499 2.855 0 C-N-CA 114.272 -3.823 . . . . 0.0 110.353 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -106.53 39.15 1.89 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 116.415 -2.114 . . . . 0.0 106.646 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -94.58 -2.66 51.07 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 116.092 -2.243 . . . . 0.0 108.803 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 24.2 t -148.63 68.38 1.07 Allowed 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 113.618 -3.233 . . . . 0.0 108.606 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' A' ' 53' ' ' HIS . 8.1 tt0 -65.31 179.3 0.77 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 115.384 -2.526 . . . . 0.0 108.631 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 4.0 4.71 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 114.718 -3.611 . . . . 0.0 111.576 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' GLU . 11.0 t-160 -173.12 96.67 0.35 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 116.14 -2.224 . . . . 0.0 109.058 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -111.92 -46.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 108.049 -1.558 . . . . 0.0 108.049 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.5 m -81.19 157.11 25.36 Favored 'General case' 0 C--O 1.253 1.241 0 C-N-CA 114.863 -2.735 . . . . 0.0 108.923 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.452 ' CD1' HD21 ' A' ' 80' ' ' ASN . 80.9 mt -90.25 175.95 6.93 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 115.964 -2.294 . . . . 0.0 108.682 -177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 56.37 43.13 26.71 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.174 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 45.66 33.38 1.42 Allowed 'General case' 0 N--CA 1.407 -2.616 0 C-N-CA 117.068 -1.853 . . . . 0.0 112.793 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.94 -170.03 1.74 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 114.77 -3.586 . . . . 0.0 109.635 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 24.2 t-80 -107.78 163.55 13.01 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 115.665 -2.414 . . . . 0.0 109.564 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 10.8 t -143.19 143.05 31.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 115.204 -2.598 . . . . 0.0 108.295 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -123.3 -144.35 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.539 -2.065 . . . . 0.0 108.114 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -140.53 152.38 45.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 114.469 -2.892 . . . . 0.0 110.315 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.95 149.55 12.02 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 115.084 -3.436 . . . . 0.0 110.026 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.532 ' C ' ' H ' ' A' ' 67' ' ' ASP . 39.4 mt -62.57 138.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.303 -176.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.6 -28.89 1.51 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 116.299 -2.857 . . . . 0.0 111.436 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 65' ' ' ILE . 34.3 t70 -176.58 141.14 0.38 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 116.521 -2.072 . . . . 0.0 110.152 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.747 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 17.9 p90 -81.48 -165.6 0.99 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 116.424 -2.111 . . . . 0.0 108.068 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -131.99 136.46 47.31 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 115.41 -2.516 . . . . 0.0 110.507 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.747 ' SG ' ' HE2' ' A' ' 68' ' ' TYR . 93.2 m -94.3 142.39 27.47 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 115.268 -2.573 . . . . 0.0 109.475 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 82.2 m -125.53 108.32 11.48 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 115.282 -2.567 . . . . 0.0 107.647 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.182 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.0 m -82.42 142.89 31.58 Favored 'General case' 0 C--O 1.259 1.559 0 C-N-CA 116.325 -2.15 . . . . 0.0 108.716 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 165.59 24.76 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.936 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -50.36 143.13 9.23 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.185 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 80.83 12.94 82.15 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 114.889 -3.529 . . . . 0.0 110.426 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 98.1 m-85 -140.25 143.64 36.07 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.382 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -145.56 -174.34 4.37 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 116.128 -2.229 . . . . 0.0 109.622 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.43 173.42 48.3 Favored Glycine 0 C--O 1.236 0.261 0 C-N-CA 114.636 -3.65 . . . . 0.0 109.658 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -71.15 -42.18 69.48 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 115.456 -2.498 . . . . 0.0 110.38 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.624 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 41.2 m-20 -83.65 -4.7 58.81 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 116.795 -1.962 . . . . 0.0 110.152 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.182 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 70.91 25.66 3.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 114.322 -2.951 . . . . 0.0 108.219 -165.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.58 -25.03 68.05 Favored 'General case' 0 C--N 1.368 1.394 0 C-N-CA 116.155 -2.218 . . . . 0.0 110.057 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -79.16 175.65 10.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 115.892 -2.323 . . . . 0.0 109.234 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 23.4 p -139.97 28.45 2.12 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 116.768 -1.973 . . . . 0.0 108.246 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p 41.92 30.07 0.15 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.4 -1.72 . . . . 0.0 110.405 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 84' ' ' SER . 48.1 ttp180 . . . . . 0 C--N 1.3 -1.557 0 C-N-CA 116.426 -2.11 . . . . 0.0 109.764 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt . . . . . 0 N--CA 1.419 -2.008 0 CA-C-O 123.234 1.492 . . . . 0.0 107.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -147.8 144.22 28.04 Favored 'General case' 0 N--CA 1.538 3.942 0 C-N-CA 113.413 -3.315 . . . . 0.0 106.196 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 103.13 0.13 Allowed Glycine 0 CA--C 1.556 2.614 0 C-N-CA 118.412 -1.852 . . . . 0.0 109.548 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -136.54 55.15 1.85 Allowed 'General case' 1 C--N 1.237 -4.287 0 C-N-CA 116.118 -2.233 . . . . 0.0 108.059 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.466 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.1 mp0 -97.76 -7.51 30.53 Favored 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 113.681 -3.208 . . . . 0.0 109.051 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.5 t -137.32 64.41 1.53 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 115.04 -2.664 . . . . 0.0 110.132 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' C ' ' N ' ' A' ' 53' ' ' HIS . 9.1 tt0 -57.48 164.76 1.78 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 115.668 -2.413 . . . . 0.0 109.311 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.22 -12.74 8.48 Favored Glycine 0 CA--C 1.529 0.959 1 C-N-CA 113.853 -4.022 . . . . 0.0 111.448 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.422 ' N ' ' C ' ' A' ' 51' ' ' GLU . 21.1 t-160 -172.3 94.48 0.39 Allowed Pre-proline 0 CA--C 1.577 1.989 0 C-N-CA 116.323 -2.151 . . . . 0.0 109.403 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -97.34 -37.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.481 0.765 0 O-C-N 123.422 1.222 . . . . 0.0 110.668 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 79.7 m -98.54 154.75 17.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 115.235 -2.586 . . . . 0.0 108.755 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.503 ' CD1' HD21 ' A' ' 80' ' ' ASN . 58.0 mt -73.84 176.93 5.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 115.483 -2.487 . . . . 0.0 111.662 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 56' ' ' LEU . 3.6 p30 46.2 53.44 9.39 Favored 'General case' 0 C--O 1.269 2.081 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.781 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 1.282 ' NE2' HE21 ' A' ' 58' ' ' GLN . 47.1 mt-30 50.94 25.07 2.05 Favored 'General case' 0 N--CA 1.396 -3.166 0 C-N-CA 116.981 -1.888 . . . . 0.0 110.26 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.09 130.44 38.69 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 115.666 -3.159 . . . . 0.0 108.252 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -80.03 174.64 11.39 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.348 -174.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 19.4 p -139.96 116.55 10.78 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 114.407 -2.917 . . . . 0.0 108.435 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -90.38 119.72 30.91 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 115.406 -2.518 . . . . 0.0 107.338 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.3 157.56 27.69 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 116.524 -2.07 . . . . 0.0 110.02 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.16 -87.11 0.07 OUTLIER Glycine 0 C--O 1.198 -2.114 0 C-N-CA 114.23 -3.843 . . . . 0.0 108.226 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.526 ' CG2' ' H ' ' A' ' 66' ' ' GLY . 50.4 mt -71.04 -176.42 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.263 1.778 0 C-N-CA 116.533 -2.067 . . . . 0.0 110.231 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' H ' ' CG2' ' A' ' 65' ' ' ILE . . . -58.65 -13.19 16.59 Favored Glycine 0 N--CA 1.486 2.002 0 C-N-CA 116.407 -2.806 . . . . 0.0 109.878 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.6 p-10 -120.62 144.88 47.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 115.931 -2.308 . . . . 0.0 106.118 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.418 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 21.1 p90 -84.91 -161.3 0.56 Allowed 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 115.858 -2.337 . . . . 0.0 108.94 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -140.14 136.94 34.02 Favored 'General case' 0 C--O 1.204 -1.314 0 C-N-CA 116.34 -2.144 . . . . 0.0 109.098 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.3 m -78.15 137.25 38.08 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 115.283 -2.567 . . . . 0.0 108.611 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.8 m -120.67 115.22 22.92 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 116.774 -1.97 . . . . 0.0 107.754 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.2 m -84.52 139.72 31.95 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 114.886 -2.726 . . . . 0.0 110.014 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.9 168.89 5.76 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.367 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.08 120.0 6.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.166 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 98.44 23.45 12.48 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 115.016 -3.469 . . . . 0.0 111.617 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 83.8 m-85 -146.37 149.71 34.29 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 115.412 -2.515 . . . . 0.0 110.554 172.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.252 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -155.84 -146.72 0.18 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 115.314 -2.554 . . . . 0.0 109.657 173.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.847 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 86.68 168.43 44.82 Favored Glycine 1 N--CA 1.52 4.263 0 C-N-CA 114.739 -3.6 . . . . 0.0 109.165 177.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -54.7 -37.25 65.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 116.254 -2.179 . . . . 0.0 109.008 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.503 HD21 ' CD1' ' A' ' 56' ' ' LEU . 75.1 m-20 -102.19 29.93 4.82 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 116.105 -2.238 . . . . 0.0 111.676 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 73.6 m 50.84 25.01 1.97 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 115.232 -2.587 . . . . 0.0 106.786 -163.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.815 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.2 tp10 -55.22 -55.03 35.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.455 -1.698 . . . . 0.0 113.022 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 1.252 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -90.1 139.1 30.95 Favored 'General case' 0 N--CA 1.387 -3.582 0 C-N-CA 113.445 -3.302 . . . . 0.0 112.098 -148.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 22.8 t -86.15 58.47 5.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 115.992 -2.283 . . . . 0.0 110.734 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.2 p 37.14 28.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 116.051 -2.26 . . . . 0.0 112.051 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' N ' ' C ' ' A' ' 84' ' ' SER . 71.4 mtp85 . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 115.941 -1.98 . . . . 0.0 108.762 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' H1 ' ' H ' ' A' ' 46' ' ' ASP . 18.0 ptpt . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.453 ' H ' ' H1 ' ' A' ' 45' ' ' LYS . 15.0 m-20 -95.62 126.3 40.8 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 112.452 -3.699 . . . . 0.0 107.566 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.02 113.33 0.28 Allowed Glycine 1 C--N 1.214 -6.208 0 C-N-CA 114.616 -3.659 . . . . 0.0 112.611 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.709 ' C ' ' H ' ' A' ' 50' ' ' CYS . 13.1 m-20 -103.85 -16.84 15.26 Favored 'General case' 0 C--O 1.26 1.628 0 C-N-CA 116.846 -1.942 . . . . 0.0 109.599 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 42.21 6.78 0.0 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.532 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.13 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 74.2 m -117.32 -0.66 11.95 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.425 -2.11 . . . . 0.0 108.98 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 115.059 -2.657 . . . . 0.0 109.85 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -95.55 18.13 57.98 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 114.903 -3.522 . . . . 0.0 111.01 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' GLY . 16.4 t-160 44.48 84.2 0.19 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 116.239 -2.185 . . . . 0.0 110.161 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -97.13 -38.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 O-C-N 123.667 1.351 . . . . 0.0 111.096 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 61.2 m -96.42 151.02 19.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 115.677 -2.409 . . . . 0.0 110.423 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.462 ' CD1' HD21 ' A' ' 80' ' ' ASN . 86.2 mt -103.78 176.39 5.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 116.128 -2.229 . . . . 0.0 110.034 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 56.75 47.77 17.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 117.218 -1.793 . . . . 0.0 111.755 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 1.415 ' NE2' HE21 ' A' ' 58' ' ' GLN . 43.5 tt0 49.52 35.12 7.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.174 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.75 -161.39 4.88 Favored Glycine 0 C--N 1.363 2.05 0 C-N-CA 114.051 -3.928 . . . . 0.0 110.468 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.523 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 9.0 t-160 -135.68 175.03 9.97 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 115.208 -2.597 . . . . 0.0 109.697 -176.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.13 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 14.3 p -153.13 138.14 17.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 114.374 -2.93 . . . . 0.0 108.702 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -115.82 133.28 56.19 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 116.124 -2.23 . . . . 0.0 109.237 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.14 159.3 29.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 116.083 -2.247 . . . . 0.0 108.607 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 66' ' ' GLY . . . -152.21 38.29 0.79 Allowed Glycine 0 N--CA 1.504 3.178 0 C-N-CA 114.471 -3.728 . . . . 0.0 110.367 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 65' ' ' ILE . 81.4 mt 36.27 36.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 116.784 -1.966 . . . . 0.0 110.037 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 162.22 85.62 0.06 OUTLIER Glycine 0 C--N 1.288 -2.101 0 C-N-CA 115.471 -3.252 . . . . 0.0 109.825 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.2 m-20 67.57 116.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 116.656 -2.017 . . . . 0.0 109.007 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.492 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 24.6 p90 -76.7 -169.9 1.4 Allowed 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.278 -2.569 . . . . 0.0 108.363 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 p -139.43 132.8 30.07 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 115.789 -2.364 . . . . 0.0 108.831 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.105 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 61.4 m -81.68 128.46 33.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.38 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 88.8 m -108.04 109.65 21.15 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 114.739 -2.785 . . . . 0.0 108.435 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.14 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.9 m -86.46 143.41 27.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 115.57 -2.452 . . . . 0.0 109.648 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.71 171.44 13.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 116.935 -1.906 . . . . 0.0 109.711 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -52.4 126.88 20.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 115.705 -2.398 . . . . 0.0 110.039 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.6 19.46 44.48 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.769 -3.586 . . . . 0.0 110.235 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.543 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 99.9 m-85 -140.49 145.99 37.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.287 -2.565 . . . . 0.0 108.538 165.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 46.2 mm-40 -146.31 -166.97 2.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 116.086 -2.245 . . . . 0.0 109.083 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.54 168.27 35.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 114.296 -3.811 . . . . 0.0 109.261 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -68.54 -37.09 79.68 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 114.58 -2.848 . . . . 0.0 109.904 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 39.9 m-20 -80.72 -16.01 55.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.16 -1.816 . . . . 0.0 111.762 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.14 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.2 m 77.98 18.67 1.16 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.16 -2.616 . . . . 0.0 107.331 -162.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.74 -31.16 69.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 117.498 -1.681 . . . . 0.0 110.211 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 49.5 m-85 -78.82 160.71 27.23 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 115.362 -2.535 . . . . 0.0 110.502 -176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.569 ' C ' ' N ' ' A' ' 86' ' ' ARG . 19.2 t -123.58 38.08 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 115.564 -2.455 . . . . 0.0 108.221 170.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p 40.03 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.324 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.569 ' N ' ' C ' ' A' ' 84' ' ' SER . 78.0 ttt-85 . . . . . 0 C--N 1.308 -1.231 0 C-N-CA 115.936 -2.306 . . . . 0.0 110.202 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.418 ' H1 ' ' N ' ' A' ' 45' ' ' LYS . 61.5 tttp . . . . . 0 C--O 1.175 -2.838 0 CA-C-O 127.877 3.703 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -88.58 164.21 15.49 Favored 'General case' 1 C--N 1.46 5.387 0 C-N-CA 114.975 -2.69 . . . . 0.0 108.941 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ASP . . . -179.63 -115.38 0.47 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 114.566 -3.683 . . . . 0.0 110.333 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' GLY . 13.9 t70 50.0 64.46 1.77 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 115.734 -2.386 . . . . 0.0 109.261 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -97.92 -8.02 28.99 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 115.669 -2.412 . . . . 0.0 109.215 -174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.4 t -127.19 -22.8 3.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 114.906 -2.718 . . . . 0.0 111.532 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.3 -17.41 64.77 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 114.311 -2.956 . . . . 0.0 110.122 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -88.88 36.36 3.48 Favored Glycine 0 C--O 1.259 1.657 0 C-N-CA 115.872 -3.061 . . . . 0.0 110.993 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.72 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.7 m-70 13.98 88.47 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 117.843 -1.543 . . . . 0.0 110.678 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -89.98 -42.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.974 1.782 . . . . 0.0 109.746 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 38.7 m -81.97 113.42 19.86 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 116.12 -2.232 . . . . 0.0 110.969 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.461 ' CD1' HD21 ' A' ' 80' ' ' ASN . 81.2 mt -74.82 175.93 7.55 Favored 'General case' 0 CA--C 1.58 2.126 0 C-N-CA 115.023 -2.671 . . . . 0.0 110.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 62.11 50.44 4.0 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 117.146 -1.821 . . . . 0.0 109.972 168.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 53.39 27.79 6.74 Favored 'General case' 0 C--O 1.281 2.711 0 C-N-CA 116.7 -2.0 . . . . 0.0 111.389 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.18 -150.46 3.86 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 114.081 -3.914 . . . . 0.0 110.44 175.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -141.07 135.13 30.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 114.606 -2.838 . . . . 0.0 108.308 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.7 p -113.93 128.11 56.26 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 116.051 -2.26 . . . . 0.0 110.032 176.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -97.78 -165.24 1.23 Allowed 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.599 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -151.81 138.03 18.37 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 115.945 -2.302 . . . . 0.0 109.26 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.29 -95.96 0.1 Allowed Glycine 0 C--O 1.247 0.959 0 C-N-CA 114.49 -3.719 . . . . 0.0 109.766 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 66' ' ' GLY . 71.6 mt -62.82 177.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 116.007 -2.277 . . . . 0.0 110.833 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.524 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.32 -18.76 5.22 Favored Glycine 0 CA--C 1.549 2.205 0 C-N-CA 114.772 -3.585 . . . . 0.0 111.067 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' C ' ' A' ' 65' ' ' ILE . 3.3 p-10 -112.81 146.56 38.64 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 116.005 -2.278 . . . . 0.0 108.014 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.539 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -83.89 -166.03 1.3 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 116.762 -1.975 . . . . 0.0 108.604 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.87 136.15 36.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 114.985 -2.686 . . . . 0.0 108.542 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 8.6 m -95.88 155.33 16.8 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 114.676 -2.81 . . . . 0.0 110.937 -174.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -135.49 131.04 35.61 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 115.506 -2.478 . . . . 0.0 109.0 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.6 m -107.51 142.45 37.37 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 114.697 -2.801 . . . . 0.0 108.503 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.87 172.71 10.36 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 116.233 -2.187 . . . . 0.0 109.319 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -55.85 146.21 22.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.863 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.743 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.23 8.73 87.62 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 114.487 -3.721 . . . . 0.0 110.994 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 92.4 m-85 -136.82 140.74 42.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 114.506 -2.878 . . . . 0.0 109.998 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -147.08 -166.75 2.59 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 116.197 -2.201 . . . . 0.0 107.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.56 167.06 38.06 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 114.383 -3.77 . . . . 0.0 109.501 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -67.8 -34.44 76.75 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 116.375 -2.13 . . . . 0.0 108.391 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.59 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.4 m-20 -89.71 -4.74 57.57 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 116.35 -2.14 . . . . 0.0 111.933 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.208 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.8 m 71.66 17.48 5.53 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 114.484 -2.886 . . . . 0.0 107.452 -166.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.28 -31.12 68.82 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 118.021 -1.472 . . . . 0.0 109.406 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -79.74 165.01 23.24 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 115.517 -2.473 . . . . 0.0 111.296 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.5 t -127.29 38.67 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.53 -2.468 . . . . 0.0 107.898 173.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 84' ' ' SER . 24.6 p 46.1 22.95 0.16 Allowed 'General case' 0 N--CA 1.511 2.588 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.836 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' N ' ' C ' ' A' ' 84' ' ' SER . 8.8 mmm180 . . . . . 0 N--CA 1.514 2.732 0 CA-C-O 115.702 -2.094 . . . . 0.0 108.135 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.53 ' HD3' ' CD ' ' A' ' 45' ' ' LYS . 65.0 pttt . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -131.52 166.61 20.98 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 113.216 -3.394 . . . . 0.0 109.55 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.22 52.38 0.1 OUTLIER Glycine 0 N--CA 1.499 2.87 1 C-N-CA 113.12 -4.372 . . . . 0.0 110.815 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.735 ' C ' ' H ' ' A' ' 50' ' ' CYS . 1.3 p30 -111.6 -24.47 10.08 Favored 'General case' 0 C--O 1.254 1.333 0 C-N-CA 114.465 -2.894 . . . . 0.0 107.589 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 85.9 mm-40 43.29 4.91 0.0 OUTLIER 'General case' 0 C--N 1.375 1.689 0 CA-C-O 122.552 1.168 . . . . 0.0 111.732 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 50.1 t -112.53 54.97 0.7 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 115.101 -2.639 . . . . 0.0 109.513 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' CYS . 16.9 tt0 -40.61 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 115.669 -2.412 . . . . 0.0 111.204 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.6 -14.01 8.77 Favored Glycine 0 CA--C 1.559 2.832 0 C-N-CA 114.488 -3.72 . . . . 0.0 112.115 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -174.26 93.03 0.32 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 115.191 -2.604 . . . . 0.0 109.888 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -99.74 -41.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.823 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.213 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -81.72 169.39 17.01 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 115.926 -2.31 . . . . 0.0 109.122 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.44 ' CD1' HD21 ' A' ' 80' ' ' ASN . 73.8 mt -98.91 176.88 5.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 115.181 -2.608 . . . . 0.0 109.784 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 56.52 44.13 24.67 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.029 -1.869 . . . . 0.0 110.356 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 50.49 29.29 3.87 Favored 'General case' 0 N--CA 1.385 -3.693 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.14 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.45 -166.99 7.9 Favored Glycine 0 N--CA 1.475 1.277 1 C-N-CA 113.099 -4.382 . . . . 0.0 111.48 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -120.13 166.08 13.9 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 116.179 -2.208 . . . . 0.0 110.089 -173.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 20.2 p -144.87 130.12 18.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 115.355 -2.538 . . . . 0.0 108.576 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -103.29 -132.75 0.3 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 115.241 -2.584 . . . . 0.0 108.188 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -144.84 156.04 43.81 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 115.227 -2.589 . . . . 0.0 110.19 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.37 141.47 4.81 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 114.849 -3.548 . . . . 0.0 108.804 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 67' ' ' ASP . 11.1 mt -59.65 137.19 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 113.047 -3.461 . . . . 0.0 110.769 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.99 -38.32 2.97 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 115.176 -3.392 . . . . 0.0 110.236 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.9 147.23 5.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 116.124 -2.23 . . . . 0.0 108.997 -174.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.458 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.7 p90 -86.13 -166.59 1.58 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 116.237 -2.185 . . . . 0.0 108.001 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -134.36 142.67 47.28 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 114.297 -2.961 . . . . 0.0 108.936 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.213 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 97.3 m -90.64 145.86 24.5 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 115.182 -2.607 . . . . 0.0 110.05 -176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.1 m -126.8 116.83 21.49 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 116.15 -2.22 . . . . 0.0 107.848 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.158 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.3 m -90.05 143.88 26.39 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 116.049 -2.26 . . . . 0.0 109.745 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.48 171.57 12.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 116.313 -2.155 . . . . 0.0 110.468 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.82 137.96 43.71 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.179 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.15 16.28 69.91 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 115.447 -3.263 . . . . 0.0 111.121 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.8 m-85 -144.2 145.07 31.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.807 -2.357 . . . . 0.0 108.878 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 5.0 mt-10 -147.63 -178.95 6.53 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.488 -2.085 . . . . 0.0 109.555 -176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.7 174.66 39.88 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 114.859 -3.543 . . . . 0.0 109.762 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.34 -48.33 56.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 115.577 -2.449 . . . . 0.0 109.725 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 37.7 m-20 -82.08 -5.0 58.07 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 116.741 -1.984 . . . . 0.0 110.622 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.158 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 74.25 27.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 115.159 -2.617 . . . . 0.0 108.922 -165.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.9 -22.59 65.7 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 117.38 -1.728 . . . . 0.0 110.076 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -85.04 165.26 17.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 114.82 -2.752 . . . . 0.0 109.177 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.8 t -128.49 35.81 4.34 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 115.713 -2.395 . . . . 0.0 107.695 169.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.557 ' OG1' ' O ' ' A' ' 84' ' ' SER . 20.7 p 44.29 16.15 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 117.439 -1.704 . . . . 0.0 111.39 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 84' ' ' SER . 15.6 ptm180 . . . . . 0 C--O 1.196 -1.76 0 C-N-CA 114.938 -2.705 . . . . 0.0 108.949 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.517 ' CE ' ' HE2' ' A' ' 45' ' ' LYS 0.274 61.1 mttp . . . . . 0 C--O 1.264 1.856 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.54 139.98 38.65 Favored 'General case' 0 C--O 1.19 -2.04 0 C-N-CA 117.157 -1.817 . . . . 0.0 106.712 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.6 -117.71 0.41 Allowed Glycine 0 C--N 1.369 2.391 0 C-N-CA 115.367 -3.301 . . . . 0.0 110.729 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -166.43 29.73 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 110.1 -3.05 . . . . 0.0 106.926 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 2.3 mp0 -89.93 -11.8 40.72 Favored 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 116.018 -2.273 . . . . 0.0 109.046 -167.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 49' ' ' GLN . 59.1 m -163.87 14.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 116.191 -2.204 . . . . 0.0 109.47 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -78.67 -14.09 59.48 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 114.965 -2.694 . . . . 0.0 108.437 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -117.04 26.0 8.53 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 114.986 -3.483 . . . . 0.0 110.327 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' GLY . 13.2 t-160 39.65 91.5 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 116.066 -2.254 . . . . 0.0 110.788 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -91.68 -31.95 0.09 OUTLIER 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 121.339 1.36 . . . . 0.0 109.878 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 60' ' ' HIS . 15.7 m -75.83 124.38 27.22 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.696 -2.401 . . . . 0.0 110.598 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.508 ' CD1' HD21 ' A' ' 80' ' ' ASN . 46.9 mt -77.07 176.44 8.68 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 116.476 -2.09 . . . . 0.0 109.404 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 63.36 40.33 8.6 Favored 'General case' 0 C--O 1.29 3.202 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.895 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 46.5 35.88 3.19 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 115.266 -2.574 . . . . 0.0 110.35 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.11 -134.82 0.05 OUTLIER Glycine 0 CA--C 1.563 3.042 1 C-N-CA 113.141 -4.361 . . . . 0.0 110.2 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.424 ' O ' ' SG ' ' A' ' 55' ' ' CYS . 2.0 t-160 -159.17 -175.46 5.27 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 114.64 -2.824 . . . . 0.0 109.003 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.5 t -155.46 128.94 8.39 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 114.429 -2.908 . . . . 0.0 108.36 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.6 ' O ' ' O ' ' A' ' 87' ' ' ' OH' . 5.3 mptp? -89.43 -20.97 23.28 Favored 'General case' 0 C--O 1.256 1.418 0 C-N-CA 114.629 -2.828 . . . . 0.0 110.301 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 63.22 146.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 117.59 -1.644 . . . . 0.0 110.443 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 -100.91 0.14 Allowed Glycine 0 C--O 1.211 -1.282 0 C-N-CA 114.81 -3.567 . . . . 0.0 109.417 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.428 ' C ' ' N ' ' A' ' 67' ' ' ASP . 4.6 mm -69.4 178.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 116.081 -2.248 . . . . 0.0 110.713 172.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.422 ' N ' ' CG2' ' A' ' 65' ' ' ILE . . . -49.92 -23.39 5.3 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 115.561 -3.209 . . . . 0.0 110.192 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' N ' ' C ' ' A' ' 65' ' ' ILE . 6.0 m-20 -98.27 132.05 44.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 116.569 -2.052 . . . . 0.0 108.669 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 17.9 p90 -90.65 -173.81 3.87 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 115.256 -2.578 . . . . 0.0 109.941 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 p -123.95 133.79 53.63 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 115.95 -2.3 . . . . 0.0 108.942 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.83 128.96 49.37 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 115.584 -2.446 . . . . 0.0 109.614 -171.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.9 m -99.26 170.03 8.95 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 115.441 -2.504 . . . . 0.0 106.636 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.0 m -122.09 -45.05 2.26 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 114.276 -2.97 . . . . 0.0 110.897 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 72' ' ' CYS . . . 115.88 162.28 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.99 119.35 5.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 115.58 -2.448 . . . . 0.0 110.943 -175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.2 29.94 32.36 Favored Glycine 0 N--CA 1.504 3.218 0 C-N-CA 114.156 -3.878 . . . . 0.0 111.839 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.665 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 88.5 m-85 -142.96 152.1 41.63 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 114.088 -3.045 . . . . 0.0 108.943 170.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 6.5 mt-10 -153.32 -176.68 5.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 115.336 -2.546 . . . . 0.0 108.442 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.74 176.32 28.27 Favored Glycine 0 C--N 1.361 1.919 0 C-N-CA 114.315 -3.802 . . . . 0.0 110.568 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -58.01 -63.18 1.35 Allowed 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 116.463 -2.095 . . . . 0.0 110.568 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.825 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 22.9 m-20 -78.85 -21.0 48.23 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 116.15 -2.22 . . . . 0.0 110.713 177.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.119 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 19.5 m 94.1 26.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 116.647 -2.021 . . . . 0.0 107.671 -168.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.76 -19.91 65.34 Favored 'General case' 0 CA--C 1.6 2.897 0 C-N-CA 117.078 -1.849 . . . . 0.0 109.274 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 27.5 m-85 -78.14 176.2 9.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.764 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.721 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 80.5 p -133.97 28.4 3.84 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 116.12 -2.232 . . . . 0.0 108.278 172.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 84' ' ' SER . 41.0 p 47.54 5.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 117.54 -1.664 . . . . 0.0 111.148 -172.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.709 ' H ' ' C ' ' A' ' 84' ' ' SER . 16.1 tpt180 . . . . . 0 CA--C 1.572 1.815 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.83 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . 0.6 ' O ' ' O ' ' A' ' 62' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.3 mttp . . . . . 1 N--CA 1.549 4.495 0 CA-C-O 125.637 2.637 . . . . 0.0 104.408 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.12 117.41 31.26 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 113.657 -3.217 . . . . 0.0 107.577 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.92 101.35 0.14 Allowed Glycine 0 N--CA 1.51 3.592 1 C-N-CA 113.358 -4.258 . . . . 0.0 109.831 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -119.44 66.67 0.8 Allowed 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 115.896 -2.322 . . . . 0.0 110.335 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 1.429 ' NE2' HE21 ' A' ' 49' ' ' GLN . 8.8 mp0 -89.13 -6.84 56.71 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 115.554 -2.458 . . . . 0.0 109.097 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.0 m -145.23 -22.75 0.49 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 115.416 -2.514 . . . . 0.0 109.563 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -78.58 -15.67 58.28 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 116.349 -2.14 . . . . 0.0 108.748 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -87.8 13.37 61.11 Favored Glycine 0 C--O 1.215 -1.057 0 C-N-CA 114.817 -3.563 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.6 t-160 44.3 82.18 0.24 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 116.485 -2.086 . . . . 0.0 110.018 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -95.69 -42.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.029 1.153 . . . . 0.0 110.606 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.175 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 72.4 m -77.74 160.42 28.42 Favored 'General case' 0 C--O 1.253 1.258 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.713 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' CD1' HD21 ' A' ' 80' ' ' ASN . 82.7 mt -101.99 175.86 5.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 116.038 -2.265 . . . . 0.0 110.989 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 55.43 38.9 30.94 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 117.458 -1.697 . . . . 0.0 110.319 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 56.79 25.95 10.91 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.827 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.16 136.6 32.63 Favored Glycine 0 N--CA 1.424 -2.16 0 C-N-CA 114.723 -3.608 . . . . 0.0 108.864 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -78.47 179.37 7.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.725 -2.237 . . . . 0.0 108.725 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 11.1 p -154.61 137.49 15.39 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.661 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -102.35 128.32 48.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 115.76 -2.376 . . . . 0.0 108.855 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.4 149.39 42.52 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 115.681 -2.407 . . . . 0.0 109.878 -173.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.55 161.99 35.79 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 115.469 -3.253 . . . . 0.0 108.356 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.74 144.0 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 116.195 -2.202 . . . . 0.0 109.16 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 68.8 69.56 1.36 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 114.728 -3.606 . . . . 0.0 111.802 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 32.4 m-20 68.08 153.51 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.95 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -82.75 -164.47 0.86 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 118.045 -1.462 . . . . 0.0 107.239 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 17.6 p -135.16 152.11 51.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 116.218 -2.193 . . . . 0.0 108.797 171.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.175 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.0 m -96.22 154.03 17.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 115.738 -2.385 . . . . 0.0 110.802 -174.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.2 m -142.24 113.73 7.81 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 115.27 -2.572 . . . . 0.0 108.147 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.127 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 22.2 m -89.67 140.63 29.38 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 115.141 -2.624 . . . . 0.0 108.846 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.2 169.72 15.55 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.583 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 127.76 28.42 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 116.259 -2.177 . . . . 0.0 110.196 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.17 18.59 49.44 Favored Glycine 0 N--CA 1.48 1.57 1 C-N-CA 113.714 -4.089 . . . . 0.0 111.209 -178.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.65 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 92.9 m-85 -140.63 142.15 35.03 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 115.298 -2.561 . . . . 0.0 111.322 161.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.374 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -143.2 -145.86 0.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.341 -2.544 . . . . 0.0 109.719 169.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.994 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 82.13 164.25 33.87 Favored Glycine 1 N--CA 1.519 4.207 0 C-N-CA 114.229 -3.844 . . . . 0.0 107.067 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.08 -50.74 70.18 Favored 'General case' 0 N--CA 1.511 2.625 0 C-N-CA 115.063 -2.655 . . . . 0.0 110.869 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.571 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 29.3 m-20 -90.13 29.04 1.28 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.408 -1.717 . . . . 0.0 110.348 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.127 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 47.8 m 57.07 20.78 5.76 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 113.943 -3.103 . . . . 0.0 106.678 -164.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 80' ' ' ASN . 9.3 tp10 -49.08 -52.47 25.56 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 117.528 -1.669 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 1.374 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.93 174.85 6.96 Favored 'General case' 1 N--CA 1.365 -4.683 0 C-N-CA 112.977 -3.489 . . . . 0.0 109.311 -165.768 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.957 ' O ' HG21 ' A' ' 85' ' ' THR . 22.9 p -88.69 -68.67 0.75 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.004 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.957 HG21 ' O ' ' A' ' 84' ' ' SER . 0.9 OUTLIER -178.29 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 CA--C 1.553 1.07 0 CA-C-O 113.404 -3.188 . . . . 0.0 108.399 -179.848 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt . . . . . 0 N--CA 1.508 2.425 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -100.2 -65.56 0.96 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 113.468 -3.293 . . . . 0.0 110.69 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.09 103.4 0.18 Allowed Glycine 2 N--CA 1.356 -6.669 1 C-N-CA 113.07 -4.395 . . . . 0.0 112.723 -172.947 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.39 26.44 6.04 Favored 'General case' 0 CA--C 1.598 2.804 0 C-N-CA 117.813 -1.555 . . . . 0.0 108.77 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -83.95 -17.16 41.57 Favored 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 116.163 -2.215 . . . . 0.0 109.199 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.3 t -122.98 -3.98 8.57 Favored 'General case' 0 C--O 1.256 1.426 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.733 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.2 -21.98 58.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 114.395 -2.922 . . . . 0.0 109.458 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.07 7.6 81.79 Favored Glycine 0 CA--C 1.558 2.732 0 C-N-CA 114.242 -3.837 . . . . 0.0 112.019 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.52 86.13 0.16 Allowed Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 116.478 -2.089 . . . . 0.0 110.187 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -97.95 -46.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 109.88 -0.854 . . . . 0.0 109.88 -171.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.141 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -75.28 165.07 25.76 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.446 -170.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.478 ' CD1' HD21 ' A' ' 80' ' ' ASN . 58.7 mt -103.32 174.83 5.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 116.645 -2.022 . . . . 0.0 111.293 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 51.02 52.4 15.08 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.206 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 53.29 26.36 5.16 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 117.999 -1.48 . . . . 0.0 110.571 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.73 127.41 25.48 Favored Glycine 0 N--CA 1.465 0.602 0 C-N-CA 115.087 -3.435 . . . . 0.0 110.514 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -81.32 102.64 10.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.005 -2.098 . . . . 0.0 109.817 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 p -78.71 123.3 27.02 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 115.955 -2.298 . . . . 0.0 109.909 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -92.73 152.84 19.27 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 114.92 -2.712 . . . . 0.0 108.302 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -83.45 141.76 31.46 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 115.721 -2.391 . . . . 0.0 110.782 -170.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.68 161.31 28.79 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 115.166 -3.397 . . . . 0.0 108.903 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.542 ' C ' ' H ' ' A' ' 67' ' ' ASP . 8.6 mt -66.7 138.5 22.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 114.982 -2.687 . . . . 0.0 109.327 -172.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.72 -37.74 1.89 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.57 -3.681 . . . . 0.0 112.135 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 65' ' ' ILE . 21.9 m-20 -162.84 139.19 7.35 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 116.53 -2.068 . . . . 0.0 109.484 -169.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 27.0 p90 -78.56 -164.71 0.6 Allowed 'General case' 0 C--O 1.259 1.557 0 C-N-CA 116.153 -2.219 . . . . 0.0 108.458 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 p -137.16 140.5 41.87 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 115.399 -2.52 . . . . 0.0 109.35 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.141 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 99.5 m -85.67 128.47 34.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.717 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -117.35 108.75 15.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 114.608 -2.837 . . . . 0.0 107.786 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.122 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 11.6 m -80.98 140.39 35.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 115.067 -2.653 . . . . 0.0 108.994 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 74' ' ' GLU . . . -74.5 159.67 31.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 73' ' ' ALA . 41.7 tt0 -47.07 116.58 1.42 Allowed 'General case' 0 C--O 1.258 1.514 0 C-N-CA 115.671 -2.412 . . . . 0.0 111.012 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 113.05 7.05 21.96 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 114.418 -3.753 . . . . 0.0 110.724 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.6 m-85 -139.01 152.52 47.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 C-N-CA 116.257 -2.177 . . . . 0.0 108.617 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.464 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.1 pt-20 -154.73 -151.95 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 115.9 -2.32 . . . . 0.0 109.234 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.838 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 91.76 174.28 42.78 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 115.13 -3.414 . . . . 0.0 108.754 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -61.57 -38.22 86.7 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 115.703 -2.399 . . . . 0.0 110.52 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 10.8 m-20 -102.47 26.23 8.11 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 117.513 -1.675 . . . . 0.0 111.175 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.122 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 55.5 m 57.24 30.19 18.0 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 114.17 -3.012 . . . . 0.0 107.905 -165.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.3 tp10 -63.84 -50.4 69.01 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 116.86 -1.936 . . . . 0.0 112.405 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 1.464 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.51 135.5 35.88 Favored 'General case' 0 N--CA 1.382 -3.832 0 C-N-CA 113.477 -3.289 . . . . 0.0 110.728 -149.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 36.2 p -76.12 94.82 3.54 Favored 'General case' 0 C--O 1.251 1.159 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.878 -177.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.612 ' HB ' ' CD ' ' A' ' 77' ' ' GLU . 1.1 t -73.09 -25.78 61.01 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 115.869 -2.333 . . . . 0.0 109.47 -177.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 . . . . . 0 C--O 1.202 -1.395 0 C-N-CA 115.543 -2.463 . . . . 0.0 110.847 177.665 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.3 mttp . . . . . 0 CA--C 1.594 2.646 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -72.81 146.31 46.39 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 111.869 -3.932 . . . . 0.0 111.958 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.77 98.06 0.11 Allowed Glycine 0 C--N 1.352 1.425 1 C-N-CA 113.594 -4.146 . . . . 0.0 110.81 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.78 ' O ' ' N ' ' A' ' 50' ' ' CYS . 5.1 m-20 -97.29 -6.03 35.33 Favored 'General case' 0 C--O 1.264 1.858 0 C-N-CA 115.182 -2.607 . . . . 0.0 109.693 173.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 89.9 mm-40 41.99 6.58 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 117.999 -1.48 . . . . 0.0 111.885 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.78 ' N ' ' O ' ' A' ' 48' ' ' ASP . 46.2 t -116.16 4.76 13.64 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.473 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -73.26 143.91 46.87 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 116.109 -2.236 . . . . 0.0 109.423 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.68 75.67 Favored Glycine 0 CA--C 1.541 1.716 0 C-N-CA 114.072 -3.918 . . . . 0.0 111.266 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.1 t60 48.08 90.74 0.07 OUTLIER Pre-proline 0 C--N 1.36 1.045 0 C-N-CA 115.65 -2.42 . . . . 0.0 109.179 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -93.32 -35.31 0.04 OUTLIER 'Trans proline' 0 C--O 1.249 1.047 0 C-N-CA 121.116 1.21 . . . . 0.0 110.228 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.111 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 88.7 m -81.76 146.94 29.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 114.883 -2.727 . . . . 0.0 109.19 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.56 ' CD1' HD21 ' A' ' 80' ' ' ASN . 74.2 mt -96.96 175.26 6.4 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 116.147 -2.221 . . . . 0.0 109.553 -174.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 57.46 46.81 17.41 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.085 -1.871 . . . . 0.0 107.02 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 50.69 33.48 8.35 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.871 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.66 -168.72 5.26 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 113.976 -3.964 . . . . 0.0 109.839 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -130.7 120.26 23.61 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.311 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.3 p -104.9 117.35 33.81 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 115.175 -2.61 . . . . 0.0 109.036 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -98.82 148.71 23.63 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 116.0 -2.28 . . . . 0.0 107.304 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.03 149.55 21.14 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 115.419 -2.512 . . . . 0.0 108.587 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.67 0.1 OUTLIER Glycine 0 C--O 1.255 1.458 0 C-N-CA 114.947 -3.501 . . . . 0.0 109.671 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.659 ' CG2' ' H ' ' A' ' 66' ' ' GLY . 5.6 mm -70.32 -173.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.288 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.659 ' H ' ' CG2' ' A' ' 65' ' ' ILE . . . -62.79 -4.95 7.89 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 114.244 -3.836 . . . . 0.0 110.774 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.3 p30 -123.67 146.91 47.87 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.787 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.0 p90 -84.76 -164.5 0.98 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 115.306 -2.558 . . . . 0.0 107.82 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.6 135.35 40.19 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.362 171.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.111 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 57.0 m -86.65 140.08 30.17 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 115.594 -2.442 . . . . 0.0 107.931 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -122.5 110.79 16.02 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 115.963 -2.295 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 1.129 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 6.9 m -83.08 140.53 32.61 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 115.464 -2.495 . . . . 0.0 109.432 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.66 164.23 22.03 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 115.416 -2.514 . . . . 0.0 110.191 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -50.62 109.85 0.35 Allowed 'General case' 0 C--O 1.215 -0.741 0 C-N-CA 115.277 -2.569 . . . . 0.0 109.519 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 115.88 15.13 7.5 Favored Glycine 0 CA--C 1.551 2.323 0 C-N-CA 114.984 -3.484 . . . . 0.0 112.299 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.0 m-85 -146.0 153.77 41.13 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 115.143 -2.623 . . . . 0.0 109.015 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.573 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.6 pt-20 -157.15 -145.52 0.15 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 114.593 -2.843 . . . . 0.0 107.846 177.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.896 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 84.49 176.09 50.93 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 115.089 -3.434 . . . . 0.0 108.085 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.38 -36.68 71.55 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 115.342 -2.543 . . . . 0.0 111.115 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.674 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 55.2 m-20 -107.56 21.61 17.2 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.436 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 1.129 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 62.3 m 62.02 24.52 14.61 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 114.963 -2.695 . . . . 0.0 107.278 -160.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.736 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.8 tp10 -58.7 -53.76 54.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 116.115 -2.234 . . . . 0.0 112.197 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 1.573 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.44 129.85 41.04 Favored 'General case' 0 N--CA 1.394 -3.236 0 C-N-CA 111.82 -3.952 . . . . 0.0 111.97 -149.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 20.4 p -74.29 102.5 4.37 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 115.507 -2.477 . . . . 0.0 109.664 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.454 HG22 ' CD ' ' A' ' 77' ' ' GLU . 76.2 p -44.64 -43.11 8.01 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 114.888 -2.725 . . . . 0.0 110.877 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 . . . . . 0 N--CA 1.433 -1.301 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.027 -176.44 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 1.526 ' CE ' ' HE3' ' A' ' 45' ' ' LYS . 60.0 mttm . . . . . 0 CA--C 1.5 -0.947 0 CA-C-O 122.099 0.952 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -109.16 -31.56 7.55 Favored 'General case' 0 C--O 1.178 -2.659 0 CA-C-O 126.633 3.111 . . . . 0.0 112.187 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.84 118.35 0.64 Allowed Glycine 0 CA--C 1.569 3.446 0 C-N-CA 114.676 -3.63 . . . . 0.0 109.724 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.09 39.26 1.15 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 115.154 -2.618 . . . . 0.0 108.826 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -79.92 -24.44 41.07 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 117.039 -1.864 . . . . 0.0 107.677 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 1.13 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 15.0 p -154.69 23.07 0.46 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 115.918 -2.313 . . . . 0.0 110.064 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.22 -14.52 61.36 Favored 'General case' 0 C--O 1.197 -1.674 0 C-N-CA 115.697 -2.401 . . . . 0.0 110.351 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.62 20.19 36.37 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 114.734 -3.603 . . . . 0.0 110.853 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 49.84 83.12 0.23 Allowed Pre-proline 0 C--O 1.254 1.34 0 C-N-CA 116.639 -2.024 . . . . 0.0 109.944 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -88.95 -37.53 0.06 OUTLIER 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 121.434 1.423 . . . . 0.0 110.666 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.074 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 56.6 m -72.94 127.19 31.83 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 115.108 -2.637 . . . . 0.0 110.43 -176.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.419 ' CD1' HD21 ' A' ' 80' ' ' ASN . 82.2 mt -83.32 175.04 10.18 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 116.137 -2.225 . . . . 0.0 109.873 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.43 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 60.9 m-80 64.94 50.81 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.986 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 51.28 22.85 1.48 Allowed 'General case' 0 C--O 1.253 1.241 0 C-N-CA 115.518 -2.473 . . . . 0.0 113.374 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.95 -142.65 0.38 Allowed Glycine 0 N--CA 1.499 2.85 1 C-N-CA 113.677 -4.106 . . . . 0.0 110.05 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -153.13 164.42 38.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 114.974 -2.69 . . . . 0.0 109.005 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.13 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 25.0 p -141.11 150.33 42.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 114.842 -2.743 . . . . 0.0 109.747 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -138.27 134.76 34.75 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 108.295 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.06 151.98 33.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 116.022 -2.271 . . . . 0.0 111.578 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.557 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -142.44 -176.28 16.44 Favored Glycine 0 CA--C 1.544 1.901 1 C-N-CA 113.743 -4.075 . . . . 0.0 109.216 178.106 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 65' ' ' ILE . 48.5 mt -84.93 29.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.278 -1.769 . . . . 0.0 109.297 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . 165.09 86.88 0.06 OUTLIER Glycine 0 C--N 1.262 -3.542 0 C-N-CA 115.417 -3.278 . . . . 0.0 109.849 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 73.13 134.62 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 116.174 -2.21 . . . . 0.0 109.306 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.453 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -77.89 -170.86 2.05 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 117.844 -1.542 . . . . 0.0 108.62 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -130.77 136.53 48.81 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 116.607 -2.037 . . . . 0.0 109.659 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 1.074 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -103.47 129.31 50.59 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 113.448 -3.301 . . . . 0.0 110.238 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 m -104.28 173.11 6.44 Favored 'General case' 0 C--O 1.25 1.105 0 C-N-CA 115.814 -2.355 . . . . 0.0 107.844 168.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.835 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 47.8 m -123.56 -48.96 1.91 Allowed 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 115.997 -2.281 . . . . 0.0 110.007 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.835 ' HB2' ' O ' ' A' ' 72' ' ' CYS . . . 119.75 165.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.858 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -57.3 122.21 11.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 115.375 -2.53 . . . . 0.0 111.145 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 76.95 34.91 40.81 Favored Glycine 0 N--CA 1.47 0.956 0 C-N-CA 115.114 -3.422 . . . . 0.0 111.502 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.59 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 82.7 m-85 -143.58 150.38 38.75 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.036 167.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 2.4 mt-10 -155.83 178.43 10.27 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 115.721 -2.391 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.1 179.09 21.39 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 114.72 -3.609 . . . . 0.0 110.036 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.86 -61.0 2.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 115.222 -2.591 . . . . 0.0 108.092 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.783 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 16.0 m-20 -78.91 -20.91 48.21 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 116.633 -2.027 . . . . 0.0 111.156 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.783 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 12.5 m 92.18 27.25 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 116.394 -2.123 . . . . 0.0 108.383 -164.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.25 -19.77 56.12 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 116.005 -2.278 . . . . 0.0 110.547 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.499 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 35.4 m-85 -81.16 177.48 9.0 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.825 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.9 m -136.24 39.85 2.68 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.503 166.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.511 ' OG1' ' O ' ' A' ' 84' ' ' SER . 35.2 p 43.5 30.26 0.32 Allowed 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.964 -1.894 . . . . 0.0 109.932 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 85' ' ' THR . 31.7 tpt180 . . . . . 0 C--N 1.298 -1.657 0 CA-C-O 115.888 -2.006 . . . . 0.0 109.254 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 . . . . . 0 C--O 1.213 -0.816 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 89.2 m -110.74 19.92 18.12 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 114.126 -3.03 . . . . 0.0 107.631 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.64 142.88 44.51 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 115.201 -2.599 . . . . 0.0 110.048 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.714 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 76.04 47.75 10.85 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 115.172 -3.394 . . . . 0.0 110.161 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.714 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.5 m80 9.25 91.99 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 118.161 -1.416 . . . . 0.0 111.616 173.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -91.75 -43.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.627 0.804 . . . . 0.0 110.65 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 77.2 m -77.76 151.88 33.86 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 115.611 -2.435 . . . . 0.0 110.349 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.0 mt -101.67 173.47 6.4 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.596 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.0 m120 47.69 64.69 1.51 Allowed 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 117.415 -1.714 . . . . 0.0 111.688 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 46.83 26.86 0.62 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.081 -1.448 . . . . 0.0 111.497 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.36 132.49 12.69 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 113.95 -3.976 . . . . 0.0 110.155 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -77.86 167.93 20.73 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.345 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.5 p -147.62 123.61 10.71 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 115.75 -2.38 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.0 -141.6 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 115.345 -2.542 . . . . 0.0 108.611 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -144.47 161.64 38.54 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 115.894 -2.322 . . . . 0.0 109.168 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -166.9 173.5 42.2 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 115.092 -3.433 . . . . 0.0 109.917 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.76 30.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 116.274 -2.17 . . . . 0.0 108.612 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 176.16 80.7 0.05 OUTLIER Glycine 0 C--N 1.279 -2.612 0 C-N-CA 115.614 -3.184 . . . . 0.0 108.298 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.65 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 42.3 m-20 73.81 137.21 0.05 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 116.527 -2.069 . . . . 0.0 109.355 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.4 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 26.9 p90 -78.25 -165.16 0.63 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 116.501 -2.08 . . . . 0.0 109.491 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -133.68 143.8 48.77 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.975 -2.29 . . . . 0.0 109.67 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 44.4 m -90.03 144.14 26.16 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 115.647 -2.421 . . . . 0.0 110.001 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.6 m -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 116.789 -1.964 . . . . 0.0 108.246 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 8.2 m -79.44 141.14 37.07 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 115.836 -2.346 . . . . 0.0 109.689 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.85 164.84 18.79 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 115.462 -2.495 . . . . 0.0 109.479 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.88 115.15 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.174 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.63 12.85 13.81 Favored Glycine 0 C--N 1.357 1.722 0 C-N-CA 115.068 -3.444 . . . . 0.0 112.08 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.4 m-85 -141.62 153.52 44.82 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 115.059 -2.656 . . . . 0.0 109.638 174.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.609 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -155.03 -146.31 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 115.379 -2.528 . . . . 0.0 108.914 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.918 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 87.58 168.89 45.04 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 114.285 -3.817 . . . . 0.0 107.917 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -58.32 -29.9 66.27 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 115.14 -2.624 . . . . 0.0 110.213 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -108.64 19.62 19.5 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 116.225 -2.19 . . . . 0.0 111.242 -176.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 56.0 m 60.11 27.52 16.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 115.102 -2.639 . . . . 0.0 106.945 -162.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.692 ' N ' ' O ' ' A' ' 77' ' ' GLU . 7.7 tt0 -61.61 -47.8 83.8 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 117.595 -1.642 . . . . 0.0 112.643 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 1.609 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -98.75 134.18 42.01 Favored 'General case' 0 N--CA 1.404 -2.771 0 C-N-CA 112.533 -3.667 . . . . 0.0 113.169 -152.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.3 p -79.49 106.03 11.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 115.676 -2.409 . . . . 0.0 109.748 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.46 HG22 ' CD ' ' A' ' 77' ' ' GLU . 69.6 p -46.46 -43.53 16.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 116.269 -2.172 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 . . . . . 0 C--O 1.21 -1.0 0 C-N-CA 115.278 -2.569 . . . . 0.0 110.775 -179.542 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.715 HE21 ' N ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.9 t -143.22 19.88 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 115.681 -2.408 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -81.88 -1.96 49.5 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 115.758 -2.377 . . . . 0.0 110.912 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.13 18.67 5.53 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 114.446 -3.74 . . . . 0.0 110.882 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.9 t60 51.29 90.33 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.797 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -98.92 -26.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.28 1.32 . . . . 0.0 110.041 -174.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 65.7 m -78.07 141.31 38.91 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 115.663 -2.415 . . . . 0.0 110.061 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.6 mt -88.09 177.42 6.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 117.433 -1.707 . . . . 0.0 110.216 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.553 HD22 ' HB3' ' A' ' 81' ' ' CYS . 3.2 p-10 43.67 56.88 4.28 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.891 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 57' ' ' ASN . 6.6 tt0 49.73 29.2 3.04 Favored 'General case' 0 N--CA 1.397 -3.097 0 C-N-CA 116.503 -2.079 . . . . 0.0 112.268 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.83 -176.33 16.78 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 114.815 -3.564 . . . . 0.0 111.334 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 61.0 t-80 -109.87 147.14 33.9 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 116.71 -1.996 . . . . 0.0 109.236 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.2 p -128.26 107.84 10.11 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.057 -2.257 . . . . 0.0 108.774 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -91.97 121.76 33.85 Favored 'General case' 0 C--O 1.258 1.502 0 C-N-CA 115.553 -2.459 . . . . 0.0 109.173 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.0 153.14 29.06 Favored 'General case' 0 C--O 1.255 1.37 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.934 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.32 -92.71 0.08 OUTLIER Glycine 0 CA--C 1.547 2.05 0 C-N-CA 116.64 -2.695 . . . . 0.0 109.405 174.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 66' ' ' GLY . 83.9 mt -65.22 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.587 0 C-N-CA 116.836 -1.946 . . . . 0.0 110.462 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.634 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.85 -22.31 11.88 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.267 -4.301 . . . . 0.0 111.394 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' N ' ' C ' ' A' ' 65' ' ' ILE . 31.5 m-20 -107.18 135.58 48.46 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 115.965 -2.294 . . . . 0.0 108.991 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.485 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -77.4 -166.19 0.71 Allowed 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 116.243 -2.183 . . . . 0.0 109.177 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.67 133.99 38.72 Favored 'General case' 0 C--O 1.255 1.36 0 C-N-CA 113.256 -3.378 . . . . 0.0 108.646 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 7.4 m -90.95 110.97 22.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 115.535 -2.466 . . . . 0.0 108.965 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 98.1 m -96.8 119.32 35.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.832 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.06 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 61.6 m -88.28 156.93 18.93 Favored 'General case' 0 C--O 1.276 2.457 0 C-N-CA 114.256 -2.977 . . . . 0.0 109.342 -173.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 176.11 10.0 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 115.236 -2.586 . . . . 0.0 110.392 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.02 134.02 56.62 Favored 'General case' 0 C--O 1.266 1.941 0 C-N-CA 115.954 -2.298 . . . . 0.0 110.047 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.59 24.67 60.12 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 115.522 -3.228 . . . . 0.0 110.39 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.8 m-85 -141.95 140.94 32.89 Favored 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 115.455 -2.498 . . . . 0.0 108.704 171.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -144.57 -172.42 3.81 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 116.167 -2.213 . . . . 0.0 108.728 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.72 172.56 46.55 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 115.638 -3.172 . . . . 0.0 110.79 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -64.89 -47.0 79.37 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 115.658 -2.417 . . . . 0.0 109.594 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.772 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 2.5 m-80 -79.67 -17.26 54.1 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 115.741 -2.384 . . . . 0.0 109.979 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.06 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.7 m 86.48 18.67 0.09 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 115.574 -2.45 . . . . 0.0 107.616 -164.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -55.95 -29.55 60.35 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.003 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 65.5 m-85 -78.92 162.56 25.92 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 115.032 -2.667 . . . . 0.0 110.066 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 35.7 t -121.85 29.54 7.07 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 115.243 -2.583 . . . . 0.0 107.949 170.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 84' ' ' SER . 26.3 p 43.87 19.95 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.153 0 C-N-CA 117.311 -1.755 . . . . 0.0 111.178 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.463 ' N ' ' C ' ' A' ' 84' ' ' SER . 45.2 ttt85 . . . . . 0 C--N 1.287 -2.119 0 C-N-CA 116.527 -2.069 . . . . 0.0 111.013 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -109.94 -14.33 14.28 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 114.846 -2.742 . . . . 0.0 109.967 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -74.96 144.72 43.06 Favored 'General case' 0 C--O 1.268 2.057 0 C-N-CA 114.945 -2.702 . . . . 0.0 108.965 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.762 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 87.28 43.13 5.99 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 114.666 -3.635 . . . . 0.0 110.495 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.762 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER 10.61 92.63 0.04 OUTLIER Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 112.46 -1.87 . . . . 0.0 110.506 175.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.78 -40.22 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.136 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 83.8 m -74.63 150.01 39.79 Favored 'General case' 0 C--O 1.256 1.439 0 C-N-CA 113.82 -3.152 . . . . 0.0 109.762 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.6 mt -88.63 -178.55 5.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.118 -2.233 . . . . 0.0 109.888 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.525 HD22 ' CB ' ' A' ' 81' ' ' CYS . 2.9 p-10 41.72 38.97 1.06 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.879 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 54.55 26.5 7.34 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.541 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 177.23 6.12 Favored Glycine 0 C--N 1.282 -2.462 0 C-N-CA 114.161 -3.876 . . . . 0.0 108.124 171.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -106.71 154.27 21.2 Favored 'General case' 0 C--N 1.278 -2.516 0 C-N-CA 116.229 -2.188 . . . . 0.0 108.492 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 31.4 p -133.53 93.72 3.19 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 115.658 -2.417 . . . . 0.0 108.48 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -76.99 147.41 36.85 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.117 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.58 158.53 15.41 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 116.182 -2.207 . . . . 0.0 110.025 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.4 -100.66 0.14 Allowed Glycine 0 C--O 1.24 0.517 0 C-N-CA 115.261 -3.352 . . . . 0.0 109.309 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 66' ' ' GLY . 63.2 mt -62.77 170.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 115.584 -2.447 . . . . 0.0 108.462 173.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -53.83 -19.18 9.73 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 114.46 -3.733 . . . . 0.0 110.401 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' C ' ' A' ' 65' ' ' ILE . 9.1 t70 -101.95 139.45 37.57 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.651 -1.62 . . . . 0.0 107.222 169.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.586 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -83.98 -162.12 0.61 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 116.923 -1.911 . . . . 0.0 107.296 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -141.05 141.99 34.24 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.265 -2.174 . . . . 0.0 108.594 173.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 95.1 m -94.7 114.44 26.36 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 116.131 -2.228 . . . . 0.0 110.274 -173.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 m -98.62 120.18 38.61 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 115.528 -2.469 . . . . 0.0 108.171 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 41.3 m -93.89 147.21 23.29 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 114.855 -2.738 . . . . 0.0 109.086 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.52 24.68 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 114.483 -2.887 . . . . 0.0 109.004 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.14 134.72 49.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 115.959 -2.296 . . . . 0.0 108.372 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 99.34 -13.05 61.74 Favored Glycine 0 CA--C 1.489 -1.588 0 C-N-CA 114.585 -3.674 . . . . 0.0 110.85 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.698 ' HB3' ' HB3' ' A' ' 81' ' ' CYS . 85.4 m-85 -126.95 147.94 50.09 Favored 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 114.051 -3.06 . . . . 0.0 109.436 167.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.1 170.68 19.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 114.517 -2.873 . . . . 0.0 110.652 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.47 -175.67 19.02 Favored Glycine 0 N--CA 1.434 -1.474 1 C-N-CA 113.035 -4.412 . . . . 0.0 111.343 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -74.31 -61.64 1.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 C-N-CA 113.807 -3.157 . . . . 0.0 109.394 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.3 m120 -76.56 -5.14 46.38 Favored 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 114.776 -2.77 . . . . 0.0 111.711 175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.1 m 82.51 17.44 0.34 Allowed 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 116.539 -2.065 . . . . 0.0 107.698 -169.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.75 -22.32 5.13 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 116.281 -2.168 . . . . 0.0 112.573 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.27 153.2 30.08 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 114.834 -2.747 . . . . 0.0 109.597 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 39.1 m -120.44 42.86 2.88 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 114.602 -2.839 . . . . 0.0 106.457 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p 41.41 47.42 3.12 Favored 'General case' 0 N--CA 1.512 2.665 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.833 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 . . . . . 0 C--N 1.277 -2.579 0 C-N-CA 115.262 -2.575 . . . . 0.0 109.099 -174.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 CA--C 1.565 1.538 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 24.2 t -148.63 68.38 1.07 Allowed 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 113.618 -3.233 . . . . 0.0 108.606 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 53' ' ' HIS . 8.1 tt0 -65.31 179.3 0.77 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 115.384 -2.526 . . . . 0.0 108.631 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 4.0 4.71 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 114.718 -3.611 . . . . 0.0 111.576 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 51' ' ' GLU . 11.0 t-160 -173.12 96.67 0.35 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 116.14 -2.224 . . . . 0.0 109.058 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -111.92 -46.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 108.049 -1.558 . . . . 0.0 108.049 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.5 m -81.19 157.11 25.36 Favored 'General case' 0 C--O 1.253 1.241 0 C-N-CA 114.863 -2.735 . . . . 0.0 108.923 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.9 mt -90.25 175.95 6.93 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 115.964 -2.294 . . . . 0.0 108.682 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.3 m120 56.37 43.13 26.71 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.174 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 45.66 33.38 1.42 Allowed 'General case' 0 N--CA 1.407 -2.616 0 C-N-CA 117.068 -1.853 . . . . 0.0 112.793 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.94 -170.03 1.74 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 114.77 -3.586 . . . . 0.0 109.635 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 24.2 t-80 -107.78 163.55 13.01 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 115.665 -2.414 . . . . 0.0 109.564 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 10.8 t -143.19 143.05 31.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 115.204 -2.598 . . . . 0.0 108.295 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -123.3 -144.35 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.539 -2.065 . . . . 0.0 108.114 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -140.53 152.38 45.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 114.469 -2.892 . . . . 0.0 110.315 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.95 149.55 12.02 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 115.084 -3.436 . . . . 0.0 110.026 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 67' ' ' ASP . 39.4 mt -62.57 138.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.303 -176.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.6 -28.89 1.51 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 116.299 -2.857 . . . . 0.0 111.436 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' A' ' 65' ' ' ILE . 34.3 t70 -176.58 141.14 0.38 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 116.521 -2.072 . . . . 0.0 110.152 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.773 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 17.9 p90 -81.48 -165.6 0.99 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 116.424 -2.111 . . . . 0.0 108.068 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -131.99 136.46 47.31 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 115.41 -2.516 . . . . 0.0 110.507 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.773 ' SG ' ' HE2' ' A' ' 68' ' ' TYR . 93.2 m -94.3 142.39 27.47 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 115.268 -2.573 . . . . 0.0 109.475 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 82.2 m -125.53 108.32 11.48 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 115.282 -2.567 . . . . 0.0 107.647 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.991 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.0 m -82.42 142.89 31.58 Favored 'General case' 0 C--O 1.259 1.559 0 C-N-CA 116.325 -2.15 . . . . 0.0 108.716 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 165.59 24.76 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.936 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -50.36 143.13 9.23 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.185 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 80.83 12.94 82.15 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 114.889 -3.529 . . . . 0.0 110.426 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 98.1 m-85 -140.25 143.64 36.07 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.382 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -145.56 -174.34 4.37 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 116.128 -2.229 . . . . 0.0 109.622 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.43 173.42 48.3 Favored Glycine 0 C--O 1.236 0.261 0 C-N-CA 114.636 -3.65 . . . . 0.0 109.658 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -71.15 -42.18 69.48 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 115.456 -2.498 . . . . 0.0 110.38 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.3 m120 -83.65 -4.7 58.81 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 116.795 -1.962 . . . . 0.0 110.152 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.991 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 70.91 25.66 3.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 114.322 -2.951 . . . . 0.0 108.219 -165.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.58 -25.03 68.05 Favored 'General case' 0 C--N 1.368 1.394 0 C-N-CA 116.155 -2.218 . . . . 0.0 110.057 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -79.16 175.65 10.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 115.892 -2.323 . . . . 0.0 109.234 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 23.4 p -139.97 28.45 2.12 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 116.768 -1.973 . . . . 0.0 108.246 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p 41.92 30.07 0.15 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.4 -1.72 . . . . 0.0 110.405 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 84' ' ' SER . 48.1 ttp180 . . . . . 0 C--N 1.3 -1.557 0 C-N-CA 116.426 -2.11 . . . . 0.0 109.764 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--O 1.239 0.543 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.5 t -137.32 64.41 1.53 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 115.04 -2.664 . . . . 0.0 110.132 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' C ' ' N ' ' A' ' 53' ' ' HIS . 9.1 tt0 -57.48 164.76 1.78 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 115.668 -2.413 . . . . 0.0 109.311 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.22 -12.74 8.48 Favored Glycine 0 CA--C 1.529 0.959 1 C-N-CA 113.853 -4.022 . . . . 0.0 111.448 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.422 ' N ' ' C ' ' A' ' 51' ' ' GLU . 21.1 t-160 -172.3 94.48 0.39 Allowed Pre-proline 0 CA--C 1.577 1.989 0 C-N-CA 116.323 -2.151 . . . . 0.0 109.403 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -97.34 -37.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.481 0.765 0 O-C-N 123.422 1.222 . . . . 0.0 110.668 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 79.7 m -98.54 154.75 17.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 115.235 -2.586 . . . . 0.0 108.755 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' H ' ' HB3' ' A' ' 80' ' ' ASN . 58.0 mt -73.84 176.93 5.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 115.483 -2.487 . . . . 0.0 111.662 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.499 HD22 ' CB ' ' A' ' 81' ' ' CYS . 1.9 p-10 46.2 53.44 9.39 Favored 'General case' 0 C--O 1.269 2.081 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.781 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 50.94 25.07 2.05 Favored 'General case' 0 N--CA 1.396 -3.166 0 C-N-CA 116.981 -1.888 . . . . 0.0 110.26 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.09 130.44 38.69 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 115.666 -3.159 . . . . 0.0 108.252 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -80.03 174.64 11.39 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.348 -174.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 19.4 p -139.96 116.55 10.78 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 114.407 -2.917 . . . . 0.0 108.435 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -90.38 119.72 30.91 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 115.406 -2.518 . . . . 0.0 107.338 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.3 157.56 27.69 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 116.524 -2.07 . . . . 0.0 110.02 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.16 -87.11 0.07 OUTLIER Glycine 0 C--O 1.198 -2.114 0 C-N-CA 114.23 -3.843 . . . . 0.0 108.226 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.751 HG22 ' H ' ' A' ' 66' ' ' GLY . 50.4 mt -71.04 -176.42 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.263 1.778 0 C-N-CA 116.533 -2.067 . . . . 0.0 110.231 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.751 ' H ' HG22 ' A' ' 65' ' ' ILE . . . -58.65 -13.19 16.59 Favored Glycine 0 N--CA 1.486 2.002 0 C-N-CA 116.407 -2.806 . . . . 0.0 109.878 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.6 p-10 -120.62 144.88 47.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 115.931 -2.308 . . . . 0.0 106.118 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.425 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 21.1 p90 -84.91 -161.3 0.56 Allowed 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 115.858 -2.337 . . . . 0.0 108.94 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -140.14 136.94 34.02 Favored 'General case' 0 C--O 1.204 -1.314 0 C-N-CA 116.34 -2.144 . . . . 0.0 109.098 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.3 m -78.15 137.25 38.08 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 115.283 -2.567 . . . . 0.0 108.611 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.8 m -120.67 115.22 22.92 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 116.774 -1.97 . . . . 0.0 107.754 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.065 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.2 m -84.52 139.72 31.95 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 114.886 -2.726 . . . . 0.0 110.014 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.9 168.89 5.76 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.367 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.08 120.0 6.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.166 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 98.44 23.45 12.48 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 115.016 -3.469 . . . . 0.0 111.617 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.669 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 83.8 m-85 -146.37 149.71 34.29 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 115.412 -2.515 . . . . 0.0 110.554 172.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.24 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -155.84 -146.72 0.18 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 115.314 -2.554 . . . . 0.0 109.657 173.238 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.847 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 86.68 168.43 44.82 Favored Glycine 1 N--CA 1.52 4.263 0 C-N-CA 114.739 -3.6 . . . . 0.0 109.165 177.353 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -54.7 -37.25 65.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 116.254 -2.179 . . . . 0.0 109.008 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.491 ' HB3' ' H ' ' A' ' 56' ' ' LEU . 1.6 m120 -102.19 29.93 4.82 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 116.105 -2.238 . . . . 0.0 111.676 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.065 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 73.6 m 50.84 25.01 1.97 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 115.232 -2.587 . . . . 0.0 106.786 -163.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.815 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.2 tp10 -55.22 -55.03 35.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.455 -1.698 . . . . 0.0 113.022 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 1.24 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -90.1 139.1 30.95 Favored 'General case' 0 N--CA 1.387 -3.582 0 C-N-CA 113.445 -3.302 . . . . 0.0 112.098 -148.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 22.8 t -86.15 58.47 5.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 115.992 -2.283 . . . . 0.0 110.734 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.2 p 37.14 28.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 116.051 -2.26 . . . . 0.0 112.051 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' N ' ' C ' ' A' ' 84' ' ' SER . 71.4 mtp85 . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 115.941 -1.98 . . . . 0.0 108.762 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 74.2 m -117.32 -0.66 11.95 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.425 -2.11 . . . . 0.0 108.98 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 115.059 -2.657 . . . . 0.0 109.85 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -95.55 18.13 57.98 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 114.903 -3.522 . . . . 0.0 111.01 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' GLY . 16.4 t-160 44.48 84.2 0.19 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 116.239 -2.185 . . . . 0.0 110.161 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -97.13 -38.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 O-C-N 123.667 1.351 . . . . 0.0 111.096 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.051 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 61.2 m -96.42 151.02 19.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 115.677 -2.409 . . . . 0.0 110.423 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.78 176.39 5.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 116.128 -2.229 . . . . 0.0 110.034 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 56.75 47.77 17.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 117.218 -1.793 . . . . 0.0 111.755 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 49.52 35.12 7.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.174 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.75 -161.39 4.88 Favored Glycine 0 C--N 1.363 2.05 0 C-N-CA 114.051 -3.928 . . . . 0.0 110.468 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 9.0 t-160 -135.68 175.03 9.97 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 115.208 -2.597 . . . . 0.0 109.697 -176.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 14.3 p -153.13 138.14 17.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 114.374 -2.93 . . . . 0.0 108.702 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -115.82 133.28 56.19 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 116.124 -2.23 . . . . 0.0 109.237 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.14 159.3 29.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 116.083 -2.247 . . . . 0.0 108.607 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 66' ' ' GLY . . . -152.21 38.29 0.79 Allowed Glycine 0 N--CA 1.504 3.178 0 C-N-CA 114.471 -3.728 . . . . 0.0 110.367 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 65' ' ' ILE . 81.4 mt 36.27 36.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 116.784 -1.966 . . . . 0.0 110.037 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 162.22 85.62 0.06 OUTLIER Glycine 0 C--N 1.288 -2.101 0 C-N-CA 115.471 -3.252 . . . . 0.0 109.825 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.2 m-20 67.57 116.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 116.656 -2.017 . . . . 0.0 109.007 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.488 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 24.6 p90 -76.7 -169.9 1.4 Allowed 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.278 -2.569 . . . . 0.0 108.363 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 p -139.43 132.8 30.07 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 115.789 -2.364 . . . . 0.0 108.831 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.051 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 61.4 m -81.68 128.46 33.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.38 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 88.8 m -108.04 109.65 21.15 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 114.739 -2.785 . . . . 0.0 108.435 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.9 m -86.46 143.41 27.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 115.57 -2.452 . . . . 0.0 109.648 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.71 171.44 13.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 116.935 -1.906 . . . . 0.0 109.711 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -52.4 126.88 20.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 115.705 -2.398 . . . . 0.0 110.039 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.6 19.46 44.48 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.769 -3.586 . . . . 0.0 110.235 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 99.9 m-85 -140.49 145.99 37.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.287 -2.565 . . . . 0.0 108.538 165.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 46.2 mm-40 -146.31 -166.97 2.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 116.086 -2.245 . . . . 0.0 109.083 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.54 168.27 35.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 114.296 -3.811 . . . . 0.0 109.261 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -68.54 -37.09 79.68 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 114.58 -2.848 . . . . 0.0 109.904 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.1 m120 -80.72 -16.01 55.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.16 -1.816 . . . . 0.0 111.762 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.2 m 77.98 18.67 1.16 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.16 -2.616 . . . . 0.0 107.331 -162.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.74 -31.16 69.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 117.498 -1.681 . . . . 0.0 110.211 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 49.5 m-85 -78.82 160.71 27.23 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 115.362 -2.535 . . . . 0.0 110.502 -176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.569 ' C ' ' N ' ' A' ' 86' ' ' ARG . 19.2 t -123.58 38.08 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 115.564 -2.455 . . . . 0.0 108.221 170.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p 40.03 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.324 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.569 ' N ' ' C ' ' A' ' 84' ' ' SER . 78.0 ttt-85 . . . . . 0 C--N 1.308 -1.231 0 C-N-CA 115.936 -2.306 . . . . 0.0 110.202 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.4 t -127.19 -22.8 3.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 114.906 -2.718 . . . . 0.0 111.532 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.3 -17.41 64.77 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 114.311 -2.956 . . . . 0.0 110.122 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -88.88 36.36 3.48 Favored Glycine 0 C--O 1.259 1.657 0 C-N-CA 115.872 -3.061 . . . . 0.0 110.993 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.72 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.7 m-70 13.98 88.47 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 117.843 -1.543 . . . . 0.0 110.678 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -89.98 -42.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.974 1.782 . . . . 0.0 109.746 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 38.7 m -81.97 113.42 19.86 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 116.12 -2.232 . . . . 0.0 110.969 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -74.82 175.93 7.55 Favored 'General case' 0 CA--C 1.58 2.126 0 C-N-CA 115.023 -2.671 . . . . 0.0 110.666 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.7 m120 62.11 50.44 4.0 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 117.146 -1.821 . . . . 0.0 109.972 168.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 53.39 27.79 6.74 Favored 'General case' 0 C--O 1.281 2.711 0 C-N-CA 116.7 -2.0 . . . . 0.0 111.389 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.18 -150.46 3.86 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 114.081 -3.914 . . . . 0.0 110.44 175.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -141.07 135.13 30.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 114.606 -2.838 . . . . 0.0 108.308 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.7 p -113.93 128.11 56.26 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 116.051 -2.26 . . . . 0.0 110.032 176.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -97.78 -165.24 1.23 Allowed 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.599 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -151.81 138.03 18.37 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 115.945 -2.302 . . . . 0.0 109.26 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.29 -95.96 0.1 Allowed Glycine 0 C--O 1.247 0.959 0 C-N-CA 114.49 -3.719 . . . . 0.0 109.766 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.649 HG22 ' N ' ' A' ' 66' ' ' GLY . 71.6 mt -62.82 177.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 116.007 -2.277 . . . . 0.0 110.833 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.649 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.32 -18.76 5.22 Favored Glycine 0 CA--C 1.549 2.205 0 C-N-CA 114.772 -3.585 . . . . 0.0 111.067 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' C ' ' A' ' 65' ' ' ILE . 3.3 p-10 -112.81 146.56 38.64 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 116.005 -2.278 . . . . 0.0 108.014 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -83.89 -166.03 1.3 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 116.762 -1.975 . . . . 0.0 108.604 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.87 136.15 36.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 114.985 -2.686 . . . . 0.0 108.542 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 8.6 m -95.88 155.33 16.8 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 114.676 -2.81 . . . . 0.0 110.937 -174.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -135.49 131.04 35.61 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 115.506 -2.478 . . . . 0.0 109.0 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.033 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.6 m -107.51 142.45 37.37 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 114.697 -2.801 . . . . 0.0 108.503 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.87 172.71 10.36 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 116.233 -2.187 . . . . 0.0 109.319 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -55.85 146.21 22.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.863 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.23 8.73 87.62 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 114.487 -3.721 . . . . 0.0 110.994 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 92.4 m-85 -136.82 140.74 42.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 114.506 -2.878 . . . . 0.0 109.998 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -147.08 -166.75 2.59 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 116.197 -2.201 . . . . 0.0 107.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.56 167.06 38.06 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 114.383 -3.77 . . . . 0.0 109.501 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -67.8 -34.44 76.75 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 116.375 -2.13 . . . . 0.0 108.391 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.59 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.3 m120 -89.71 -4.74 57.57 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 116.35 -2.14 . . . . 0.0 111.933 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.033 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.8 m 71.66 17.48 5.53 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 114.484 -2.886 . . . . 0.0 107.452 -166.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.28 -31.12 68.82 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 118.021 -1.472 . . . . 0.0 109.406 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 38.3 m-85 -79.74 165.01 23.24 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 115.517 -2.473 . . . . 0.0 111.296 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.5 t -127.29 38.67 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.53 -2.468 . . . . 0.0 107.898 173.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.6 p 46.1 22.95 0.16 Allowed 'General case' 0 N--CA 1.511 2.588 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.836 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' N ' ' C ' ' A' ' 84' ' ' SER . 8.8 mmm180 . . . . . 0 N--CA 1.514 2.732 0 CA-C-O 115.702 -2.094 . . . . 0.0 108.135 176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 85.9 mm-40 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 122.552 1.168 . . . . 0.0 111.732 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 50.1 t -112.53 54.97 0.7 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 115.101 -2.639 . . . . 0.0 109.513 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' CYS . 16.9 tt0 -40.61 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 115.669 -2.412 . . . . 0.0 111.204 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.6 -14.01 8.77 Favored Glycine 0 CA--C 1.559 2.832 0 C-N-CA 114.488 -3.72 . . . . 0.0 112.115 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -174.26 93.03 0.32 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 115.191 -2.604 . . . . 0.0 109.888 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -99.74 -41.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.823 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.203 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -81.72 169.39 17.01 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 115.926 -2.31 . . . . 0.0 109.122 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.91 176.88 5.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 115.181 -2.608 . . . . 0.0 109.784 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.1 m120 56.52 44.13 24.67 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.029 -1.869 . . . . 0.0 110.356 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 50.49 29.29 3.87 Favored 'General case' 0 N--CA 1.385 -3.693 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.14 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.45 -166.99 7.9 Favored Glycine 0 N--CA 1.475 1.277 1 C-N-CA 113.099 -4.382 . . . . 0.0 111.48 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 13.9 t-160 -120.13 166.08 13.9 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 116.179 -2.208 . . . . 0.0 110.089 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 20.2 p -144.87 130.12 18.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 115.355 -2.538 . . . . 0.0 108.576 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -103.29 -132.75 0.3 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 115.241 -2.584 . . . . 0.0 108.188 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -144.84 156.04 43.81 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 115.227 -2.589 . . . . 0.0 110.19 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.37 141.47 4.81 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 114.849 -3.548 . . . . 0.0 108.804 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 67' ' ' ASP . 11.1 mt -59.65 137.19 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 113.047 -3.461 . . . . 0.0 110.769 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.99 -38.32 2.97 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 115.176 -3.392 . . . . 0.0 110.236 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.9 147.23 5.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 116.124 -2.23 . . . . 0.0 108.997 -174.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HD1' ' HB3' ' A' ' 49' ' ' GLN . 16.7 p90 -86.13 -166.59 1.58 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 116.237 -2.185 . . . . 0.0 108.001 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -134.36 142.67 47.28 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 114.297 -2.961 . . . . 0.0 108.936 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.203 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 97.3 m -90.64 145.86 24.5 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 115.182 -2.607 . . . . 0.0 110.05 -176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 97.1 m -126.8 116.83 21.49 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 116.15 -2.22 . . . . 0.0 107.848 172.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.3 m -90.05 143.88 26.39 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 116.049 -2.26 . . . . 0.0 109.745 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.48 171.57 12.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 116.313 -2.155 . . . . 0.0 110.468 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.82 137.96 43.71 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.179 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.15 16.28 69.91 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 115.447 -3.263 . . . . 0.0 111.121 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.8 m-85 -144.2 145.07 31.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.807 -2.357 . . . . 0.0 108.878 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 5.0 mt-10 -147.63 -178.95 6.53 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.488 -2.085 . . . . 0.0 109.555 -176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.7 174.66 39.88 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 114.859 -3.543 . . . . 0.0 109.762 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.34 -48.33 56.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 115.577 -2.449 . . . . 0.0 109.725 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.2 m120 -82.08 -5.0 58.07 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 116.741 -1.984 . . . . 0.0 110.622 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 74.25 27.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 115.159 -2.617 . . . . 0.0 108.922 -165.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.9 -22.59 65.7 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 117.38 -1.728 . . . . 0.0 110.076 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -85.04 165.26 17.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 114.82 -2.752 . . . . 0.0 109.177 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.8 t -128.49 35.81 4.34 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 115.713 -2.395 . . . . 0.0 107.695 169.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 84' ' ' SER . 20.7 p 44.29 16.15 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 117.439 -1.704 . . . . 0.0 111.39 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.549 ' N ' ' C ' ' A' ' 84' ' ' SER . 15.6 ptm180 . . . . . 0 C--O 1.196 -1.76 0 C-N-CA 114.938 -2.705 . . . . 0.0 108.949 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.753 HE21 ' N ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.575 1.908 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 49' ' ' GLN . 59.1 m -163.87 14.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 116.191 -2.204 . . . . 0.0 109.47 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -78.67 -14.09 59.48 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 114.965 -2.694 . . . . 0.0 108.437 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -117.04 26.0 8.53 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 114.986 -3.483 . . . . 0.0 110.327 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' GLY . 13.2 t-160 39.65 91.5 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 116.066 -2.254 . . . . 0.0 110.788 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -91.68 -31.95 0.09 OUTLIER 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 121.339 1.36 . . . . 0.0 109.878 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 60' ' ' HIS . 15.7 m -75.83 124.38 27.22 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.696 -2.401 . . . . 0.0 110.598 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.07 176.44 8.68 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 116.476 -2.09 . . . . 0.0 109.404 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 63.36 40.33 8.6 Favored 'General case' 0 C--O 1.29 3.202 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.895 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 46.5 35.88 3.19 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 115.266 -2.574 . . . . 0.0 110.35 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.11 -134.82 0.05 OUTLIER Glycine 0 CA--C 1.563 3.042 1 C-N-CA 113.141 -4.361 . . . . 0.0 110.2 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.424 ' O ' ' SG ' ' A' ' 55' ' ' CYS . 2.0 t-160 -159.17 -175.46 5.27 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 114.64 -2.824 . . . . 0.0 109.003 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.5 t -155.46 128.94 8.39 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 114.429 -2.908 . . . . 0.0 108.36 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -89.43 -20.97 23.28 Favored 'General case' 0 C--O 1.256 1.418 0 C-N-CA 114.629 -2.828 . . . . 0.0 110.301 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 63.22 146.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 117.59 -1.644 . . . . 0.0 110.443 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 -100.91 0.14 Allowed Glycine 0 C--O 1.211 -1.282 0 C-N-CA 114.81 -3.567 . . . . 0.0 109.417 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 66' ' ' GLY . 4.6 mm -69.4 178.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 116.081 -2.248 . . . . 0.0 110.713 172.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.653 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -49.92 -23.39 5.3 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 115.561 -3.209 . . . . 0.0 110.192 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.428 ' N ' ' C ' ' A' ' 65' ' ' ILE . 6.0 m-20 -98.27 132.05 44.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 116.569 -2.052 . . . . 0.0 108.669 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 17.9 p90 -90.65 -173.81 3.87 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 115.256 -2.578 . . . . 0.0 109.941 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 p -123.95 133.79 53.63 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 115.95 -2.3 . . . . 0.0 108.942 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.83 128.96 49.37 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 115.584 -2.446 . . . . 0.0 109.614 -171.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 72' ' ' CYS . 38.9 m -99.26 170.03 8.95 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 115.441 -2.504 . . . . 0.0 106.636 171.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.022 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.0 m -122.09 -45.05 2.26 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 114.276 -2.97 . . . . 0.0 110.897 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' CB ' ' O ' ' A' ' 72' ' ' CYS . . . 115.88 162.28 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.99 119.35 5.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 115.58 -2.448 . . . . 0.0 110.943 -175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.2 29.94 32.36 Favored Glycine 0 N--CA 1.504 3.218 0 C-N-CA 114.156 -3.878 . . . . 0.0 111.839 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.732 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 88.5 m-85 -142.96 152.1 41.63 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 114.088 -3.045 . . . . 0.0 108.943 170.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 6.5 mt-10 -153.32 -176.68 5.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 115.336 -2.546 . . . . 0.0 108.442 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.74 176.32 28.27 Favored Glycine 0 C--N 1.361 1.919 0 C-N-CA 114.315 -3.802 . . . . 0.0 110.568 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -58.01 -63.18 1.35 Allowed 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 116.463 -2.095 . . . . 0.0 110.568 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.825 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -78.85 -21.0 48.23 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 116.15 -2.22 . . . . 0.0 110.713 177.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.022 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 19.5 m 94.1 26.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 116.647 -2.021 . . . . 0.0 107.671 -168.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.76 -19.91 65.34 Favored 'General case' 0 CA--C 1.6 2.897 0 C-N-CA 117.078 -1.849 . . . . 0.0 109.274 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.462 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 27.5 m-85 -78.14 176.2 9.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.764 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 80.5 p -133.97 28.4 3.84 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 116.12 -2.232 . . . . 0.0 108.278 172.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 84' ' ' SER . 41.0 p 47.54 5.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 117.54 -1.664 . . . . 0.0 111.148 -172.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.649 ' H ' ' C ' ' A' ' 84' ' ' SER . 16.1 tpt180 . . . . . 0 CA--C 1.572 1.815 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.83 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.0 m -145.23 -22.75 0.49 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 115.416 -2.514 . . . . 0.0 109.563 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -78.58 -15.67 58.28 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 116.349 -2.14 . . . . 0.0 108.748 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -87.8 13.37 61.11 Favored Glycine 0 C--O 1.215 -1.057 0 C-N-CA 114.817 -3.563 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.6 t-160 44.3 82.18 0.24 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 116.485 -2.086 . . . . 0.0 110.018 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -95.69 -42.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.029 1.153 . . . . 0.0 110.606 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.11 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 72.4 m -77.74 160.42 28.42 Favored 'General case' 0 C--O 1.253 1.258 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.713 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.99 175.86 5.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 116.038 -2.265 . . . . 0.0 110.989 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 55.43 38.9 30.94 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 117.458 -1.697 . . . . 0.0 110.319 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 56.79 25.95 10.91 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.827 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.16 136.6 32.63 Favored Glycine 0 N--CA 1.424 -2.16 0 C-N-CA 114.723 -3.608 . . . . 0.0 108.864 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -78.47 179.37 7.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.725 -2.237 . . . . 0.0 108.725 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 11.1 p -154.61 137.49 15.39 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.661 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -102.35 128.32 48.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 115.76 -2.376 . . . . 0.0 108.855 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.4 149.39 42.52 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 115.681 -2.407 . . . . 0.0 109.878 -173.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.55 161.99 35.79 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 115.469 -3.253 . . . . 0.0 108.356 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.74 144.0 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 116.195 -2.202 . . . . 0.0 109.16 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 68.8 69.56 1.36 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 114.728 -3.606 . . . . 0.0 111.802 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 32.4 m-20 68.08 153.51 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.95 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -82.75 -164.47 0.86 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 118.045 -1.462 . . . . 0.0 107.239 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 17.6 p -135.16 152.11 51.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 116.218 -2.193 . . . . 0.0 108.797 171.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.11 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.0 m -96.22 154.03 17.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 115.738 -2.385 . . . . 0.0 110.802 -174.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.2 m -142.24 113.73 7.81 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 115.27 -2.572 . . . . 0.0 108.147 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.036 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 22.2 m -89.67 140.63 29.38 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 115.141 -2.624 . . . . 0.0 108.846 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.2 169.72 15.55 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.583 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 127.76 28.42 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 116.259 -2.177 . . . . 0.0 110.196 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.17 18.59 49.44 Favored Glycine 0 N--CA 1.48 1.57 1 C-N-CA 113.714 -4.089 . . . . 0.0 111.209 -178.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.732 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 92.9 m-85 -140.63 142.15 35.03 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 115.298 -2.561 . . . . 0.0 111.322 161.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.36 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -143.2 -145.86 0.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.341 -2.544 . . . . 0.0 109.719 169.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.994 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 82.13 164.25 33.87 Favored Glycine 1 N--CA 1.519 4.207 0 C-N-CA 114.229 -3.844 . . . . 0.0 107.067 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.08 -50.74 70.18 Favored 'General case' 0 N--CA 1.511 2.625 0 C-N-CA 115.063 -2.655 . . . . 0.0 110.869 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -90.13 29.04 1.28 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.408 -1.717 . . . . 0.0 110.348 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.036 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 47.8 m 57.07 20.78 5.76 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 113.943 -3.103 . . . . 0.0 106.678 -164.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 80' ' ' ASN . 9.3 tp10 -49.08 -52.47 25.56 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 117.528 -1.669 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 1.36 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.93 174.85 6.96 Favored 'General case' 1 N--CA 1.365 -4.683 0 C-N-CA 112.977 -3.489 . . . . 0.0 109.311 -165.768 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.926 ' O ' HG23 ' A' ' 85' ' ' THR . 22.9 p -88.69 -68.67 0.75 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.004 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.926 HG23 ' O ' ' A' ' 84' ' ' SER . 0.9 OUTLIER -178.29 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 CA--C 1.553 1.07 0 CA-C-O 113.404 -3.188 . . . . 0.0 108.399 -179.848 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 . . . . . 0 CA--C 1.566 1.582 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.3 t -122.98 -3.98 8.57 Favored 'General case' 0 C--O 1.256 1.426 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.733 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.2 -21.98 58.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 114.395 -2.922 . . . . 0.0 109.458 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.07 7.6 81.79 Favored Glycine 0 CA--C 1.558 2.732 0 C-N-CA 114.242 -3.837 . . . . 0.0 112.019 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.52 86.13 0.16 Allowed Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 116.478 -2.089 . . . . 0.0 110.187 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -97.95 -46.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 109.88 -0.854 . . . . 0.0 109.88 -171.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -75.28 165.07 25.76 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.446 -170.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -103.32 174.83 5.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 116.645 -2.022 . . . . 0.0 111.293 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 51.02 52.4 15.08 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.206 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 53.29 26.36 5.16 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 117.999 -1.48 . . . . 0.0 110.571 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.73 127.41 25.48 Favored Glycine 0 N--CA 1.465 0.602 0 C-N-CA 115.087 -3.435 . . . . 0.0 110.514 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -81.32 102.64 10.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.005 -2.098 . . . . 0.0 109.817 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 p -78.71 123.3 27.02 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 115.955 -2.298 . . . . 0.0 109.909 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -92.73 152.84 19.27 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 114.92 -2.712 . . . . 0.0 108.302 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -83.45 141.76 31.46 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 115.721 -2.391 . . . . 0.0 110.782 -170.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.68 161.31 28.79 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 115.166 -3.397 . . . . 0.0 108.903 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 67' ' ' ASP . 8.6 mt -66.7 138.5 22.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 114.982 -2.687 . . . . 0.0 109.327 -172.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.72 -37.74 1.89 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.57 -3.681 . . . . 0.0 112.135 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 65' ' ' ILE . 21.9 m-20 -162.84 139.19 7.35 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 116.53 -2.068 . . . . 0.0 109.484 -169.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 27.0 p90 -78.56 -164.71 0.6 Allowed 'General case' 0 C--O 1.259 1.557 0 C-N-CA 116.153 -2.219 . . . . 0.0 108.458 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 p -137.16 140.5 41.87 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 115.399 -2.52 . . . . 0.0 109.35 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 99.5 m -85.67 128.47 34.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.717 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -117.35 108.75 15.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 114.608 -2.837 . . . . 0.0 107.786 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 11.6 m -80.98 140.39 35.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 115.067 -2.653 . . . . 0.0 108.994 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 74' ' ' GLU . . . -74.5 159.67 31.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 73' ' ' ALA . 41.7 tt0 -47.07 116.58 1.42 Allowed 'General case' 0 C--O 1.258 1.514 0 C-N-CA 115.671 -2.412 . . . . 0.0 111.012 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 113.05 7.05 21.96 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 114.418 -3.753 . . . . 0.0 110.724 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.6 m-85 -139.01 152.52 47.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 C-N-CA 116.257 -2.177 . . . . 0.0 108.617 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.438 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.1 pt-20 -154.73 -151.95 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 115.9 -2.32 . . . . 0.0 109.234 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.838 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 91.76 174.28 42.78 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 115.13 -3.414 . . . . 0.0 108.754 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -61.57 -38.22 86.7 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 115.703 -2.399 . . . . 0.0 110.52 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.553 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 0.7 OUTLIER -102.47 26.23 8.11 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 117.513 -1.675 . . . . 0.0 111.175 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 55.5 m 57.24 30.19 18.0 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 114.17 -3.012 . . . . 0.0 107.905 -165.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.3 tp10 -63.84 -50.4 69.01 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 116.86 -1.936 . . . . 0.0 112.405 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 1.438 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.51 135.5 35.88 Favored 'General case' 0 N--CA 1.382 -3.832 0 C-N-CA 113.477 -3.289 . . . . 0.0 110.728 -149.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 36.2 p -76.12 94.82 3.54 Favored 'General case' 0 C--O 1.251 1.159 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.878 -177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.698 ' HB ' ' CD ' ' A' ' 77' ' ' GLU . 1.1 t -73.09 -25.78 61.01 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 115.869 -2.333 . . . . 0.0 109.47 -177.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 . . . . . 0 C--O 1.202 -1.395 0 C-N-CA 115.543 -2.463 . . . . 0.0 110.847 177.665 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 89.9 mm-40 . . . . . 0 CA--C 1.559 1.311 0 CA-C-O 121.034 0.445 . . . . 0.0 111.885 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 46.2 t -116.16 4.76 13.64 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.473 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -73.26 143.91 46.87 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 116.109 -2.236 . . . . 0.0 109.423 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.68 75.67 Favored Glycine 0 CA--C 1.541 1.716 0 C-N-CA 114.072 -3.918 . . . . 0.0 111.266 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.1 t60 48.08 90.74 0.07 OUTLIER Pre-proline 0 C--N 1.36 1.045 0 C-N-CA 115.65 -2.42 . . . . 0.0 109.179 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -93.32 -35.31 0.04 OUTLIER 'Trans proline' 0 C--O 1.249 1.047 0 C-N-CA 121.116 1.21 . . . . 0.0 110.228 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.025 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 88.7 m -81.76 146.94 29.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 114.883 -2.727 . . . . 0.0 109.19 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.2 mt -96.96 175.26 6.4 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 116.147 -2.221 . . . . 0.0 109.553 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.6 m120 57.46 46.81 17.41 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.085 -1.871 . . . . 0.0 107.02 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 50.69 33.48 8.35 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.871 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.66 -168.72 5.26 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 113.976 -3.964 . . . . 0.0 109.839 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -130.7 120.26 23.61 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.311 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.3 p -104.9 117.35 33.81 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 115.175 -2.61 . . . . 0.0 109.036 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -98.82 148.71 23.63 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 116.0 -2.28 . . . . 0.0 107.304 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.03 149.55 21.14 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 115.419 -2.512 . . . . 0.0 108.587 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.67 0.1 OUTLIER Glycine 0 C--O 1.255 1.458 0 C-N-CA 114.947 -3.501 . . . . 0.0 109.671 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.811 HG22 ' H ' ' A' ' 66' ' ' GLY . 5.6 mm -70.32 -173.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.288 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.811 ' H ' HG22 ' A' ' 65' ' ' ILE . . . -62.79 -4.95 7.89 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 114.244 -3.836 . . . . 0.0 110.774 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.3 p30 -123.67 146.91 47.87 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.787 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.544 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.0 p90 -84.76 -164.5 0.98 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 115.306 -2.558 . . . . 0.0 107.82 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.6 135.35 40.19 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.362 171.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.025 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 57.0 m -86.65 140.08 30.17 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 115.594 -2.442 . . . . 0.0 107.931 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -122.5 110.79 16.02 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 115.963 -2.295 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 6.9 m -83.08 140.53 32.61 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 115.464 -2.495 . . . . 0.0 109.432 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.66 164.23 22.03 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 115.416 -2.514 . . . . 0.0 110.191 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -50.62 109.85 0.35 Allowed 'General case' 0 C--O 1.215 -0.741 0 C-N-CA 115.277 -2.569 . . . . 0.0 109.519 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 115.88 15.13 7.5 Favored Glycine 0 CA--C 1.551 2.323 0 C-N-CA 114.984 -3.484 . . . . 0.0 112.299 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.0 m-85 -146.0 153.77 41.13 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 115.143 -2.623 . . . . 0.0 109.015 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.522 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.6 pt-20 -157.15 -145.52 0.15 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 114.593 -2.843 . . . . 0.0 107.846 177.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.896 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 84.49 176.09 50.93 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 115.089 -3.434 . . . . 0.0 108.085 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.38 -36.68 71.55 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 115.342 -2.543 . . . . 0.0 111.115 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.657 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 1.4 m120 -107.56 21.61 17.2 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.436 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 62.3 m 62.02 24.52 14.61 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 114.963 -2.695 . . . . 0.0 107.278 -160.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.736 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.8 tp10 -58.7 -53.76 54.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 116.115 -2.234 . . . . 0.0 112.197 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 1.522 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.44 129.85 41.04 Favored 'General case' 0 N--CA 1.394 -3.236 0 C-N-CA 111.82 -3.952 . . . . 0.0 111.97 -149.548 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 20.4 p -74.29 102.5 4.37 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 115.507 -2.477 . . . . 0.0 109.664 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.457 HG22 ' CD ' ' A' ' 77' ' ' GLU . 76.2 p -44.64 -43.11 8.01 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 114.888 -2.725 . . . . 0.0 110.877 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 . . . . . 0 N--CA 1.433 -1.301 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.027 -176.44 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 C--O 1.238 0.47 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 15.0 p -154.69 23.07 0.46 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 115.918 -2.313 . . . . 0.0 110.064 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.22 -14.52 61.36 Favored 'General case' 0 C--O 1.197 -1.674 0 C-N-CA 115.697 -2.401 . . . . 0.0 110.351 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.62 20.19 36.37 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 114.734 -3.603 . . . . 0.0 110.853 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 49.84 83.12 0.23 Allowed Pre-proline 0 C--O 1.254 1.34 0 C-N-CA 116.639 -2.024 . . . . 0.0 109.944 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -88.95 -37.53 0.06 OUTLIER 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 121.434 1.423 . . . . 0.0 110.666 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 1.003 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 56.6 m -72.94 127.19 31.83 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 115.108 -2.637 . . . . 0.0 110.43 -176.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.32 175.04 10.18 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 116.137 -2.225 . . . . 0.0 109.873 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 14.9 m120 64.94 50.81 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.986 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 51.28 22.85 1.48 Allowed 'General case' 0 C--O 1.253 1.241 0 C-N-CA 115.518 -2.473 . . . . 0.0 113.374 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.95 -142.65 0.38 Allowed Glycine 0 N--CA 1.499 2.85 1 C-N-CA 113.677 -4.106 . . . . 0.0 110.05 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -153.13 164.42 38.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 114.974 -2.69 . . . . 0.0 109.005 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 25.0 p -141.11 150.33 42.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 114.842 -2.743 . . . . 0.0 109.747 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -138.27 134.76 34.75 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 108.295 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.06 151.98 33.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 116.022 -2.271 . . . . 0.0 111.578 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -142.44 -176.28 16.44 Favored Glycine 0 CA--C 1.544 1.901 1 C-N-CA 113.743 -4.075 . . . . 0.0 109.216 178.106 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 65' ' ' ILE . 48.5 mt -84.93 29.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.278 -1.769 . . . . 0.0 109.297 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . 165.09 86.88 0.06 OUTLIER Glycine 0 C--N 1.262 -3.542 0 C-N-CA 115.417 -3.278 . . . . 0.0 109.849 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 73.13 134.62 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 116.174 -2.21 . . . . 0.0 109.306 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.494 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -77.89 -170.86 2.05 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 117.844 -1.542 . . . . 0.0 108.62 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -130.77 136.53 48.81 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 116.607 -2.037 . . . . 0.0 109.659 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 1.003 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -103.47 129.31 50.59 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 113.448 -3.301 . . . . 0.0 110.238 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 72' ' ' CYS . 55.0 m -104.28 173.11 6.44 Favored 'General case' 0 C--O 1.25 1.105 0 C-N-CA 115.814 -2.355 . . . . 0.0 107.844 168.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.801 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.8 m -123.56 -48.96 1.91 Allowed 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 115.997 -2.281 . . . . 0.0 110.007 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.801 ' CB ' ' O ' ' A' ' 72' ' ' CYS . . . 119.75 165.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.858 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -57.3 122.21 11.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 115.375 -2.53 . . . . 0.0 111.145 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 76.95 34.91 40.81 Favored Glycine 0 N--CA 1.47 0.956 0 C-N-CA 115.114 -3.422 . . . . 0.0 111.502 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 73' ' ' ALA . 82.7 m-85 -143.58 150.38 38.75 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.036 167.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 2.4 mt-10 -155.83 178.43 10.27 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 115.721 -2.391 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.1 179.09 21.39 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 114.72 -3.609 . . . . 0.0 110.036 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.86 -61.0 2.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 115.222 -2.591 . . . . 0.0 108.092 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.783 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 0.8 OUTLIER -78.91 -20.91 48.21 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 116.633 -2.027 . . . . 0.0 111.156 176.07 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.783 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 12.5 m 92.18 27.25 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 116.394 -2.123 . . . . 0.0 108.383 -164.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.25 -19.77 56.12 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 116.005 -2.278 . . . . 0.0 110.547 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.463 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 35.4 m-85 -81.16 177.48 9.0 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.825 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.9 m -136.24 39.85 2.68 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.503 166.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 35.2 p 43.5 30.26 0.32 Allowed 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.964 -1.894 . . . . 0.0 109.932 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' THR . 31.7 tpt180 . . . . . 0 C--N 1.298 -1.657 0 CA-C-O 115.888 -2.006 . . . . 0.0 109.254 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp . . . . . 0 N--CA 1.424 -1.757 0 CA-C-O 113.279 -3.248 . . . . 0.0 115.607 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -114.71 -45.66 2.98 Favored 'General case' 0 C--O 1.268 2.039 2 C-N-CA 111.238 -4.185 . . . . 0.0 110.433 -173.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.29 98.07 0.13 Allowed Glycine 0 CA--C 1.472 -2.606 0 C-N-CA 114.574 -3.679 . . . . 0.0 108.866 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' A' ' 50' ' ' CYS . 3.7 p-10 -104.39 -10.76 17.52 Favored 'General case' 0 CA--C 1.581 2.15 0 C-N-CA 114.294 -2.962 . . . . 0.0 109.065 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 46.53 7.05 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.846 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 89.2 m -110.74 19.92 18.12 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 114.126 -3.03 . . . . 0.0 107.631 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.64 142.88 44.51 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 115.201 -2.599 . . . . 0.0 110.048 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.714 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 76.04 47.75 10.85 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 115.172 -3.394 . . . . 0.0 110.161 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.714 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.5 m80 9.25 91.99 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 118.161 -1.416 . . . . 0.0 111.616 173.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -91.75 -43.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.627 0.804 . . . . 0.0 110.65 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 77.2 m -77.76 151.88 33.86 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 115.611 -2.435 . . . . 0.0 110.349 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.0 mt -101.67 173.47 6.4 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.596 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.0 m120 47.69 64.69 1.51 Allowed 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 117.415 -1.714 . . . . 0.0 111.688 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 46.83 26.86 0.62 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.081 -1.448 . . . . 0.0 111.497 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.36 132.49 12.69 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 113.95 -3.976 . . . . 0.0 110.155 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -77.86 167.93 20.73 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.345 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.5 p -147.62 123.61 10.71 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 115.75 -2.38 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.0 -141.6 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 115.345 -2.542 . . . . 0.0 108.611 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -144.47 161.64 38.54 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 115.894 -2.322 . . . . 0.0 109.168 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -166.9 173.5 42.2 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 115.092 -3.433 . . . . 0.0 109.917 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.76 30.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 116.274 -2.17 . . . . 0.0 108.612 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 176.16 80.7 0.05 OUTLIER Glycine 0 C--N 1.279 -2.612 0 C-N-CA 115.614 -3.184 . . . . 0.0 108.298 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.65 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 42.3 m-20 73.81 137.21 0.05 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 116.527 -2.069 . . . . 0.0 109.355 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.4 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 26.9 p90 -78.25 -165.16 0.63 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 116.501 -2.08 . . . . 0.0 109.491 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -133.68 143.8 48.77 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.975 -2.29 . . . . 0.0 109.67 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 44.4 m -90.03 144.14 26.16 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 115.647 -2.421 . . . . 0.0 110.001 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.6 m -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 116.789 -1.964 . . . . 0.0 108.246 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 8.2 m -79.44 141.14 37.07 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 115.836 -2.346 . . . . 0.0 109.689 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.85 164.84 18.79 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 115.462 -2.495 . . . . 0.0 109.479 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.88 115.15 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.174 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.63 12.85 13.81 Favored Glycine 0 C--N 1.357 1.722 0 C-N-CA 115.068 -3.444 . . . . 0.0 112.08 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.4 m-85 -141.62 153.52 44.82 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 115.059 -2.656 . . . . 0.0 109.638 174.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.609 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -155.03 -146.31 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 115.379 -2.528 . . . . 0.0 108.914 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.918 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 87.58 168.89 45.04 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 114.285 -3.817 . . . . 0.0 107.917 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -58.32 -29.9 66.27 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 115.14 -2.624 . . . . 0.0 110.213 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -108.64 19.62 19.5 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 116.225 -2.19 . . . . 0.0 111.242 -176.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 56.0 m 60.11 27.52 16.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 115.102 -2.639 . . . . 0.0 106.945 -162.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.692 ' N ' ' O ' ' A' ' 77' ' ' GLU . 7.7 tt0 -61.61 -47.8 83.8 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 117.595 -1.642 . . . . 0.0 112.643 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 1.609 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -98.75 134.18 42.01 Favored 'General case' 0 N--CA 1.404 -2.771 0 C-N-CA 112.533 -3.667 . . . . 0.0 113.169 -152.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.3 p -79.49 106.03 11.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 115.676 -2.409 . . . . 0.0 109.748 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.46 HG22 ' CD ' ' A' ' 77' ' ' GLU . 69.6 p -46.46 -43.53 16.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 116.269 -2.172 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 . . . . . 0 C--O 1.21 -1.0 0 C-N-CA 115.278 -2.569 . . . . 0.0 110.775 -179.542 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 1 N--CA 1.548 4.464 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -121.01 -27.54 4.94 Favored 'General case' 0 C--O 1.274 2.374 0 C-N-CA 114.492 -2.883 . . . . 0.0 110.962 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.36 105.45 0.19 Allowed Glycine 0 C--O 1.265 2.078 0 C-N-CA 113.955 -3.974 . . . . 0.0 107.54 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -97.15 52.56 1.14 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 116.874 -1.93 . . . . 0.0 112.072 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -84.43 -25.72 28.79 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 115.928 -2.309 . . . . 0.0 109.517 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.9 t -143.22 19.88 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 115.681 -2.408 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -81.88 -1.96 49.5 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 115.758 -2.377 . . . . 0.0 110.912 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.13 18.67 5.53 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 114.446 -3.74 . . . . 0.0 110.882 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.9 t60 51.29 90.33 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.797 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -98.92 -26.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.28 1.32 . . . . 0.0 110.041 -174.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 65.7 m -78.07 141.31 38.91 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 115.663 -2.415 . . . . 0.0 110.061 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.6 mt -88.09 177.42 6.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 117.433 -1.707 . . . . 0.0 110.216 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.553 HD22 ' HB3' ' A' ' 81' ' ' CYS . 3.2 p-10 43.67 56.88 4.28 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.891 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 57' ' ' ASN . 6.6 tt0 49.73 29.2 3.04 Favored 'General case' 0 N--CA 1.397 -3.097 0 C-N-CA 116.503 -2.079 . . . . 0.0 112.268 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.83 -176.33 16.78 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 114.815 -3.564 . . . . 0.0 111.334 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 61.0 t-80 -109.87 147.14 33.9 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 116.71 -1.996 . . . . 0.0 109.236 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.2 p -128.26 107.84 10.11 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.057 -2.257 . . . . 0.0 108.774 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -91.97 121.76 33.85 Favored 'General case' 0 C--O 1.258 1.502 0 C-N-CA 115.553 -2.459 . . . . 0.0 109.173 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.0 153.14 29.06 Favored 'General case' 0 C--O 1.255 1.37 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.934 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.32 -92.71 0.08 OUTLIER Glycine 0 CA--C 1.547 2.05 0 C-N-CA 116.64 -2.695 . . . . 0.0 109.405 174.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 66' ' ' GLY . 83.9 mt -65.22 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.587 0 C-N-CA 116.836 -1.946 . . . . 0.0 110.462 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.634 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.85 -22.31 11.88 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.267 -4.301 . . . . 0.0 111.394 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' N ' ' C ' ' A' ' 65' ' ' ILE . 31.5 m-20 -107.18 135.58 48.46 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 115.965 -2.294 . . . . 0.0 108.991 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.485 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -77.4 -166.19 0.71 Allowed 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 116.243 -2.183 . . . . 0.0 109.177 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.67 133.99 38.72 Favored 'General case' 0 C--O 1.255 1.36 0 C-N-CA 113.256 -3.378 . . . . 0.0 108.646 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 7.4 m -90.95 110.97 22.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 115.535 -2.466 . . . . 0.0 108.965 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 98.1 m -96.8 119.32 35.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.832 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.06 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 61.6 m -88.28 156.93 18.93 Favored 'General case' 0 C--O 1.276 2.457 0 C-N-CA 114.256 -2.977 . . . . 0.0 109.342 -173.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 176.11 10.0 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 115.236 -2.586 . . . . 0.0 110.392 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.02 134.02 56.62 Favored 'General case' 0 C--O 1.266 1.941 0 C-N-CA 115.954 -2.298 . . . . 0.0 110.047 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.59 24.67 60.12 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 115.522 -3.228 . . . . 0.0 110.39 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.8 m-85 -141.95 140.94 32.89 Favored 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 115.455 -2.498 . . . . 0.0 108.704 171.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -144.57 -172.42 3.81 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 116.167 -2.213 . . . . 0.0 108.728 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.72 172.56 46.55 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 115.638 -3.172 . . . . 0.0 110.79 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -64.89 -47.0 79.37 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 115.658 -2.417 . . . . 0.0 109.594 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.772 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 2.5 m-80 -79.67 -17.26 54.1 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 115.741 -2.384 . . . . 0.0 109.979 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.06 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.7 m 86.48 18.67 0.09 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 115.574 -2.45 . . . . 0.0 107.616 -164.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -55.95 -29.55 60.35 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.003 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 65.5 m-85 -78.92 162.56 25.92 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 115.032 -2.667 . . . . 0.0 110.066 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 35.7 t -121.85 29.54 7.07 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 115.243 -2.583 . . . . 0.0 107.949 170.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 84' ' ' SER . 26.3 p 43.87 19.95 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.153 0 C-N-CA 117.311 -1.755 . . . . 0.0 111.178 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.463 ' N ' ' C ' ' A' ' 84' ' ' SER . 45.2 ttt85 . . . . . 0 C--N 1.287 -2.119 0 C-N-CA 116.527 -2.069 . . . . 0.0 111.013 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.5 tttp . . . . . 0 N--CA 1.395 -3.224 0 CA-C-O 124.831 2.253 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -154.03 108.44 3.05 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 110.956 -2.838 . . . . 0.0 110.732 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.46 94.33 0.62 Allowed Glycine 0 C--O 1.206 -1.646 1 C-N-CA 113.306 -4.283 . . . . 0.0 110.393 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -110.64 58.73 0.61 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 114.912 -2.715 . . . . 0.0 107.779 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.662 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 5.0 mp0 -71.46 -36.2 71.13 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 115.033 -2.667 . . . . 0.0 109.645 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -109.94 -14.33 14.28 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 114.846 -2.742 . . . . 0.0 109.967 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -74.96 144.72 43.06 Favored 'General case' 0 C--O 1.268 2.057 0 C-N-CA 114.945 -2.702 . . . . 0.0 108.965 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.762 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 87.28 43.13 5.99 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 114.666 -3.635 . . . . 0.0 110.495 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.762 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER 10.61 92.63 0.04 OUTLIER Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 112.46 -1.87 . . . . 0.0 110.506 175.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.78 -40.22 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.136 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 83.8 m -74.63 150.01 39.79 Favored 'General case' 0 C--O 1.256 1.439 0 C-N-CA 113.82 -3.152 . . . . 0.0 109.762 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.6 mt -88.63 -178.55 5.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.118 -2.233 . . . . 0.0 109.888 -173.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.525 HD22 ' CB ' ' A' ' 81' ' ' CYS . 2.9 p-10 41.72 38.97 1.06 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.879 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 54.55 26.5 7.34 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.541 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 177.23 6.12 Favored Glycine 0 C--N 1.282 -2.462 0 C-N-CA 114.161 -3.876 . . . . 0.0 108.124 171.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -106.71 154.27 21.2 Favored 'General case' 0 C--N 1.278 -2.516 0 C-N-CA 116.229 -2.188 . . . . 0.0 108.492 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 31.4 p -133.53 93.72 3.19 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 115.658 -2.417 . . . . 0.0 108.48 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -76.99 147.41 36.85 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.117 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.58 158.53 15.41 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 116.182 -2.207 . . . . 0.0 110.025 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.4 -100.66 0.14 Allowed Glycine 0 C--O 1.24 0.517 0 C-N-CA 115.261 -3.352 . . . . 0.0 109.309 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 66' ' ' GLY . 63.2 mt -62.77 170.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 115.584 -2.447 . . . . 0.0 108.462 173.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -53.83 -19.18 9.73 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 114.46 -3.733 . . . . 0.0 110.401 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' C ' ' A' ' 65' ' ' ILE . 9.1 t70 -101.95 139.45 37.57 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.651 -1.62 . . . . 0.0 107.222 169.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.586 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -83.98 -162.12 0.61 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 116.923 -1.911 . . . . 0.0 107.296 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -141.05 141.99 34.24 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.265 -2.174 . . . . 0.0 108.594 173.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 95.1 m -94.7 114.44 26.36 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 116.131 -2.228 . . . . 0.0 110.274 -173.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 m -98.62 120.18 38.61 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 115.528 -2.469 . . . . 0.0 108.171 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 41.3 m -93.89 147.21 23.29 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 114.855 -2.738 . . . . 0.0 109.086 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.52 24.68 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 114.483 -2.887 . . . . 0.0 109.004 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.14 134.72 49.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 115.959 -2.296 . . . . 0.0 108.372 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 99.34 -13.05 61.74 Favored Glycine 0 CA--C 1.489 -1.588 0 C-N-CA 114.585 -3.674 . . . . 0.0 110.85 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.698 ' HB3' ' HB3' ' A' ' 81' ' ' CYS . 85.4 m-85 -126.95 147.94 50.09 Favored 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 114.051 -3.06 . . . . 0.0 109.436 167.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.1 170.68 19.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 114.517 -2.873 . . . . 0.0 110.652 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.47 -175.67 19.02 Favored Glycine 0 N--CA 1.434 -1.474 1 C-N-CA 113.035 -4.412 . . . . 0.0 111.343 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -74.31 -61.64 1.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 C-N-CA 113.807 -3.157 . . . . 0.0 109.394 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.3 m120 -76.56 -5.14 46.38 Favored 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 114.776 -2.77 . . . . 0.0 111.711 175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.1 m 82.51 17.44 0.34 Allowed 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 116.539 -2.065 . . . . 0.0 107.698 -169.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.75 -22.32 5.13 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 116.281 -2.168 . . . . 0.0 112.573 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.27 153.2 30.08 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 114.834 -2.747 . . . . 0.0 109.597 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 39.1 m -120.44 42.86 2.88 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 114.602 -2.839 . . . . 0.0 106.457 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p 41.41 47.42 3.12 Favored 'General case' 0 N--CA 1.512 2.665 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.833 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 . . . . . 0 C--N 1.277 -2.579 0 C-N-CA 115.262 -2.575 . . . . 0.0 109.099 -174.919 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm . . . . . 0 N--CA 1.526 3.365 0 CA-C-O 124.398 2.047 . . . . 0.0 107.345 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -67.96 170.56 8.05 Favored 'General case' 1 C--N 1.434 4.265 0 CA-C-N 111.616 -2.538 . . . . 0.0 109.035 -175.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.09 -124.35 1.43 Allowed Glycine 0 N--CA 1.499 2.855 0 C-N-CA 114.272 -3.823 . . . . 0.0 110.353 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -106.53 39.15 1.89 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 116.415 -2.114 . . . . 0.0 106.646 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -94.58 -2.66 51.07 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 116.092 -2.243 . . . . 0.0 108.803 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 24.2 t -148.63 68.38 1.07 Allowed 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 113.618 -3.233 . . . . 0.0 108.606 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 53' ' ' HIS . 8.1 tt0 -65.31 179.3 0.77 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 115.384 -2.526 . . . . 0.0 108.631 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 4.0 4.71 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 114.718 -3.611 . . . . 0.0 111.576 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 51' ' ' GLU . 11.0 t-160 -173.12 96.67 0.35 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 116.14 -2.224 . . . . 0.0 109.058 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -111.92 -46.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 108.049 -1.558 . . . . 0.0 108.049 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.5 m -81.19 157.11 25.36 Favored 'General case' 0 C--O 1.253 1.241 0 C-N-CA 114.863 -2.735 . . . . 0.0 108.923 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.9 mt -90.25 175.95 6.93 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 115.964 -2.294 . . . . 0.0 108.682 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.3 m120 56.37 43.13 26.71 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.174 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 45.66 33.38 1.42 Allowed 'General case' 0 N--CA 1.407 -2.616 0 C-N-CA 117.068 -1.853 . . . . 0.0 112.793 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.94 -170.03 1.74 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 114.77 -3.586 . . . . 0.0 109.635 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 24.2 t-80 -107.78 163.55 13.01 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 115.665 -2.414 . . . . 0.0 109.564 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 10.8 t -143.19 143.05 31.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 115.204 -2.598 . . . . 0.0 108.295 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -123.3 -144.35 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.539 -2.065 . . . . 0.0 108.114 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -140.53 152.38 45.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 114.469 -2.892 . . . . 0.0 110.315 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.95 149.55 12.02 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 115.084 -3.436 . . . . 0.0 110.026 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 67' ' ' ASP . 39.4 mt -62.57 138.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.303 -176.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.6 -28.89 1.51 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 116.299 -2.857 . . . . 0.0 111.436 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' A' ' 65' ' ' ILE . 34.3 t70 -176.58 141.14 0.38 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 116.521 -2.072 . . . . 0.0 110.152 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.773 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 17.9 p90 -81.48 -165.6 0.99 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 116.424 -2.111 . . . . 0.0 108.068 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -131.99 136.46 47.31 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 115.41 -2.516 . . . . 0.0 110.507 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.773 ' SG ' ' HE2' ' A' ' 68' ' ' TYR . 93.2 m -94.3 142.39 27.47 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 115.268 -2.573 . . . . 0.0 109.475 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 82.2 m -125.53 108.32 11.48 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 115.282 -2.567 . . . . 0.0 107.647 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.991 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.0 m -82.42 142.89 31.58 Favored 'General case' 0 C--O 1.259 1.559 0 C-N-CA 116.325 -2.15 . . . . 0.0 108.716 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 165.59 24.76 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.936 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -50.36 143.13 9.23 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.185 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 80.83 12.94 82.15 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 114.889 -3.529 . . . . 0.0 110.426 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 98.1 m-85 -140.25 143.64 36.07 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.382 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -145.56 -174.34 4.37 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 116.128 -2.229 . . . . 0.0 109.622 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.43 173.42 48.3 Favored Glycine 0 C--O 1.236 0.261 0 C-N-CA 114.636 -3.65 . . . . 0.0 109.658 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -71.15 -42.18 69.48 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 115.456 -2.498 . . . . 0.0 110.38 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.3 m120 -83.65 -4.7 58.81 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 116.795 -1.962 . . . . 0.0 110.152 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.991 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 70.91 25.66 3.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 114.322 -2.951 . . . . 0.0 108.219 -165.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.58 -25.03 68.05 Favored 'General case' 0 C--N 1.368 1.394 0 C-N-CA 116.155 -2.218 . . . . 0.0 110.057 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -79.16 175.65 10.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 115.892 -2.323 . . . . 0.0 109.234 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 23.4 p -139.97 28.45 2.12 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 116.768 -1.973 . . . . 0.0 108.246 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p 41.92 30.07 0.15 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.4 -1.72 . . . . 0.0 110.405 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 84' ' ' SER . 48.1 ttp180 . . . . . 0 C--N 1.3 -1.557 0 C-N-CA 116.426 -2.11 . . . . 0.0 109.764 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt . . . . . 0 N--CA 1.419 -2.008 0 CA-C-O 123.234 1.492 . . . . 0.0 107.165 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -147.8 144.22 28.04 Favored 'General case' 0 N--CA 1.538 3.942 0 C-N-CA 113.413 -3.315 . . . . 0.0 106.196 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 103.13 0.13 Allowed Glycine 0 CA--C 1.556 2.614 0 C-N-CA 118.412 -1.852 . . . . 0.0 109.548 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -136.54 55.15 1.85 Allowed 'General case' 1 C--N 1.237 -4.287 0 C-N-CA 116.118 -2.233 . . . . 0.0 108.059 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.1 mp0 -97.76 -7.51 30.53 Favored 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 113.681 -3.208 . . . . 0.0 109.051 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.5 t -137.32 64.41 1.53 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 115.04 -2.664 . . . . 0.0 110.132 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' C ' ' N ' ' A' ' 53' ' ' HIS . 9.1 tt0 -57.48 164.76 1.78 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 115.668 -2.413 . . . . 0.0 109.311 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.22 -12.74 8.48 Favored Glycine 0 CA--C 1.529 0.959 1 C-N-CA 113.853 -4.022 . . . . 0.0 111.448 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.422 ' N ' ' C ' ' A' ' 51' ' ' GLU . 21.1 t-160 -172.3 94.48 0.39 Allowed Pre-proline 0 CA--C 1.577 1.989 0 C-N-CA 116.323 -2.151 . . . . 0.0 109.403 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -97.34 -37.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.481 0.765 0 O-C-N 123.422 1.222 . . . . 0.0 110.668 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 79.7 m -98.54 154.75 17.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 115.235 -2.586 . . . . 0.0 108.755 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' H ' ' HB3' ' A' ' 80' ' ' ASN . 58.0 mt -73.84 176.93 5.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 115.483 -2.487 . . . . 0.0 111.662 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.499 HD22 ' CB ' ' A' ' 81' ' ' CYS . 1.9 p-10 46.2 53.44 9.39 Favored 'General case' 0 C--O 1.269 2.081 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.781 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 50.94 25.07 2.05 Favored 'General case' 0 N--CA 1.396 -3.166 0 C-N-CA 116.981 -1.888 . . . . 0.0 110.26 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.09 130.44 38.69 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 115.666 -3.159 . . . . 0.0 108.252 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -80.03 174.64 11.39 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.348 -174.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 19.4 p -139.96 116.55 10.78 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 114.407 -2.917 . . . . 0.0 108.435 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -90.38 119.72 30.91 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 115.406 -2.518 . . . . 0.0 107.338 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.3 157.56 27.69 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 116.524 -2.07 . . . . 0.0 110.02 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.16 -87.11 0.07 OUTLIER Glycine 0 C--O 1.198 -2.114 0 C-N-CA 114.23 -3.843 . . . . 0.0 108.226 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.751 HG22 ' H ' ' A' ' 66' ' ' GLY . 50.4 mt -71.04 -176.42 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.263 1.778 0 C-N-CA 116.533 -2.067 . . . . 0.0 110.231 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.751 ' H ' HG22 ' A' ' 65' ' ' ILE . . . -58.65 -13.19 16.59 Favored Glycine 0 N--CA 1.486 2.002 0 C-N-CA 116.407 -2.806 . . . . 0.0 109.878 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.6 p-10 -120.62 144.88 47.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 115.931 -2.308 . . . . 0.0 106.118 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.425 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 21.1 p90 -84.91 -161.3 0.56 Allowed 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 115.858 -2.337 . . . . 0.0 108.94 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -140.14 136.94 34.02 Favored 'General case' 0 C--O 1.204 -1.314 0 C-N-CA 116.34 -2.144 . . . . 0.0 109.098 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.3 m -78.15 137.25 38.08 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 115.283 -2.567 . . . . 0.0 108.611 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.8 m -120.67 115.22 22.92 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 116.774 -1.97 . . . . 0.0 107.754 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.065 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.2 m -84.52 139.72 31.95 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 114.886 -2.726 . . . . 0.0 110.014 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.9 168.89 5.76 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.367 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.08 120.0 6.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.166 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 98.44 23.45 12.48 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 115.016 -3.469 . . . . 0.0 111.617 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.669 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 83.8 m-85 -146.37 149.71 34.29 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 115.412 -2.515 . . . . 0.0 110.554 172.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.24 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -155.84 -146.72 0.18 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 115.314 -2.554 . . . . 0.0 109.657 173.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.847 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 86.68 168.43 44.82 Favored Glycine 1 N--CA 1.52 4.263 0 C-N-CA 114.739 -3.6 . . . . 0.0 109.165 177.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -54.7 -37.25 65.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 116.254 -2.179 . . . . 0.0 109.008 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.491 ' HB3' ' H ' ' A' ' 56' ' ' LEU . 1.6 m120 -102.19 29.93 4.82 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 116.105 -2.238 . . . . 0.0 111.676 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.065 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 73.6 m 50.84 25.01 1.97 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 115.232 -2.587 . . . . 0.0 106.786 -163.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.815 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.2 tp10 -55.22 -55.03 35.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.455 -1.698 . . . . 0.0 113.022 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 1.24 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -90.1 139.1 30.95 Favored 'General case' 0 N--CA 1.387 -3.582 0 C-N-CA 113.445 -3.302 . . . . 0.0 112.098 -148.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 22.8 t -86.15 58.47 5.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 115.992 -2.283 . . . . 0.0 110.734 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.2 p 37.14 28.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 116.051 -2.26 . . . . 0.0 112.051 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' N ' ' C ' ' A' ' 84' ' ' SER . 71.4 mtp85 . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 115.941 -1.98 . . . . 0.0 108.762 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -95.62 126.3 40.8 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 112.452 -3.699 . . . . 0.0 107.566 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.02 113.33 0.28 Allowed Glycine 1 C--N 1.214 -6.208 0 C-N-CA 114.616 -3.659 . . . . 0.0 112.611 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.617 ' C ' ' H ' ' A' ' 50' ' ' CYS . 13.1 m-20 -103.85 -16.84 15.26 Favored 'General case' 0 C--O 1.26 1.628 0 C-N-CA 116.846 -1.942 . . . . 0.0 109.599 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 42.21 6.78 0.0 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.532 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 74.2 m -117.32 -0.66 11.95 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.425 -2.11 . . . . 0.0 108.98 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 115.059 -2.657 . . . . 0.0 109.85 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -95.55 18.13 57.98 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 114.903 -3.522 . . . . 0.0 111.01 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' GLY . 16.4 t-160 44.48 84.2 0.19 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 116.239 -2.185 . . . . 0.0 110.161 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -97.13 -38.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 O-C-N 123.667 1.351 . . . . 0.0 111.096 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.051 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 61.2 m -96.42 151.02 19.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 115.677 -2.409 . . . . 0.0 110.423 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.2 mt -103.78 176.39 5.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 116.128 -2.229 . . . . 0.0 110.034 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 56.75 47.77 17.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 117.218 -1.793 . . . . 0.0 111.755 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 49.52 35.12 7.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.174 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.75 -161.39 4.88 Favored Glycine 0 C--N 1.363 2.05 0 C-N-CA 114.051 -3.928 . . . . 0.0 110.468 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 9.0 t-160 -135.68 175.03 9.97 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 115.208 -2.597 . . . . 0.0 109.697 -176.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 14.3 p -153.13 138.14 17.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 114.374 -2.93 . . . . 0.0 108.702 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -115.82 133.28 56.19 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 116.124 -2.23 . . . . 0.0 109.237 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.14 159.3 29.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 116.083 -2.247 . . . . 0.0 108.607 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 66' ' ' GLY . . . -152.21 38.29 0.79 Allowed Glycine 0 N--CA 1.504 3.178 0 C-N-CA 114.471 -3.728 . . . . 0.0 110.367 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 65' ' ' ILE . 81.4 mt 36.27 36.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 116.784 -1.966 . . . . 0.0 110.037 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 162.22 85.62 0.06 OUTLIER Glycine 0 C--N 1.288 -2.101 0 C-N-CA 115.471 -3.252 . . . . 0.0 109.825 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.2 m-20 67.57 116.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 116.656 -2.017 . . . . 0.0 109.007 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.488 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 24.6 p90 -76.7 -169.9 1.4 Allowed 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.278 -2.569 . . . . 0.0 108.363 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 p -139.43 132.8 30.07 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 115.789 -2.364 . . . . 0.0 108.831 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.051 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 61.4 m -81.68 128.46 33.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.38 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 88.8 m -108.04 109.65 21.15 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 114.739 -2.785 . . . . 0.0 108.435 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.9 m -86.46 143.41 27.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 115.57 -2.452 . . . . 0.0 109.648 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.71 171.44 13.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 116.935 -1.906 . . . . 0.0 109.711 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -52.4 126.88 20.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 115.705 -2.398 . . . . 0.0 110.039 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.6 19.46 44.48 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.769 -3.586 . . . . 0.0 110.235 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 99.9 m-85 -140.49 145.99 37.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.287 -2.565 . . . . 0.0 108.538 165.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 46.2 mm-40 -146.31 -166.97 2.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 116.086 -2.245 . . . . 0.0 109.083 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.54 168.27 35.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 114.296 -3.811 . . . . 0.0 109.261 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -68.54 -37.09 79.68 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 114.58 -2.848 . . . . 0.0 109.904 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.1 m120 -80.72 -16.01 55.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.16 -1.816 . . . . 0.0 111.762 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.2 m 77.98 18.67 1.16 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.16 -2.616 . . . . 0.0 107.331 -162.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.74 -31.16 69.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 117.498 -1.681 . . . . 0.0 110.211 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 49.5 m-85 -78.82 160.71 27.23 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 115.362 -2.535 . . . . 0.0 110.502 -176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.569 ' C ' ' N ' ' A' ' 86' ' ' ARG . 19.2 t -123.58 38.08 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 115.564 -2.455 . . . . 0.0 108.221 170.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p 40.03 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.324 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.569 ' N ' ' C ' ' A' ' 84' ' ' SER . 78.0 ttt-85 . . . . . 0 C--N 1.308 -1.231 0 C-N-CA 115.936 -2.306 . . . . 0.0 110.202 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.5 tttp . . . . . 0 C--O 1.175 -2.838 0 CA-C-O 127.877 3.703 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -88.58 164.21 15.49 Favored 'General case' 1 C--N 1.46 5.387 0 C-N-CA 114.975 -2.69 . . . . 0.0 108.941 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ASP . . . -179.63 -115.38 0.47 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 114.566 -3.683 . . . . 0.0 110.333 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' GLY . 13.9 t70 50.0 64.46 1.77 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 115.734 -2.386 . . . . 0.0 109.261 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -97.92 -8.02 28.99 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 115.669 -2.412 . . . . 0.0 109.215 -174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.4 t -127.19 -22.8 3.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 114.906 -2.718 . . . . 0.0 111.532 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.3 -17.41 64.77 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 114.311 -2.956 . . . . 0.0 110.122 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -88.88 36.36 3.48 Favored Glycine 0 C--O 1.259 1.657 0 C-N-CA 115.872 -3.061 . . . . 0.0 110.993 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.72 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.7 m-70 13.98 88.47 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 117.843 -1.543 . . . . 0.0 110.678 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -89.98 -42.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.974 1.782 . . . . 0.0 109.746 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 38.7 m -81.97 113.42 19.86 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 116.12 -2.232 . . . . 0.0 110.969 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.2 mt -74.82 175.93 7.55 Favored 'General case' 0 CA--C 1.58 2.126 0 C-N-CA 115.023 -2.671 . . . . 0.0 110.666 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.7 m120 62.11 50.44 4.0 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 117.146 -1.821 . . . . 0.0 109.972 168.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 53.39 27.79 6.74 Favored 'General case' 0 C--O 1.281 2.711 0 C-N-CA 116.7 -2.0 . . . . 0.0 111.389 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.18 -150.46 3.86 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 114.081 -3.914 . . . . 0.0 110.44 175.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -141.07 135.13 30.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 114.606 -2.838 . . . . 0.0 108.308 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.7 p -113.93 128.11 56.26 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 116.051 -2.26 . . . . 0.0 110.032 176.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -97.78 -165.24 1.23 Allowed 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.599 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -151.81 138.03 18.37 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 115.945 -2.302 . . . . 0.0 109.26 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.29 -95.96 0.1 Allowed Glycine 0 C--O 1.247 0.959 0 C-N-CA 114.49 -3.719 . . . . 0.0 109.766 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.649 HG22 ' N ' ' A' ' 66' ' ' GLY . 71.6 mt -62.82 177.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 116.007 -2.277 . . . . 0.0 110.833 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.649 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.32 -18.76 5.22 Favored Glycine 0 CA--C 1.549 2.205 0 C-N-CA 114.772 -3.585 . . . . 0.0 111.067 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' C ' ' A' ' 65' ' ' ILE . 3.3 p-10 -112.81 146.56 38.64 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 116.005 -2.278 . . . . 0.0 108.014 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -83.89 -166.03 1.3 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 116.762 -1.975 . . . . 0.0 108.604 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.87 136.15 36.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 114.985 -2.686 . . . . 0.0 108.542 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 8.6 m -95.88 155.33 16.8 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 114.676 -2.81 . . . . 0.0 110.937 -174.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -135.49 131.04 35.61 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 115.506 -2.478 . . . . 0.0 109.0 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.033 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.6 m -107.51 142.45 37.37 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 114.697 -2.801 . . . . 0.0 108.503 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.87 172.71 10.36 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 116.233 -2.187 . . . . 0.0 109.319 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -55.85 146.21 22.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.863 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.23 8.73 87.62 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 114.487 -3.721 . . . . 0.0 110.994 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 92.4 m-85 -136.82 140.74 42.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 114.506 -2.878 . . . . 0.0 109.998 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -147.08 -166.75 2.59 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 116.197 -2.201 . . . . 0.0 107.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.56 167.06 38.06 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 114.383 -3.77 . . . . 0.0 109.501 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -67.8 -34.44 76.75 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 116.375 -2.13 . . . . 0.0 108.391 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.59 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.3 m120 -89.71 -4.74 57.57 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 116.35 -2.14 . . . . 0.0 111.933 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.033 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.8 m 71.66 17.48 5.53 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 114.484 -2.886 . . . . 0.0 107.452 -166.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.28 -31.12 68.82 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 118.021 -1.472 . . . . 0.0 109.406 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 38.3 m-85 -79.74 165.01 23.24 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 115.517 -2.473 . . . . 0.0 111.296 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.5 t -127.29 38.67 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.53 -2.468 . . . . 0.0 107.898 173.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.6 p 46.1 22.95 0.16 Allowed 'General case' 0 N--CA 1.511 2.588 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.836 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' N ' ' C ' ' A' ' 84' ' ' SER . 8.8 mmm180 . . . . . 0 N--CA 1.514 2.732 0 CA-C-O 115.702 -2.094 . . . . 0.0 108.135 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -131.52 166.61 20.98 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 113.216 -3.394 . . . . 0.0 109.55 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.22 52.38 0.1 OUTLIER Glycine 0 N--CA 1.499 2.87 1 C-N-CA 113.12 -4.372 . . . . 0.0 110.815 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.717 ' C ' ' H ' ' A' ' 50' ' ' CYS . 1.3 p30 -111.6 -24.47 10.08 Favored 'General case' 0 C--O 1.254 1.333 0 C-N-CA 114.465 -2.894 . . . . 0.0 107.589 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 85.9 mm-40 43.29 4.91 0.0 OUTLIER 'General case' 0 C--N 1.375 1.689 0 CA-C-O 122.552 1.168 . . . . 0.0 111.732 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 50.1 t -112.53 54.97 0.7 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 115.101 -2.639 . . . . 0.0 109.513 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' CYS . 16.9 tt0 -40.61 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 115.669 -2.412 . . . . 0.0 111.204 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.6 -14.01 8.77 Favored Glycine 0 CA--C 1.559 2.832 0 C-N-CA 114.488 -3.72 . . . . 0.0 112.115 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -174.26 93.03 0.32 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 115.191 -2.604 . . . . 0.0 109.888 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -99.74 -41.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.823 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.203 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -81.72 169.39 17.01 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 115.926 -2.31 . . . . 0.0 109.122 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.8 mt -98.91 176.88 5.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 115.181 -2.608 . . . . 0.0 109.784 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.1 m120 56.52 44.13 24.67 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.029 -1.869 . . . . 0.0 110.356 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 50.49 29.29 3.87 Favored 'General case' 0 N--CA 1.385 -3.693 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.14 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.45 -166.99 7.9 Favored Glycine 0 N--CA 1.475 1.277 1 C-N-CA 113.099 -4.382 . . . . 0.0 111.48 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 13.9 t-160 -120.13 166.08 13.9 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 116.179 -2.208 . . . . 0.0 110.089 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 20.2 p -144.87 130.12 18.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 115.355 -2.538 . . . . 0.0 108.576 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -103.29 -132.75 0.3 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 115.241 -2.584 . . . . 0.0 108.188 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -144.84 156.04 43.81 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 115.227 -2.589 . . . . 0.0 110.19 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.37 141.47 4.81 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 114.849 -3.548 . . . . 0.0 108.804 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 67' ' ' ASP . 11.1 mt -59.65 137.19 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 113.047 -3.461 . . . . 0.0 110.769 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.99 -38.32 2.97 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 115.176 -3.392 . . . . 0.0 110.236 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.9 147.23 5.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 116.124 -2.23 . . . . 0.0 108.997 -174.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HD1' ' HB3' ' A' ' 49' ' ' GLN . 16.7 p90 -86.13 -166.59 1.58 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 116.237 -2.185 . . . . 0.0 108.001 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -134.36 142.67 47.28 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 114.297 -2.961 . . . . 0.0 108.936 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.203 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 97.3 m -90.64 145.86 24.5 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 115.182 -2.607 . . . . 0.0 110.05 -176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 97.1 m -126.8 116.83 21.49 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 116.15 -2.22 . . . . 0.0 107.848 172.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.3 m -90.05 143.88 26.39 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 116.049 -2.26 . . . . 0.0 109.745 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.48 171.57 12.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 116.313 -2.155 . . . . 0.0 110.468 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.82 137.96 43.71 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.179 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.15 16.28 69.91 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 115.447 -3.263 . . . . 0.0 111.121 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.8 m-85 -144.2 145.07 31.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.807 -2.357 . . . . 0.0 108.878 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 5.0 mt-10 -147.63 -178.95 6.53 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.488 -2.085 . . . . 0.0 109.555 -176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.7 174.66 39.88 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 114.859 -3.543 . . . . 0.0 109.762 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.34 -48.33 56.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 115.577 -2.449 . . . . 0.0 109.725 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.2 m120 -82.08 -5.0 58.07 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 116.741 -1.984 . . . . 0.0 110.622 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 74.25 27.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 115.159 -2.617 . . . . 0.0 108.922 -165.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.9 -22.59 65.7 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 117.38 -1.728 . . . . 0.0 110.076 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -85.04 165.26 17.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 114.82 -2.752 . . . . 0.0 109.177 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.8 t -128.49 35.81 4.34 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 115.713 -2.395 . . . . 0.0 107.695 169.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 84' ' ' SER . 20.7 p 44.29 16.15 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 117.439 -1.704 . . . . 0.0 111.39 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.549 ' N ' ' C ' ' A' ' 84' ' ' SER . 15.6 ptm180 . . . . . 0 C--O 1.196 -1.76 0 C-N-CA 114.938 -2.705 . . . . 0.0 108.949 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . 0.274 61.1 mttp . . . . . 0 C--O 1.264 1.856 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.54 139.98 38.65 Favored 'General case' 0 C--O 1.19 -2.04 0 C-N-CA 117.157 -1.817 . . . . 0.0 106.712 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.6 -117.71 0.41 Allowed Glycine 0 C--N 1.369 2.391 0 C-N-CA 115.367 -3.301 . . . . 0.0 110.729 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -166.43 29.73 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 110.1 -3.05 . . . . 0.0 106.926 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 2.3 mp0 -89.93 -11.8 40.72 Favored 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 116.018 -2.273 . . . . 0.0 109.046 -167.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 49' ' ' GLN . 59.1 m -163.87 14.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 116.191 -2.204 . . . . 0.0 109.47 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -78.67 -14.09 59.48 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 114.965 -2.694 . . . . 0.0 108.437 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -117.04 26.0 8.53 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 114.986 -3.483 . . . . 0.0 110.327 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' GLY . 13.2 t-160 39.65 91.5 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 116.066 -2.254 . . . . 0.0 110.788 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -91.68 -31.95 0.09 OUTLIER 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 121.339 1.36 . . . . 0.0 109.878 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 60' ' ' HIS . 15.7 m -75.83 124.38 27.22 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.696 -2.401 . . . . 0.0 110.598 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.07 176.44 8.68 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 116.476 -2.09 . . . . 0.0 109.404 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 63.36 40.33 8.6 Favored 'General case' 0 C--O 1.29 3.202 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.895 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 46.5 35.88 3.19 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 115.266 -2.574 . . . . 0.0 110.35 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.11 -134.82 0.05 OUTLIER Glycine 0 CA--C 1.563 3.042 1 C-N-CA 113.141 -4.361 . . . . 0.0 110.2 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.424 ' O ' ' SG ' ' A' ' 55' ' ' CYS . 2.0 t-160 -159.17 -175.46 5.27 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 114.64 -2.824 . . . . 0.0 109.003 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.5 t -155.46 128.94 8.39 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 114.429 -2.908 . . . . 0.0 108.36 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.6 ' O ' ' O ' ' A' ' 87' ' ' ' OH' . 5.3 mptp? -89.43 -20.97 23.28 Favored 'General case' 0 C--O 1.256 1.418 0 C-N-CA 114.629 -2.828 . . . . 0.0 110.301 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 63.22 146.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 117.59 -1.644 . . . . 0.0 110.443 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 -100.91 0.14 Allowed Glycine 0 C--O 1.211 -1.282 0 C-N-CA 114.81 -3.567 . . . . 0.0 109.417 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 66' ' ' GLY . 4.6 mm -69.4 178.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 116.081 -2.248 . . . . 0.0 110.713 172.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.653 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -49.92 -23.39 5.3 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 115.561 -3.209 . . . . 0.0 110.192 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' N ' ' C ' ' A' ' 65' ' ' ILE . 6.0 m-20 -98.27 132.05 44.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 116.569 -2.052 . . . . 0.0 108.669 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 17.9 p90 -90.65 -173.81 3.87 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 115.256 -2.578 . . . . 0.0 109.941 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 p -123.95 133.79 53.63 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 115.95 -2.3 . . . . 0.0 108.942 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.83 128.96 49.37 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 115.584 -2.446 . . . . 0.0 109.614 -171.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 72' ' ' CYS . 38.9 m -99.26 170.03 8.95 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 115.441 -2.504 . . . . 0.0 106.636 171.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.022 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.0 m -122.09 -45.05 2.26 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 114.276 -2.97 . . . . 0.0 110.897 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' CB ' ' O ' ' A' ' 72' ' ' CYS . . . 115.88 162.28 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.99 119.35 5.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 115.58 -2.448 . . . . 0.0 110.943 -175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.2 29.94 32.36 Favored Glycine 0 N--CA 1.504 3.218 0 C-N-CA 114.156 -3.878 . . . . 0.0 111.839 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.732 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 88.5 m-85 -142.96 152.1 41.63 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 114.088 -3.045 . . . . 0.0 108.943 170.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 6.5 mt-10 -153.32 -176.68 5.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 115.336 -2.546 . . . . 0.0 108.442 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.74 176.32 28.27 Favored Glycine 0 C--N 1.361 1.919 0 C-N-CA 114.315 -3.802 . . . . 0.0 110.568 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -58.01 -63.18 1.35 Allowed 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 116.463 -2.095 . . . . 0.0 110.568 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.825 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -78.85 -21.0 48.23 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 116.15 -2.22 . . . . 0.0 110.713 177.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.022 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 19.5 m 94.1 26.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 116.647 -2.021 . . . . 0.0 107.671 -168.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.76 -19.91 65.34 Favored 'General case' 0 CA--C 1.6 2.897 0 C-N-CA 117.078 -1.849 . . . . 0.0 109.274 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.462 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 27.5 m-85 -78.14 176.2 9.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.764 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 80.5 p -133.97 28.4 3.84 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 116.12 -2.232 . . . . 0.0 108.278 172.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 84' ' ' SER . 41.0 p 47.54 5.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 117.54 -1.664 . . . . 0.0 111.148 -172.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.649 ' H ' ' C ' ' A' ' 84' ' ' SER . 16.1 tpt180 . . . . . 0 CA--C 1.572 1.815 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.83 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . 0.6 ' O ' ' O ' ' A' ' 62' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.3 mttp . . . . . 1 N--CA 1.549 4.495 0 CA-C-O 125.637 2.637 . . . . 0.0 104.408 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.12 117.41 31.26 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 113.657 -3.217 . . . . 0.0 107.577 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.92 101.35 0.14 Allowed Glycine 0 N--CA 1.51 3.592 1 C-N-CA 113.358 -4.258 . . . . 0.0 109.831 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -119.44 66.67 0.8 Allowed 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 115.896 -2.322 . . . . 0.0 110.335 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -89.13 -6.84 56.71 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 115.554 -2.458 . . . . 0.0 109.097 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.0 m -145.23 -22.75 0.49 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 115.416 -2.514 . . . . 0.0 109.563 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -78.58 -15.67 58.28 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 116.349 -2.14 . . . . 0.0 108.748 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -87.8 13.37 61.11 Favored Glycine 0 C--O 1.215 -1.057 0 C-N-CA 114.817 -3.563 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.6 t-160 44.3 82.18 0.24 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 116.485 -2.086 . . . . 0.0 110.018 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -95.69 -42.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.029 1.153 . . . . 0.0 110.606 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.11 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 72.4 m -77.74 160.42 28.42 Favored 'General case' 0 C--O 1.253 1.258 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.713 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -101.99 175.86 5.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 116.038 -2.265 . . . . 0.0 110.989 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 55.43 38.9 30.94 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 117.458 -1.697 . . . . 0.0 110.319 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 56.79 25.95 10.91 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.827 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.16 136.6 32.63 Favored Glycine 0 N--CA 1.424 -2.16 0 C-N-CA 114.723 -3.608 . . . . 0.0 108.864 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -78.47 179.37 7.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.725 -2.237 . . . . 0.0 108.725 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 11.1 p -154.61 137.49 15.39 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.661 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -102.35 128.32 48.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 115.76 -2.376 . . . . 0.0 108.855 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.4 149.39 42.52 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 115.681 -2.407 . . . . 0.0 109.878 -173.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.55 161.99 35.79 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 115.469 -3.253 . . . . 0.0 108.356 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.74 144.0 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 116.195 -2.202 . . . . 0.0 109.16 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 68.8 69.56 1.36 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 114.728 -3.606 . . . . 0.0 111.802 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 32.4 m-20 68.08 153.51 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.95 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -82.75 -164.47 0.86 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 118.045 -1.462 . . . . 0.0 107.239 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 17.6 p -135.16 152.11 51.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 116.218 -2.193 . . . . 0.0 108.797 171.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.11 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.0 m -96.22 154.03 17.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 115.738 -2.385 . . . . 0.0 110.802 -174.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.2 m -142.24 113.73 7.81 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 115.27 -2.572 . . . . 0.0 108.147 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.036 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 22.2 m -89.67 140.63 29.38 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 115.141 -2.624 . . . . 0.0 108.846 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.2 169.72 15.55 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.583 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 127.76 28.42 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 116.259 -2.177 . . . . 0.0 110.196 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.17 18.59 49.44 Favored Glycine 0 N--CA 1.48 1.57 1 C-N-CA 113.714 -4.089 . . . . 0.0 111.209 -178.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.732 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 92.9 m-85 -140.63 142.15 35.03 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 115.298 -2.561 . . . . 0.0 111.322 161.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.36 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -143.2 -145.86 0.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.341 -2.544 . . . . 0.0 109.719 169.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.994 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 82.13 164.25 33.87 Favored Glycine 1 N--CA 1.519 4.207 0 C-N-CA 114.229 -3.844 . . . . 0.0 107.067 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.08 -50.74 70.18 Favored 'General case' 0 N--CA 1.511 2.625 0 C-N-CA 115.063 -2.655 . . . . 0.0 110.869 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -90.13 29.04 1.28 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.408 -1.717 . . . . 0.0 110.348 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.036 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 47.8 m 57.07 20.78 5.76 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 113.943 -3.103 . . . . 0.0 106.678 -164.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 80' ' ' ASN . 9.3 tp10 -49.08 -52.47 25.56 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 117.528 -1.669 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 1.36 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.93 174.85 6.96 Favored 'General case' 1 N--CA 1.365 -4.683 0 C-N-CA 112.977 -3.489 . . . . 0.0 109.311 -165.768 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.926 ' O ' HG23 ' A' ' 85' ' ' THR . 22.9 p -88.69 -68.67 0.75 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.004 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.926 HG23 ' O ' ' A' ' 84' ' ' SER . 0.9 OUTLIER -178.29 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 CA--C 1.553 1.07 0 CA-C-O 113.404 -3.188 . . . . 0.0 108.399 -179.848 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt . . . . . 0 N--CA 1.508 2.425 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -100.2 -65.56 0.96 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 113.468 -3.293 . . . . 0.0 110.69 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.09 103.4 0.18 Allowed Glycine 2 N--CA 1.356 -6.669 1 C-N-CA 113.07 -4.395 . . . . 0.0 112.723 -172.947 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.39 26.44 6.04 Favored 'General case' 0 CA--C 1.598 2.804 0 C-N-CA 117.813 -1.555 . . . . 0.0 108.77 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -83.95 -17.16 41.57 Favored 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 116.163 -2.215 . . . . 0.0 109.199 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.3 t -122.98 -3.98 8.57 Favored 'General case' 0 C--O 1.256 1.426 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.733 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.2 -21.98 58.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 114.395 -2.922 . . . . 0.0 109.458 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.07 7.6 81.79 Favored Glycine 0 CA--C 1.558 2.732 0 C-N-CA 114.242 -3.837 . . . . 0.0 112.019 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.52 86.13 0.16 Allowed Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 116.478 -2.089 . . . . 0.0 110.187 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -97.95 -46.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 109.88 -0.854 . . . . 0.0 109.88 -171.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -75.28 165.07 25.76 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.446 -170.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.7 mt -103.32 174.83 5.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 116.645 -2.022 . . . . 0.0 111.293 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 51.02 52.4 15.08 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.206 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 53.29 26.36 5.16 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 117.999 -1.48 . . . . 0.0 110.571 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.73 127.41 25.48 Favored Glycine 0 N--CA 1.465 0.602 0 C-N-CA 115.087 -3.435 . . . . 0.0 110.514 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -81.32 102.64 10.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.005 -2.098 . . . . 0.0 109.817 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 p -78.71 123.3 27.02 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 115.955 -2.298 . . . . 0.0 109.909 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -92.73 152.84 19.27 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 114.92 -2.712 . . . . 0.0 108.302 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -83.45 141.76 31.46 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 115.721 -2.391 . . . . 0.0 110.782 -170.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.68 161.31 28.79 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 115.166 -3.397 . . . . 0.0 108.903 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 67' ' ' ASP . 8.6 mt -66.7 138.5 22.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 114.982 -2.687 . . . . 0.0 109.327 -172.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.72 -37.74 1.89 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.57 -3.681 . . . . 0.0 112.135 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 65' ' ' ILE . 21.9 m-20 -162.84 139.19 7.35 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 116.53 -2.068 . . . . 0.0 109.484 -169.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 27.0 p90 -78.56 -164.71 0.6 Allowed 'General case' 0 C--O 1.259 1.557 0 C-N-CA 116.153 -2.219 . . . . 0.0 108.458 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 p -137.16 140.5 41.87 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 115.399 -2.52 . . . . 0.0 109.35 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 99.5 m -85.67 128.47 34.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.717 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -117.35 108.75 15.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 114.608 -2.837 . . . . 0.0 107.786 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 11.6 m -80.98 140.39 35.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 115.067 -2.653 . . . . 0.0 108.994 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 74' ' ' GLU . . . -74.5 159.67 31.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 73' ' ' ALA . 41.7 tt0 -47.07 116.58 1.42 Allowed 'General case' 0 C--O 1.258 1.514 0 C-N-CA 115.671 -2.412 . . . . 0.0 111.012 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 113.05 7.05 21.96 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 114.418 -3.753 . . . . 0.0 110.724 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.6 m-85 -139.01 152.52 47.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 C-N-CA 116.257 -2.177 . . . . 0.0 108.617 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.438 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.1 pt-20 -154.73 -151.95 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 115.9 -2.32 . . . . 0.0 109.234 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.838 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 91.76 174.28 42.78 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 115.13 -3.414 . . . . 0.0 108.754 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -61.57 -38.22 86.7 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 115.703 -2.399 . . . . 0.0 110.52 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.553 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 0.7 OUTLIER -102.47 26.23 8.11 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 117.513 -1.675 . . . . 0.0 111.175 -178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 55.5 m 57.24 30.19 18.0 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 114.17 -3.012 . . . . 0.0 107.905 -165.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.3 tp10 -63.84 -50.4 69.01 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 116.86 -1.936 . . . . 0.0 112.405 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 1.438 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.51 135.5 35.88 Favored 'General case' 0 N--CA 1.382 -3.832 0 C-N-CA 113.477 -3.289 . . . . 0.0 110.728 -149.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 36.2 p -76.12 94.82 3.54 Favored 'General case' 0 C--O 1.251 1.159 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.878 -177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.698 ' HB ' ' CD ' ' A' ' 77' ' ' GLU . 1.1 t -73.09 -25.78 61.01 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 115.869 -2.333 . . . . 0.0 109.47 -177.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 . . . . . 0 C--O 1.202 -1.395 0 C-N-CA 115.543 -2.463 . . . . 0.0 110.847 177.665 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.3 mttp . . . . . 0 CA--C 1.594 2.646 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -72.81 146.31 46.39 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 111.869 -3.932 . . . . 0.0 111.958 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.77 98.06 0.11 Allowed Glycine 0 C--N 1.352 1.425 1 C-N-CA 113.594 -4.146 . . . . 0.0 110.81 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.78 ' O ' ' N ' ' A' ' 50' ' ' CYS . 5.1 m-20 -97.29 -6.03 35.33 Favored 'General case' 0 C--O 1.264 1.858 0 C-N-CA 115.182 -2.607 . . . . 0.0 109.693 173.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 89.9 mm-40 41.99 6.58 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 117.999 -1.48 . . . . 0.0 111.885 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.78 ' N ' ' O ' ' A' ' 48' ' ' ASP . 46.2 t -116.16 4.76 13.64 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.473 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -73.26 143.91 46.87 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 116.109 -2.236 . . . . 0.0 109.423 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.68 75.67 Favored Glycine 0 CA--C 1.541 1.716 0 C-N-CA 114.072 -3.918 . . . . 0.0 111.266 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.1 t60 48.08 90.74 0.07 OUTLIER Pre-proline 0 C--N 1.36 1.045 0 C-N-CA 115.65 -2.42 . . . . 0.0 109.179 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -93.32 -35.31 0.04 OUTLIER 'Trans proline' 0 C--O 1.249 1.047 0 C-N-CA 121.116 1.21 . . . . 0.0 110.228 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.025 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 88.7 m -81.76 146.94 29.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 114.883 -2.727 . . . . 0.0 109.19 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.2 mt -96.96 175.26 6.4 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 116.147 -2.221 . . . . 0.0 109.553 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.6 m120 57.46 46.81 17.41 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.085 -1.871 . . . . 0.0 107.02 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 50.69 33.48 8.35 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.871 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.66 -168.72 5.26 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 113.976 -3.964 . . . . 0.0 109.839 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -130.7 120.26 23.61 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.311 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.3 p -104.9 117.35 33.81 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 115.175 -2.61 . . . . 0.0 109.036 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -98.82 148.71 23.63 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 116.0 -2.28 . . . . 0.0 107.304 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.03 149.55 21.14 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 115.419 -2.512 . . . . 0.0 108.587 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.67 0.1 OUTLIER Glycine 0 C--O 1.255 1.458 0 C-N-CA 114.947 -3.501 . . . . 0.0 109.671 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.811 HG22 ' H ' ' A' ' 66' ' ' GLY . 5.6 mm -70.32 -173.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.288 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.811 ' H ' HG22 ' A' ' 65' ' ' ILE . . . -62.79 -4.95 7.89 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 114.244 -3.836 . . . . 0.0 110.774 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.3 p30 -123.67 146.91 47.87 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.787 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.544 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.0 p90 -84.76 -164.5 0.98 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 115.306 -2.558 . . . . 0.0 107.82 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.6 135.35 40.19 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.362 171.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.025 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 57.0 m -86.65 140.08 30.17 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 115.594 -2.442 . . . . 0.0 107.931 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -122.5 110.79 16.02 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 115.963 -2.295 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 6.9 m -83.08 140.53 32.61 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 115.464 -2.495 . . . . 0.0 109.432 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.66 164.23 22.03 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 115.416 -2.514 . . . . 0.0 110.191 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -50.62 109.85 0.35 Allowed 'General case' 0 C--O 1.215 -0.741 0 C-N-CA 115.277 -2.569 . . . . 0.0 109.519 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 115.88 15.13 7.5 Favored Glycine 0 CA--C 1.551 2.323 0 C-N-CA 114.984 -3.484 . . . . 0.0 112.299 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.0 m-85 -146.0 153.77 41.13 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 115.143 -2.623 . . . . 0.0 109.015 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.522 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.6 pt-20 -157.15 -145.52 0.15 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 114.593 -2.843 . . . . 0.0 107.846 177.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.896 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 84.49 176.09 50.93 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 115.089 -3.434 . . . . 0.0 108.085 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.38 -36.68 71.55 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 115.342 -2.543 . . . . 0.0 111.115 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.657 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 1.4 m120 -107.56 21.61 17.2 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.436 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 62.3 m 62.02 24.52 14.61 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 114.963 -2.695 . . . . 0.0 107.278 -160.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.736 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.8 tp10 -58.7 -53.76 54.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 116.115 -2.234 . . . . 0.0 112.197 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 1.522 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.44 129.85 41.04 Favored 'General case' 0 N--CA 1.394 -3.236 0 C-N-CA 111.82 -3.952 . . . . 0.0 111.97 -149.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 20.4 p -74.29 102.5 4.37 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 115.507 -2.477 . . . . 0.0 109.664 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.457 HG22 ' CD ' ' A' ' 77' ' ' GLU . 76.2 p -44.64 -43.11 8.01 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 114.888 -2.725 . . . . 0.0 110.877 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 . . . . . 0 N--CA 1.433 -1.301 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.027 -176.44 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.0 mttm . . . . . 0 CA--C 1.5 -0.947 0 CA-C-O 122.099 0.952 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -109.16 -31.56 7.55 Favored 'General case' 0 C--O 1.178 -2.659 0 CA-C-O 126.633 3.111 . . . . 0.0 112.187 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.84 118.35 0.64 Allowed Glycine 0 CA--C 1.569 3.446 0 C-N-CA 114.676 -3.63 . . . . 0.0 109.724 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.09 39.26 1.15 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 115.154 -2.618 . . . . 0.0 108.826 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -79.92 -24.44 41.07 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 117.039 -1.864 . . . . 0.0 107.677 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 15.0 p -154.69 23.07 0.46 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 115.918 -2.313 . . . . 0.0 110.064 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.22 -14.52 61.36 Favored 'General case' 0 C--O 1.197 -1.674 0 C-N-CA 115.697 -2.401 . . . . 0.0 110.351 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.62 20.19 36.37 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 114.734 -3.603 . . . . 0.0 110.853 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 49.84 83.12 0.23 Allowed Pre-proline 0 C--O 1.254 1.34 0 C-N-CA 116.639 -2.024 . . . . 0.0 109.944 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -88.95 -37.53 0.06 OUTLIER 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 121.434 1.423 . . . . 0.0 110.666 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 1.003 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 56.6 m -72.94 127.19 31.83 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 115.108 -2.637 . . . . 0.0 110.43 -176.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.32 175.04 10.18 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 116.137 -2.225 . . . . 0.0 109.873 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 14.9 m120 64.94 50.81 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.986 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 51.28 22.85 1.48 Allowed 'General case' 0 C--O 1.253 1.241 0 C-N-CA 115.518 -2.473 . . . . 0.0 113.374 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.95 -142.65 0.38 Allowed Glycine 0 N--CA 1.499 2.85 1 C-N-CA 113.677 -4.106 . . . . 0.0 110.05 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -153.13 164.42 38.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 114.974 -2.69 . . . . 0.0 109.005 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 25.0 p -141.11 150.33 42.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 114.842 -2.743 . . . . 0.0 109.747 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -138.27 134.76 34.75 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 108.295 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.06 151.98 33.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 116.022 -2.271 . . . . 0.0 111.578 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -142.44 -176.28 16.44 Favored Glycine 0 CA--C 1.544 1.901 1 C-N-CA 113.743 -4.075 . . . . 0.0 109.216 178.106 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 65' ' ' ILE . 48.5 mt -84.93 29.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.278 -1.769 . . . . 0.0 109.297 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . 165.09 86.88 0.06 OUTLIER Glycine 0 C--N 1.262 -3.542 0 C-N-CA 115.417 -3.278 . . . . 0.0 109.849 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 73.13 134.62 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 116.174 -2.21 . . . . 0.0 109.306 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.494 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -77.89 -170.86 2.05 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 117.844 -1.542 . . . . 0.0 108.62 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -130.77 136.53 48.81 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 116.607 -2.037 . . . . 0.0 109.659 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 1.003 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -103.47 129.31 50.59 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 113.448 -3.301 . . . . 0.0 110.238 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 72' ' ' CYS . 55.0 m -104.28 173.11 6.44 Favored 'General case' 0 C--O 1.25 1.105 0 C-N-CA 115.814 -2.355 . . . . 0.0 107.844 168.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.801 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.8 m -123.56 -48.96 1.91 Allowed 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 115.997 -2.281 . . . . 0.0 110.007 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.801 ' CB ' ' O ' ' A' ' 72' ' ' CYS . . . 119.75 165.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.858 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -57.3 122.21 11.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 115.375 -2.53 . . . . 0.0 111.145 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 76.95 34.91 40.81 Favored Glycine 0 N--CA 1.47 0.956 0 C-N-CA 115.114 -3.422 . . . . 0.0 111.502 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 73' ' ' ALA . 82.7 m-85 -143.58 150.38 38.75 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.036 167.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 2.4 mt-10 -155.83 178.43 10.27 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 115.721 -2.391 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.1 179.09 21.39 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 114.72 -3.609 . . . . 0.0 110.036 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.86 -61.0 2.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 115.222 -2.591 . . . . 0.0 108.092 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.783 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 0.8 OUTLIER -78.91 -20.91 48.21 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 116.633 -2.027 . . . . 0.0 111.156 176.07 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.783 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 12.5 m 92.18 27.25 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 116.394 -2.123 . . . . 0.0 108.383 -164.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.25 -19.77 56.12 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 116.005 -2.278 . . . . 0.0 110.547 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.463 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 35.4 m-85 -81.16 177.48 9.0 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.825 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.9 m -136.24 39.85 2.68 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.503 166.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 35.2 p 43.5 30.26 0.32 Allowed 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.964 -1.894 . . . . 0.0 109.932 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' THR . 31.7 tpt180 . . . . . 0 C--N 1.298 -1.657 0 CA-C-O 115.888 -2.006 . . . . 0.0 109.254 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 . . . . . 0 C--O 1.213 -0.816 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 89.2 m -110.74 19.92 18.12 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 114.126 -3.03 . . . . 0.0 107.631 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.64 142.88 44.51 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 115.201 -2.599 . . . . 0.0 110.048 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.714 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 76.04 47.75 10.85 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 115.172 -3.394 . . . . 0.0 110.161 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.714 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.5 m80 9.25 91.99 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 118.161 -1.416 . . . . 0.0 111.616 173.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -91.75 -43.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.627 0.804 . . . . 0.0 110.65 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 77.2 m -77.76 151.88 33.86 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 115.611 -2.435 . . . . 0.0 110.349 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.601 ' CD1' HD22 ' A' ' 80' ' ' ASN . 74.0 mt -101.67 173.47 6.4 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.596 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 47.69 64.69 1.51 Allowed 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 117.415 -1.714 . . . . 0.0 111.688 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 46.83 26.86 0.62 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.081 -1.448 . . . . 0.0 111.497 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.36 132.49 12.69 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 113.95 -3.976 . . . . 0.0 110.155 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -77.86 167.93 20.73 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.345 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.5 p -147.62 123.61 10.71 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 115.75 -2.38 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.0 -141.6 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 115.345 -2.542 . . . . 0.0 108.611 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -144.47 161.64 38.54 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 115.894 -2.322 . . . . 0.0 109.168 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -166.9 173.5 42.2 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 115.092 -3.433 . . . . 0.0 109.917 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.76 30.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 116.274 -2.17 . . . . 0.0 108.612 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 176.16 80.7 0.05 OUTLIER Glycine 0 C--N 1.279 -2.612 0 C-N-CA 115.614 -3.184 . . . . 0.0 108.298 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.65 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 42.3 m-20 73.81 137.21 0.05 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 116.527 -2.069 . . . . 0.0 109.355 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.4 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 26.9 p90 -78.25 -165.16 0.63 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 116.501 -2.08 . . . . 0.0 109.491 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -133.68 143.8 48.77 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.975 -2.29 . . . . 0.0 109.67 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 44.4 m -90.03 144.14 26.16 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 115.647 -2.421 . . . . 0.0 110.001 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.6 m -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 116.789 -1.964 . . . . 0.0 108.246 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 8.2 m -79.44 141.14 37.07 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 115.836 -2.346 . . . . 0.0 109.689 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.85 164.84 18.79 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 115.462 -2.495 . . . . 0.0 109.479 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.88 115.15 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.174 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.63 12.85 13.81 Favored Glycine 0 C--N 1.357 1.722 0 C-N-CA 115.068 -3.444 . . . . 0.0 112.08 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.4 m-85 -141.62 153.52 44.82 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 115.059 -2.656 . . . . 0.0 109.638 174.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.609 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -155.03 -146.31 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 115.379 -2.528 . . . . 0.0 108.914 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.918 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 87.58 168.89 45.04 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 114.285 -3.817 . . . . 0.0 107.917 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -58.32 -29.9 66.27 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 115.14 -2.624 . . . . 0.0 110.213 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.601 HD22 ' CD1' ' A' ' 56' ' ' LEU . 19.9 m-20 -108.64 19.62 19.5 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 116.225 -2.19 . . . . 0.0 111.242 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 56.0 m 60.11 27.52 16.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 115.102 -2.639 . . . . 0.0 106.945 -162.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.692 ' N ' ' O ' ' A' ' 77' ' ' GLU . 7.7 tt0 -61.61 -47.8 83.8 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 117.595 -1.642 . . . . 0.0 112.643 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 1.609 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -98.75 134.18 42.01 Favored 'General case' 0 N--CA 1.404 -2.771 0 C-N-CA 112.533 -3.667 . . . . 0.0 113.169 -152.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.3 p -79.49 106.03 11.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 115.676 -2.409 . . . . 0.0 109.748 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.46 HG22 ' CD ' ' A' ' 77' ' ' GLU . 69.6 p -46.46 -43.53 16.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 116.269 -2.172 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 . . . . . 0 C--O 1.21 -1.0 0 C-N-CA 115.278 -2.569 . . . . 0.0 110.775 -179.542 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.419 ' OE1' ' N ' ' A' ' 49' ' ' GLN . 14.2 mp0 . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.9 t -143.22 19.88 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 115.681 -2.408 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -81.88 -1.96 49.5 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 115.758 -2.377 . . . . 0.0 110.912 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.13 18.67 5.53 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 114.446 -3.74 . . . . 0.0 110.882 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.9 t60 51.29 90.33 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.797 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -98.92 -26.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.28 1.32 . . . . 0.0 110.041 -174.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 65.7 m -78.07 141.31 38.91 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 115.663 -2.415 . . . . 0.0 110.061 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.6 mt -88.09 177.42 6.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 117.433 -1.707 . . . . 0.0 110.216 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 81' ' ' CYS . 5.4 p30 43.67 56.88 4.28 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.891 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 57' ' ' ASN . 6.6 tt0 49.73 29.2 3.04 Favored 'General case' 0 N--CA 1.397 -3.097 0 C-N-CA 116.503 -2.079 . . . . 0.0 112.268 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.83 -176.33 16.78 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 114.815 -3.564 . . . . 0.0 111.334 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 61.0 t-80 -109.87 147.14 33.9 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 116.71 -1.996 . . . . 0.0 109.236 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.2 p -128.26 107.84 10.11 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.057 -2.257 . . . . 0.0 108.774 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -91.97 121.76 33.85 Favored 'General case' 0 C--O 1.258 1.502 0 C-N-CA 115.553 -2.459 . . . . 0.0 109.173 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.0 153.14 29.06 Favored 'General case' 0 C--O 1.255 1.37 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.934 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.32 -92.71 0.08 OUTLIER Glycine 0 CA--C 1.547 2.05 0 C-N-CA 116.64 -2.695 . . . . 0.0 109.405 174.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 66' ' ' GLY . 83.9 mt -65.22 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.587 0 C-N-CA 116.836 -1.946 . . . . 0.0 110.462 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.634 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.85 -22.31 11.88 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.267 -4.301 . . . . 0.0 111.394 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.403 ' N ' ' C ' ' A' ' 65' ' ' ILE . 31.5 m-20 -107.18 135.58 48.46 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 115.965 -2.294 . . . . 0.0 108.991 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.485 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -77.4 -166.19 0.71 Allowed 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 116.243 -2.183 . . . . 0.0 109.177 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.67 133.99 38.72 Favored 'General case' 0 C--O 1.255 1.36 0 C-N-CA 113.256 -3.378 . . . . 0.0 108.646 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 7.4 m -90.95 110.97 22.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 115.535 -2.466 . . . . 0.0 108.965 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 98.1 m -96.8 119.32 35.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.832 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.06 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 61.6 m -88.28 156.93 18.93 Favored 'General case' 0 C--O 1.276 2.457 0 C-N-CA 114.256 -2.977 . . . . 0.0 109.342 -173.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 176.11 10.0 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 115.236 -2.586 . . . . 0.0 110.392 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.02 134.02 56.62 Favored 'General case' 0 C--O 1.266 1.941 0 C-N-CA 115.954 -2.298 . . . . 0.0 110.047 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.59 24.67 60.12 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 115.522 -3.228 . . . . 0.0 110.39 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.8 m-85 -141.95 140.94 32.89 Favored 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 115.455 -2.498 . . . . 0.0 108.704 171.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -144.57 -172.42 3.81 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 116.167 -2.213 . . . . 0.0 108.728 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.72 172.56 46.55 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 115.638 -3.172 . . . . 0.0 110.79 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -64.89 -47.0 79.37 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 115.658 -2.417 . . . . 0.0 109.594 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.772 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 13.3 m120 -79.67 -17.26 54.1 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 115.741 -2.384 . . . . 0.0 109.979 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.06 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.7 m 86.48 18.67 0.09 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 115.574 -2.45 . . . . 0.0 107.616 -164.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -55.95 -29.55 60.35 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.003 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 65.5 m-85 -78.92 162.56 25.92 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 115.032 -2.667 . . . . 0.0 110.066 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 35.7 t -121.85 29.54 7.07 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 115.243 -2.583 . . . . 0.0 107.949 170.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 84' ' ' SER . 26.3 p 43.87 19.95 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.153 0 C-N-CA 117.311 -1.755 . . . . 0.0 111.178 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.463 ' N ' ' C ' ' A' ' 84' ' ' SER . 45.2 ttt85 . . . . . 0 C--N 1.287 -2.119 0 C-N-CA 116.527 -2.069 . . . . 0.0 111.013 173.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.442 HE21 ' HB2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -109.94 -14.33 14.28 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 114.846 -2.742 . . . . 0.0 109.967 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -74.96 144.72 43.06 Favored 'General case' 0 C--O 1.268 2.057 0 C-N-CA 114.945 -2.702 . . . . 0.0 108.965 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.762 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 87.28 43.13 5.99 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 114.666 -3.635 . . . . 0.0 110.495 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.762 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER 10.61 92.63 0.04 OUTLIER Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 112.46 -1.87 . . . . 0.0 110.506 175.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.78 -40.22 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.136 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 83.8 m -74.63 150.01 39.79 Favored 'General case' 0 C--O 1.256 1.439 0 C-N-CA 113.82 -3.152 . . . . 0.0 109.762 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.462 ' CD1' HD22 ' A' ' 80' ' ' ASN . 17.6 mt -88.63 -178.55 5.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.118 -2.233 . . . . 0.0 109.888 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.693 HD21 ' HB2' ' A' ' 81' ' ' CYS . 6.7 p30 41.72 38.97 1.06 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.879 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 54.55 26.5 7.34 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.541 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 177.23 6.12 Favored Glycine 0 C--N 1.282 -2.462 0 C-N-CA 114.161 -3.876 . . . . 0.0 108.124 171.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -106.71 154.27 21.2 Favored 'General case' 0 C--N 1.278 -2.516 0 C-N-CA 116.229 -2.188 . . . . 0.0 108.492 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 31.4 p -133.53 93.72 3.19 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 115.658 -2.417 . . . . 0.0 108.48 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -76.99 147.41 36.85 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.117 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.58 158.53 15.41 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 116.182 -2.207 . . . . 0.0 110.025 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.4 -100.66 0.14 Allowed Glycine 0 C--O 1.24 0.517 0 C-N-CA 115.261 -3.352 . . . . 0.0 109.309 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 66' ' ' GLY . 63.2 mt -62.77 170.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 115.584 -2.447 . . . . 0.0 108.462 173.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -53.83 -19.18 9.73 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 114.46 -3.733 . . . . 0.0 110.401 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' C ' ' A' ' 65' ' ' ILE . 9.1 t70 -101.95 139.45 37.57 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.651 -1.62 . . . . 0.0 107.222 169.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.586 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -83.98 -162.12 0.61 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 116.923 -1.911 . . . . 0.0 107.296 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -141.05 141.99 34.24 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.265 -2.174 . . . . 0.0 108.594 173.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 95.1 m -94.7 114.44 26.36 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 116.131 -2.228 . . . . 0.0 110.274 -173.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 m -98.62 120.18 38.61 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 115.528 -2.469 . . . . 0.0 108.171 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 41.3 m -93.89 147.21 23.29 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 114.855 -2.738 . . . . 0.0 109.086 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.52 24.68 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 114.483 -2.887 . . . . 0.0 109.004 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.14 134.72 49.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 115.959 -2.296 . . . . 0.0 108.372 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 99.34 -13.05 61.74 Favored Glycine 0 CA--C 1.489 -1.588 0 C-N-CA 114.585 -3.674 . . . . 0.0 110.85 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.698 ' HB3' ' HB3' ' A' ' 81' ' ' CYS . 85.4 m-85 -126.95 147.94 50.09 Favored 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 114.051 -3.06 . . . . 0.0 109.436 167.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.1 170.68 19.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 114.517 -2.873 . . . . 0.0 110.652 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.47 -175.67 19.02 Favored Glycine 0 N--CA 1.434 -1.474 1 C-N-CA 113.035 -4.412 . . . . 0.0 111.343 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -74.31 -61.64 1.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 C-N-CA 113.807 -3.157 . . . . 0.0 109.394 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 46.6 m-20 -76.56 -5.14 46.38 Favored 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 114.776 -2.77 . . . . 0.0 111.711 175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.1 m 82.51 17.44 0.34 Allowed 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 116.539 -2.065 . . . . 0.0 107.698 -169.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.75 -22.32 5.13 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 116.281 -2.168 . . . . 0.0 112.573 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.27 153.2 30.08 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 114.834 -2.747 . . . . 0.0 109.597 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 39.1 m -120.44 42.86 2.88 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 114.602 -2.839 . . . . 0.0 106.457 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p 41.41 47.42 3.12 Favored 'General case' 0 N--CA 1.512 2.665 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.833 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 . . . . . 0 C--N 1.277 -2.579 0 C-N-CA 115.262 -2.575 . . . . 0.0 109.099 -174.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 . . . . . 0 CA--C 1.565 1.538 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 24.2 t -148.63 68.38 1.07 Allowed 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 113.618 -3.233 . . . . 0.0 108.606 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 53' ' ' HIS . 8.1 tt0 -65.31 179.3 0.77 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 115.384 -2.526 . . . . 0.0 108.631 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 4.0 4.71 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 114.718 -3.611 . . . . 0.0 111.576 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 51' ' ' GLU . 11.0 t-160 -173.12 96.67 0.35 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 116.14 -2.224 . . . . 0.0 109.058 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -111.92 -46.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 108.049 -1.558 . . . . 0.0 108.049 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.5 m -81.19 157.11 25.36 Favored 'General case' 0 C--O 1.253 1.241 0 C-N-CA 114.863 -2.735 . . . . 0.0 108.923 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' CD1' HD22 ' A' ' 80' ' ' ASN . 80.9 mt -90.25 175.95 6.93 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 115.964 -2.294 . . . . 0.0 108.682 -177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 56.37 43.13 26.71 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.174 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 45.66 33.38 1.42 Allowed 'General case' 0 N--CA 1.407 -2.616 0 C-N-CA 117.068 -1.853 . . . . 0.0 112.793 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.94 -170.03 1.74 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 114.77 -3.586 . . . . 0.0 109.635 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 24.2 t-80 -107.78 163.55 13.01 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 115.665 -2.414 . . . . 0.0 109.564 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 10.8 t -143.19 143.05 31.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 115.204 -2.598 . . . . 0.0 108.295 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -123.3 -144.35 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.539 -2.065 . . . . 0.0 108.114 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -140.53 152.38 45.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 114.469 -2.892 . . . . 0.0 110.315 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.95 149.55 12.02 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 115.084 -3.436 . . . . 0.0 110.026 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 67' ' ' ASP . 39.4 mt -62.57 138.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.303 -176.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.6 -28.89 1.51 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 116.299 -2.857 . . . . 0.0 111.436 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' A' ' 65' ' ' ILE . 34.3 t70 -176.58 141.14 0.38 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 116.521 -2.072 . . . . 0.0 110.152 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.773 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 17.9 p90 -81.48 -165.6 0.99 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 116.424 -2.111 . . . . 0.0 108.068 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -131.99 136.46 47.31 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 115.41 -2.516 . . . . 0.0 110.507 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.773 ' SG ' ' HE2' ' A' ' 68' ' ' TYR . 93.2 m -94.3 142.39 27.47 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 115.268 -2.573 . . . . 0.0 109.475 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 82.2 m -125.53 108.32 11.48 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 115.282 -2.567 . . . . 0.0 107.647 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.991 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.0 m -82.42 142.89 31.58 Favored 'General case' 0 C--O 1.259 1.559 0 C-N-CA 116.325 -2.15 . . . . 0.0 108.716 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 165.59 24.76 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.936 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -50.36 143.13 9.23 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.185 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 80.83 12.94 82.15 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 114.889 -3.529 . . . . 0.0 110.426 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 98.1 m-85 -140.25 143.64 36.07 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.382 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -145.56 -174.34 4.37 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 116.128 -2.229 . . . . 0.0 109.622 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.43 173.42 48.3 Favored Glycine 0 C--O 1.236 0.261 0 C-N-CA 114.636 -3.65 . . . . 0.0 109.658 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -71.15 -42.18 69.48 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 115.456 -2.498 . . . . 0.0 110.38 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 41.2 m-20 -83.65 -4.7 58.81 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 116.795 -1.962 . . . . 0.0 110.152 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.991 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 70.91 25.66 3.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 114.322 -2.951 . . . . 0.0 108.219 -165.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.58 -25.03 68.05 Favored 'General case' 0 C--N 1.368 1.394 0 C-N-CA 116.155 -2.218 . . . . 0.0 110.057 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -79.16 175.65 10.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 115.892 -2.323 . . . . 0.0 109.234 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 23.4 p -139.97 28.45 2.12 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 116.768 -1.973 . . . . 0.0 108.246 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p 41.92 30.07 0.15 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.4 -1.72 . . . . 0.0 110.405 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 84' ' ' SER . 48.1 ttp180 . . . . . 0 C--N 1.3 -1.557 0 C-N-CA 116.426 -2.11 . . . . 0.0 109.764 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 C--O 1.239 0.543 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.5 t -137.32 64.41 1.53 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 115.04 -2.664 . . . . 0.0 110.132 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' C ' ' N ' ' A' ' 53' ' ' HIS . 9.1 tt0 -57.48 164.76 1.78 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 115.668 -2.413 . . . . 0.0 109.311 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.22 -12.74 8.48 Favored Glycine 0 CA--C 1.529 0.959 1 C-N-CA 113.853 -4.022 . . . . 0.0 111.448 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.422 ' N ' ' C ' ' A' ' 51' ' ' GLU . 21.1 t-160 -172.3 94.48 0.39 Allowed Pre-proline 0 CA--C 1.577 1.989 0 C-N-CA 116.323 -2.151 . . . . 0.0 109.403 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -97.34 -37.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.481 0.765 0 O-C-N 123.422 1.222 . . . . 0.0 110.668 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 79.7 m -98.54 154.75 17.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 115.235 -2.586 . . . . 0.0 108.755 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.554 ' CD1' HD22 ' A' ' 80' ' ' ASN . 58.0 mt -73.84 176.93 5.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 115.483 -2.487 . . . . 0.0 111.662 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.519 HD21 ' C ' ' A' ' 81' ' ' CYS . 3.6 p30 46.2 53.44 9.39 Favored 'General case' 0 C--O 1.269 2.081 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.781 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 50.94 25.07 2.05 Favored 'General case' 0 N--CA 1.396 -3.166 0 C-N-CA 116.981 -1.888 . . . . 0.0 110.26 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.09 130.44 38.69 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 115.666 -3.159 . . . . 0.0 108.252 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -80.03 174.64 11.39 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.348 -174.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 19.4 p -139.96 116.55 10.78 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 114.407 -2.917 . . . . 0.0 108.435 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -90.38 119.72 30.91 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 115.406 -2.518 . . . . 0.0 107.338 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.3 157.56 27.69 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 116.524 -2.07 . . . . 0.0 110.02 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.16 -87.11 0.07 OUTLIER Glycine 0 C--O 1.198 -2.114 0 C-N-CA 114.23 -3.843 . . . . 0.0 108.226 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.751 HG22 ' N ' ' A' ' 66' ' ' GLY . 50.4 mt -71.04 -176.42 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.263 1.778 0 C-N-CA 116.533 -2.067 . . . . 0.0 110.231 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.751 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -58.65 -13.19 16.59 Favored Glycine 0 N--CA 1.486 2.002 0 C-N-CA 116.407 -2.806 . . . . 0.0 109.878 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.6 p-10 -120.62 144.88 47.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 115.931 -2.308 . . . . 0.0 106.118 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.425 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 21.1 p90 -84.91 -161.3 0.56 Allowed 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 115.858 -2.337 . . . . 0.0 108.94 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -140.14 136.94 34.02 Favored 'General case' 0 C--O 1.204 -1.314 0 C-N-CA 116.34 -2.144 . . . . 0.0 109.098 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.3 m -78.15 137.25 38.08 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 115.283 -2.567 . . . . 0.0 108.611 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.8 m -120.67 115.22 22.92 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 116.774 -1.97 . . . . 0.0 107.754 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.065 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.2 m -84.52 139.72 31.95 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 114.886 -2.726 . . . . 0.0 110.014 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.9 168.89 5.76 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.367 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.08 120.0 6.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.166 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 98.44 23.45 12.48 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 115.016 -3.469 . . . . 0.0 111.617 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.669 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 83.8 m-85 -146.37 149.71 34.29 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 115.412 -2.515 . . . . 0.0 110.554 172.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.24 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -155.84 -146.72 0.18 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 115.314 -2.554 . . . . 0.0 109.657 173.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.847 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 86.68 168.43 44.82 Favored Glycine 1 N--CA 1.52 4.263 0 C-N-CA 114.739 -3.6 . . . . 0.0 109.165 177.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -54.7 -37.25 65.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 116.254 -2.179 . . . . 0.0 109.008 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.554 HD22 ' CD1' ' A' ' 56' ' ' LEU . 75.1 m-20 -102.19 29.93 4.82 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 116.105 -2.238 . . . . 0.0 111.676 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.065 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 73.6 m 50.84 25.01 1.97 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 115.232 -2.587 . . . . 0.0 106.786 -163.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.815 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.2 tp10 -55.22 -55.03 35.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.455 -1.698 . . . . 0.0 113.022 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 1.24 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -90.1 139.1 30.95 Favored 'General case' 0 N--CA 1.387 -3.582 0 C-N-CA 113.445 -3.302 . . . . 0.0 112.098 -148.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 22.8 t -86.15 58.47 5.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 115.992 -2.283 . . . . 0.0 110.734 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.2 p 37.14 28.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 116.051 -2.26 . . . . 0.0 112.051 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' N ' ' C ' ' A' ' 84' ' ' SER . 71.4 mtp85 . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 115.941 -1.98 . . . . 0.0 108.762 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 74.2 m -117.32 -0.66 11.95 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.425 -2.11 . . . . 0.0 108.98 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 115.059 -2.657 . . . . 0.0 109.85 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -95.55 18.13 57.98 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 114.903 -3.522 . . . . 0.0 111.01 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' GLY . 16.4 t-160 44.48 84.2 0.19 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 116.239 -2.185 . . . . 0.0 110.161 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -97.13 -38.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 O-C-N 123.667 1.351 . . . . 0.0 111.096 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.051 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 61.2 m -96.42 151.02 19.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 115.677 -2.409 . . . . 0.0 110.423 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.442 ' CD1' HD22 ' A' ' 80' ' ' ASN . 86.2 mt -103.78 176.39 5.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 116.128 -2.229 . . . . 0.0 110.034 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 56.75 47.77 17.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 117.218 -1.793 . . . . 0.0 111.755 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 49.52 35.12 7.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.174 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.75 -161.39 4.88 Favored Glycine 0 C--N 1.363 2.05 0 C-N-CA 114.051 -3.928 . . . . 0.0 110.468 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 9.0 t-160 -135.68 175.03 9.97 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 115.208 -2.597 . . . . 0.0 109.697 -176.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 14.3 p -153.13 138.14 17.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 114.374 -2.93 . . . . 0.0 108.702 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -115.82 133.28 56.19 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 116.124 -2.23 . . . . 0.0 109.237 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.14 159.3 29.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 116.083 -2.247 . . . . 0.0 108.607 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 66' ' ' GLY . . . -152.21 38.29 0.79 Allowed Glycine 0 N--CA 1.504 3.178 0 C-N-CA 114.471 -3.728 . . . . 0.0 110.367 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 65' ' ' ILE . 81.4 mt 36.27 36.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 116.784 -1.966 . . . . 0.0 110.037 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 162.22 85.62 0.06 OUTLIER Glycine 0 C--N 1.288 -2.101 0 C-N-CA 115.471 -3.252 . . . . 0.0 109.825 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.2 m-20 67.57 116.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 116.656 -2.017 . . . . 0.0 109.007 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.488 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 24.6 p90 -76.7 -169.9 1.4 Allowed 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.278 -2.569 . . . . 0.0 108.363 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 p -139.43 132.8 30.07 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 115.789 -2.364 . . . . 0.0 108.831 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.051 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 61.4 m -81.68 128.46 33.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.38 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 88.8 m -108.04 109.65 21.15 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 114.739 -2.785 . . . . 0.0 108.435 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.9 m -86.46 143.41 27.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 115.57 -2.452 . . . . 0.0 109.648 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.71 171.44 13.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 116.935 -1.906 . . . . 0.0 109.711 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -52.4 126.88 20.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 115.705 -2.398 . . . . 0.0 110.039 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.6 19.46 44.48 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.769 -3.586 . . . . 0.0 110.235 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 99.9 m-85 -140.49 145.99 37.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.287 -2.565 . . . . 0.0 108.538 165.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 46.2 mm-40 -146.31 -166.97 2.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 116.086 -2.245 . . . . 0.0 109.083 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.54 168.27 35.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 114.296 -3.811 . . . . 0.0 109.261 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -68.54 -37.09 79.68 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 114.58 -2.848 . . . . 0.0 109.904 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 39.9 m-20 -80.72 -16.01 55.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.16 -1.816 . . . . 0.0 111.762 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.2 m 77.98 18.67 1.16 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.16 -2.616 . . . . 0.0 107.331 -162.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.74 -31.16 69.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 117.498 -1.681 . . . . 0.0 110.211 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 49.5 m-85 -78.82 160.71 27.23 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 115.362 -2.535 . . . . 0.0 110.502 -176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.569 ' C ' ' N ' ' A' ' 86' ' ' ARG . 19.2 t -123.58 38.08 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 115.564 -2.455 . . . . 0.0 108.221 170.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p 40.03 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.324 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.569 ' N ' ' C ' ' A' ' 84' ' ' SER . 78.0 ttt-85 . . . . . 0 C--N 1.308 -1.231 0 C-N-CA 115.936 -2.306 . . . . 0.0 110.202 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 . . . . . 0 CA--C 1.546 0.805 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.4 t -127.19 -22.8 3.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 114.906 -2.718 . . . . 0.0 111.532 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.3 -17.41 64.77 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 114.311 -2.956 . . . . 0.0 110.122 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -88.88 36.36 3.48 Favored Glycine 0 C--O 1.259 1.657 0 C-N-CA 115.872 -3.061 . . . . 0.0 110.993 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.72 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.7 m-70 13.98 88.47 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 117.843 -1.543 . . . . 0.0 110.678 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -89.98 -42.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.974 1.782 . . . . 0.0 109.746 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 38.7 m -81.97 113.42 19.86 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 116.12 -2.232 . . . . 0.0 110.969 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.445 ' CD1' HD22 ' A' ' 80' ' ' ASN . 81.2 mt -74.82 175.93 7.55 Favored 'General case' 0 CA--C 1.58 2.126 0 C-N-CA 115.023 -2.671 . . . . 0.0 110.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 62.11 50.44 4.0 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 117.146 -1.821 . . . . 0.0 109.972 168.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 53.39 27.79 6.74 Favored 'General case' 0 C--O 1.281 2.711 0 C-N-CA 116.7 -2.0 . . . . 0.0 111.389 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.18 -150.46 3.86 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 114.081 -3.914 . . . . 0.0 110.44 175.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -141.07 135.13 30.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 114.606 -2.838 . . . . 0.0 108.308 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.7 p -113.93 128.11 56.26 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 116.051 -2.26 . . . . 0.0 110.032 176.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -97.78 -165.24 1.23 Allowed 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.599 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -151.81 138.03 18.37 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 115.945 -2.302 . . . . 0.0 109.26 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.29 -95.96 0.1 Allowed Glycine 0 C--O 1.247 0.959 0 C-N-CA 114.49 -3.719 . . . . 0.0 109.766 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.649 HG22 ' N ' ' A' ' 66' ' ' GLY . 71.6 mt -62.82 177.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 116.007 -2.277 . . . . 0.0 110.833 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.649 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.32 -18.76 5.22 Favored Glycine 0 CA--C 1.549 2.205 0 C-N-CA 114.772 -3.585 . . . . 0.0 111.067 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' C ' ' A' ' 65' ' ' ILE . 3.3 p-10 -112.81 146.56 38.64 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 116.005 -2.278 . . . . 0.0 108.014 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -83.89 -166.03 1.3 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 116.762 -1.975 . . . . 0.0 108.604 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.87 136.15 36.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 114.985 -2.686 . . . . 0.0 108.542 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 8.6 m -95.88 155.33 16.8 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 114.676 -2.81 . . . . 0.0 110.937 -174.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -135.49 131.04 35.61 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 115.506 -2.478 . . . . 0.0 109.0 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.033 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.6 m -107.51 142.45 37.37 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 114.697 -2.801 . . . . 0.0 108.503 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.87 172.71 10.36 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 116.233 -2.187 . . . . 0.0 109.319 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -55.85 146.21 22.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.863 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.23 8.73 87.62 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 114.487 -3.721 . . . . 0.0 110.994 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 92.4 m-85 -136.82 140.74 42.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 114.506 -2.878 . . . . 0.0 109.998 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -147.08 -166.75 2.59 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 116.197 -2.201 . . . . 0.0 107.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.56 167.06 38.06 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 114.383 -3.77 . . . . 0.0 109.501 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -67.8 -34.44 76.75 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 116.375 -2.13 . . . . 0.0 108.391 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.59 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.4 m-20 -89.71 -4.74 57.57 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 116.35 -2.14 . . . . 0.0 111.933 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.033 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.8 m 71.66 17.48 5.53 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 114.484 -2.886 . . . . 0.0 107.452 -166.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.28 -31.12 68.82 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 118.021 -1.472 . . . . 0.0 109.406 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 38.3 m-85 -79.74 165.01 23.24 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 115.517 -2.473 . . . . 0.0 111.296 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.5 t -127.29 38.67 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.53 -2.468 . . . . 0.0 107.898 173.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.6 p 46.1 22.95 0.16 Allowed 'General case' 0 N--CA 1.511 2.588 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.836 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.443 ' N ' ' C ' ' A' ' 84' ' ' SER . 8.8 mmm180 . . . . . 0 N--CA 1.514 2.732 0 CA-C-O 115.702 -2.094 . . . . 0.0 108.135 176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 85.9 mm-40 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 122.552 1.168 . . . . 0.0 111.732 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 50.1 t -112.53 54.97 0.7 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 115.101 -2.639 . . . . 0.0 109.513 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' CYS . 16.9 tt0 -40.61 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 115.669 -2.412 . . . . 0.0 111.204 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.6 -14.01 8.77 Favored Glycine 0 CA--C 1.559 2.832 0 C-N-CA 114.488 -3.72 . . . . 0.0 112.115 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -174.26 93.03 0.32 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 115.191 -2.604 . . . . 0.0 109.888 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -99.74 -41.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.823 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.203 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -81.72 169.39 17.01 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 115.926 -2.31 . . . . 0.0 109.122 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.474 ' CD1' HD22 ' A' ' 80' ' ' ASN . 73.8 mt -98.91 176.88 5.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 115.181 -2.608 . . . . 0.0 109.784 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 56.52 44.13 24.67 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.029 -1.869 . . . . 0.0 110.356 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 50.49 29.29 3.87 Favored 'General case' 0 N--CA 1.385 -3.693 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.14 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.45 -166.99 7.9 Favored Glycine 0 N--CA 1.475 1.277 1 C-N-CA 113.099 -4.382 . . . . 0.0 111.48 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 13.9 t-160 -120.13 166.08 13.9 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 116.179 -2.208 . . . . 0.0 110.089 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 20.2 p -144.87 130.12 18.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 115.355 -2.538 . . . . 0.0 108.576 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -103.29 -132.75 0.3 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 115.241 -2.584 . . . . 0.0 108.188 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -144.84 156.04 43.81 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 115.227 -2.589 . . . . 0.0 110.19 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.37 141.47 4.81 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 114.849 -3.548 . . . . 0.0 108.804 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 67' ' ' ASP . 11.1 mt -59.65 137.19 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 113.047 -3.461 . . . . 0.0 110.769 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.99 -38.32 2.97 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 115.176 -3.392 . . . . 0.0 110.236 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.9 147.23 5.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 116.124 -2.23 . . . . 0.0 108.997 -174.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HD1' ' HB3' ' A' ' 49' ' ' GLN . 16.7 p90 -86.13 -166.59 1.58 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 116.237 -2.185 . . . . 0.0 108.001 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -134.36 142.67 47.28 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 114.297 -2.961 . . . . 0.0 108.936 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.203 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 97.3 m -90.64 145.86 24.5 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 115.182 -2.607 . . . . 0.0 110.05 -176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 97.1 m -126.8 116.83 21.49 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 116.15 -2.22 . . . . 0.0 107.848 172.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.3 m -90.05 143.88 26.39 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 116.049 -2.26 . . . . 0.0 109.745 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.48 171.57 12.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 116.313 -2.155 . . . . 0.0 110.468 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.82 137.96 43.71 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.179 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.15 16.28 69.91 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 115.447 -3.263 . . . . 0.0 111.121 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.8 m-85 -144.2 145.07 31.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.807 -2.357 . . . . 0.0 108.878 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 5.0 mt-10 -147.63 -178.95 6.53 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.488 -2.085 . . . . 0.0 109.555 -176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.7 174.66 39.88 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 114.859 -3.543 . . . . 0.0 109.762 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.34 -48.33 56.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 115.577 -2.449 . . . . 0.0 109.725 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 37.7 m-20 -82.08 -5.0 58.07 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 116.741 -1.984 . . . . 0.0 110.622 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 74.25 27.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 115.159 -2.617 . . . . 0.0 108.922 -165.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.9 -22.59 65.7 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 117.38 -1.728 . . . . 0.0 110.076 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -85.04 165.26 17.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 114.82 -2.752 . . . . 0.0 109.177 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.8 t -128.49 35.81 4.34 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 115.713 -2.395 . . . . 0.0 107.695 169.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 84' ' ' SER . 20.7 p 44.29 16.15 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 117.439 -1.704 . . . . 0.0 111.39 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.549 ' N ' ' C ' ' A' ' 84' ' ' SER . 15.6 ptm180 . . . . . 0 C--O 1.196 -1.76 0 C-N-CA 114.938 -2.705 . . . . 0.0 108.949 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 2.3 mp0 . . . . . 0 CA--C 1.575 1.908 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 49' ' ' GLN . 59.1 m -163.87 14.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 116.191 -2.204 . . . . 0.0 109.47 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -78.67 -14.09 59.48 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 114.965 -2.694 . . . . 0.0 108.437 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -117.04 26.0 8.53 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 114.986 -3.483 . . . . 0.0 110.327 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' GLY . 13.2 t-160 39.65 91.5 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 116.066 -2.254 . . . . 0.0 110.788 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -91.68 -31.95 0.09 OUTLIER 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 121.339 1.36 . . . . 0.0 109.878 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 60' ' ' HIS . 15.7 m -75.83 124.38 27.22 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.696 -2.401 . . . . 0.0 110.598 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD1' HD22 ' A' ' 80' ' ' ASN . 46.9 mt -77.07 176.44 8.68 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 116.476 -2.09 . . . . 0.0 109.404 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 63.36 40.33 8.6 Favored 'General case' 0 C--O 1.29 3.202 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.895 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 46.5 35.88 3.19 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 115.266 -2.574 . . . . 0.0 110.35 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.11 -134.82 0.05 OUTLIER Glycine 0 CA--C 1.563 3.042 1 C-N-CA 113.141 -4.361 . . . . 0.0 110.2 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.424 ' O ' ' SG ' ' A' ' 55' ' ' CYS . 2.0 t-160 -159.17 -175.46 5.27 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 114.64 -2.824 . . . . 0.0 109.003 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.5 t -155.46 128.94 8.39 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 114.429 -2.908 . . . . 0.0 108.36 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -89.43 -20.97 23.28 Favored 'General case' 0 C--O 1.256 1.418 0 C-N-CA 114.629 -2.828 . . . . 0.0 110.301 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 63.22 146.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 117.59 -1.644 . . . . 0.0 110.443 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 -100.91 0.14 Allowed Glycine 0 C--O 1.211 -1.282 0 C-N-CA 114.81 -3.567 . . . . 0.0 109.417 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 66' ' ' GLY . 4.6 mm -69.4 178.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 116.081 -2.248 . . . . 0.0 110.713 172.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.653 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -49.92 -23.39 5.3 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 115.561 -3.209 . . . . 0.0 110.192 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.428 ' N ' ' C ' ' A' ' 65' ' ' ILE . 6.0 m-20 -98.27 132.05 44.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 116.569 -2.052 . . . . 0.0 108.669 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 17.9 p90 -90.65 -173.81 3.87 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 115.256 -2.578 . . . . 0.0 109.941 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 p -123.95 133.79 53.63 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 115.95 -2.3 . . . . 0.0 108.942 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.83 128.96 49.37 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 115.584 -2.446 . . . . 0.0 109.614 -171.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 72' ' ' CYS . 38.9 m -99.26 170.03 8.95 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 115.441 -2.504 . . . . 0.0 106.636 171.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.022 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.0 m -122.09 -45.05 2.26 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 114.276 -2.97 . . . . 0.0 110.897 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' CB ' ' O ' ' A' ' 72' ' ' CYS . . . 115.88 162.28 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.99 119.35 5.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 115.58 -2.448 . . . . 0.0 110.943 -175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.2 29.94 32.36 Favored Glycine 0 N--CA 1.504 3.218 0 C-N-CA 114.156 -3.878 . . . . 0.0 111.839 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.732 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 88.5 m-85 -142.96 152.1 41.63 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 114.088 -3.045 . . . . 0.0 108.943 170.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 6.5 mt-10 -153.32 -176.68 5.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 115.336 -2.546 . . . . 0.0 108.442 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.74 176.32 28.27 Favored Glycine 0 C--N 1.361 1.919 0 C-N-CA 114.315 -3.802 . . . . 0.0 110.568 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -58.01 -63.18 1.35 Allowed 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 116.463 -2.095 . . . . 0.0 110.568 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.825 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 22.9 m-20 -78.85 -21.0 48.23 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 116.15 -2.22 . . . . 0.0 110.713 177.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.022 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 19.5 m 94.1 26.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 116.647 -2.021 . . . . 0.0 107.671 -168.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.76 -19.91 65.34 Favored 'General case' 0 CA--C 1.6 2.897 0 C-N-CA 117.078 -1.849 . . . . 0.0 109.274 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.462 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 27.5 m-85 -78.14 176.2 9.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.764 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 80.5 p -133.97 28.4 3.84 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 116.12 -2.232 . . . . 0.0 108.278 172.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 84' ' ' SER . 41.0 p 47.54 5.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 117.54 -1.664 . . . . 0.0 111.148 -172.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.649 ' H ' ' C ' ' A' ' 84' ' ' SER . 16.1 tpt180 . . . . . 0 CA--C 1.572 1.815 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.83 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 . . . . . 0 C--O 1.225 -0.23 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.0 m -145.23 -22.75 0.49 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 115.416 -2.514 . . . . 0.0 109.563 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -78.58 -15.67 58.28 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 116.349 -2.14 . . . . 0.0 108.748 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -87.8 13.37 61.11 Favored Glycine 0 C--O 1.215 -1.057 0 C-N-CA 114.817 -3.563 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.6 t-160 44.3 82.18 0.24 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 116.485 -2.086 . . . . 0.0 110.018 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -95.69 -42.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.029 1.153 . . . . 0.0 110.606 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.11 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 72.4 m -77.74 160.42 28.42 Favored 'General case' 0 C--O 1.253 1.258 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.713 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.472 ' CD1' HD22 ' A' ' 80' ' ' ASN . 82.7 mt -101.99 175.86 5.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 116.038 -2.265 . . . . 0.0 110.989 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 55.43 38.9 30.94 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 117.458 -1.697 . . . . 0.0 110.319 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 56.79 25.95 10.91 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.827 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.16 136.6 32.63 Favored Glycine 0 N--CA 1.424 -2.16 0 C-N-CA 114.723 -3.608 . . . . 0.0 108.864 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -78.47 179.37 7.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.725 -2.237 . . . . 0.0 108.725 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 11.1 p -154.61 137.49 15.39 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.661 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -102.35 128.32 48.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 115.76 -2.376 . . . . 0.0 108.855 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.4 149.39 42.52 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 115.681 -2.407 . . . . 0.0 109.878 -173.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.55 161.99 35.79 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 115.469 -3.253 . . . . 0.0 108.356 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.74 144.0 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 116.195 -2.202 . . . . 0.0 109.16 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 68.8 69.56 1.36 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 114.728 -3.606 . . . . 0.0 111.802 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 32.4 m-20 68.08 153.51 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.95 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -82.75 -164.47 0.86 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 118.045 -1.462 . . . . 0.0 107.239 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 17.6 p -135.16 152.11 51.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 116.218 -2.193 . . . . 0.0 108.797 171.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.11 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.0 m -96.22 154.03 17.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 115.738 -2.385 . . . . 0.0 110.802 -174.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.2 m -142.24 113.73 7.81 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 115.27 -2.572 . . . . 0.0 108.147 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.036 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 22.2 m -89.67 140.63 29.38 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 115.141 -2.624 . . . . 0.0 108.846 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.2 169.72 15.55 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.583 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 127.76 28.42 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 116.259 -2.177 . . . . 0.0 110.196 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.17 18.59 49.44 Favored Glycine 0 N--CA 1.48 1.57 1 C-N-CA 113.714 -4.089 . . . . 0.0 111.209 -178.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.732 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 92.9 m-85 -140.63 142.15 35.03 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 115.298 -2.561 . . . . 0.0 111.322 161.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.36 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -143.2 -145.86 0.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.341 -2.544 . . . . 0.0 109.719 169.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.994 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 82.13 164.25 33.87 Favored Glycine 1 N--CA 1.519 4.207 0 C-N-CA 114.229 -3.844 . . . . 0.0 107.067 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.08 -50.74 70.18 Favored 'General case' 0 N--CA 1.511 2.625 0 C-N-CA 115.063 -2.655 . . . . 0.0 110.869 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 29.3 m-20 -90.13 29.04 1.28 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.408 -1.717 . . . . 0.0 110.348 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.036 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 47.8 m 57.07 20.78 5.76 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 113.943 -3.103 . . . . 0.0 106.678 -164.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 80' ' ' ASN . 9.3 tp10 -49.08 -52.47 25.56 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 117.528 -1.669 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 1.36 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.93 174.85 6.96 Favored 'General case' 1 N--CA 1.365 -4.683 0 C-N-CA 112.977 -3.489 . . . . 0.0 109.311 -165.768 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.926 ' O ' HG23 ' A' ' 85' ' ' THR . 22.9 p -88.69 -68.67 0.75 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.004 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.926 HG23 ' O ' ' A' ' 84' ' ' SER . 0.9 OUTLIER -178.29 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 CA--C 1.553 1.07 0 CA-C-O 113.404 -3.188 . . . . 0.0 108.399 -179.848 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 . . . . . 0 CA--C 1.566 1.582 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.3 t -122.98 -3.98 8.57 Favored 'General case' 0 C--O 1.256 1.426 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.733 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.2 -21.98 58.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 114.395 -2.922 . . . . 0.0 109.458 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.07 7.6 81.79 Favored Glycine 0 CA--C 1.558 2.732 0 C-N-CA 114.242 -3.837 . . . . 0.0 112.019 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.52 86.13 0.16 Allowed Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 116.478 -2.089 . . . . 0.0 110.187 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -97.95 -46.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 109.88 -0.854 . . . . 0.0 109.88 -171.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -75.28 165.07 25.76 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.446 -170.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' A' ' 80' ' ' ASN . 58.7 mt -103.32 174.83 5.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 116.645 -2.022 . . . . 0.0 111.293 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 51.02 52.4 15.08 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.206 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 53.29 26.36 5.16 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 117.999 -1.48 . . . . 0.0 110.571 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.73 127.41 25.48 Favored Glycine 0 N--CA 1.465 0.602 0 C-N-CA 115.087 -3.435 . . . . 0.0 110.514 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -81.32 102.64 10.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.005 -2.098 . . . . 0.0 109.817 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 p -78.71 123.3 27.02 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 115.955 -2.298 . . . . 0.0 109.909 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -92.73 152.84 19.27 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 114.92 -2.712 . . . . 0.0 108.302 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -83.45 141.76 31.46 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 115.721 -2.391 . . . . 0.0 110.782 -170.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.68 161.31 28.79 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 115.166 -3.397 . . . . 0.0 108.903 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 67' ' ' ASP . 8.6 mt -66.7 138.5 22.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 114.982 -2.687 . . . . 0.0 109.327 -172.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.72 -37.74 1.89 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.57 -3.681 . . . . 0.0 112.135 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 65' ' ' ILE . 21.9 m-20 -162.84 139.19 7.35 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 116.53 -2.068 . . . . 0.0 109.484 -169.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 27.0 p90 -78.56 -164.71 0.6 Allowed 'General case' 0 C--O 1.259 1.557 0 C-N-CA 116.153 -2.219 . . . . 0.0 108.458 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 p -137.16 140.5 41.87 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 115.399 -2.52 . . . . 0.0 109.35 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 99.5 m -85.67 128.47 34.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.717 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -117.35 108.75 15.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 114.608 -2.837 . . . . 0.0 107.786 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 11.6 m -80.98 140.39 35.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 115.067 -2.653 . . . . 0.0 108.994 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 74' ' ' GLU . . . -74.5 159.67 31.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 73' ' ' ALA . 41.7 tt0 -47.07 116.58 1.42 Allowed 'General case' 0 C--O 1.258 1.514 0 C-N-CA 115.671 -2.412 . . . . 0.0 111.012 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 113.05 7.05 21.96 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 114.418 -3.753 . . . . 0.0 110.724 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.6 m-85 -139.01 152.52 47.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 C-N-CA 116.257 -2.177 . . . . 0.0 108.617 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.438 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.1 pt-20 -154.73 -151.95 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 115.9 -2.32 . . . . 0.0 109.234 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.838 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 91.76 174.28 42.78 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 115.13 -3.414 . . . . 0.0 108.754 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -61.57 -38.22 86.7 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 115.703 -2.399 . . . . 0.0 110.52 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.553 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 10.8 m-20 -102.47 26.23 8.11 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 117.513 -1.675 . . . . 0.0 111.175 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 55.5 m 57.24 30.19 18.0 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 114.17 -3.012 . . . . 0.0 107.905 -165.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.3 tp10 -63.84 -50.4 69.01 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 116.86 -1.936 . . . . 0.0 112.405 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 1.438 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.51 135.5 35.88 Favored 'General case' 0 N--CA 1.382 -3.832 0 C-N-CA 113.477 -3.289 . . . . 0.0 110.728 -149.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 36.2 p -76.12 94.82 3.54 Favored 'General case' 0 C--O 1.251 1.159 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.878 -177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.698 ' HB ' ' CD ' ' A' ' 77' ' ' GLU . 1.1 t -73.09 -25.78 61.01 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 115.869 -2.333 . . . . 0.0 109.47 -177.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 . . . . . 0 C--O 1.202 -1.395 0 C-N-CA 115.543 -2.463 . . . . 0.0 110.847 177.665 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 89.9 mm-40 . . . . . 0 CA--C 1.559 1.311 0 CA-C-O 121.034 0.445 . . . . 0.0 111.885 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 46.2 t -116.16 4.76 13.64 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.473 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -73.26 143.91 46.87 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 116.109 -2.236 . . . . 0.0 109.423 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.68 75.67 Favored Glycine 0 CA--C 1.541 1.716 0 C-N-CA 114.072 -3.918 . . . . 0.0 111.266 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.1 t60 48.08 90.74 0.07 OUTLIER Pre-proline 0 C--N 1.36 1.045 0 C-N-CA 115.65 -2.42 . . . . 0.0 109.179 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -93.32 -35.31 0.04 OUTLIER 'Trans proline' 0 C--O 1.249 1.047 0 C-N-CA 121.116 1.21 . . . . 0.0 110.228 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.025 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 88.7 m -81.76 146.94 29.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 114.883 -2.727 . . . . 0.0 109.19 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.601 ' CD1' HD22 ' A' ' 80' ' ' ASN . 74.2 mt -96.96 175.26 6.4 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 116.147 -2.221 . . . . 0.0 109.553 -174.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 57.46 46.81 17.41 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.085 -1.871 . . . . 0.0 107.02 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 50.69 33.48 8.35 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.871 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.66 -168.72 5.26 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 113.976 -3.964 . . . . 0.0 109.839 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -130.7 120.26 23.61 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.311 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.3 p -104.9 117.35 33.81 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 115.175 -2.61 . . . . 0.0 109.036 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -98.82 148.71 23.63 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 116.0 -2.28 . . . . 0.0 107.304 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.03 149.55 21.14 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 115.419 -2.512 . . . . 0.0 108.587 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.67 0.1 OUTLIER Glycine 0 C--O 1.255 1.458 0 C-N-CA 114.947 -3.501 . . . . 0.0 109.671 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.811 HG22 ' H ' ' A' ' 66' ' ' GLY . 5.6 mm -70.32 -173.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.288 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.811 ' H ' HG22 ' A' ' 65' ' ' ILE . . . -62.79 -4.95 7.89 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 114.244 -3.836 . . . . 0.0 110.774 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.3 p30 -123.67 146.91 47.87 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.787 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.544 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.0 p90 -84.76 -164.5 0.98 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 115.306 -2.558 . . . . 0.0 107.82 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.6 135.35 40.19 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.362 171.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.025 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 57.0 m -86.65 140.08 30.17 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 115.594 -2.442 . . . . 0.0 107.931 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -122.5 110.79 16.02 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 115.963 -2.295 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 6.9 m -83.08 140.53 32.61 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 115.464 -2.495 . . . . 0.0 109.432 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.66 164.23 22.03 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 115.416 -2.514 . . . . 0.0 110.191 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -50.62 109.85 0.35 Allowed 'General case' 0 C--O 1.215 -0.741 0 C-N-CA 115.277 -2.569 . . . . 0.0 109.519 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 115.88 15.13 7.5 Favored Glycine 0 CA--C 1.551 2.323 0 C-N-CA 114.984 -3.484 . . . . 0.0 112.299 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.0 m-85 -146.0 153.77 41.13 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 115.143 -2.623 . . . . 0.0 109.015 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.522 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.6 pt-20 -157.15 -145.52 0.15 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 114.593 -2.843 . . . . 0.0 107.846 177.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.896 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 84.49 176.09 50.93 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 115.089 -3.434 . . . . 0.0 108.085 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.38 -36.68 71.55 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 115.342 -2.543 . . . . 0.0 111.115 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.657 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 55.2 m-20 -107.56 21.61 17.2 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.436 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 62.3 m 62.02 24.52 14.61 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 114.963 -2.695 . . . . 0.0 107.278 -160.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.736 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.8 tp10 -58.7 -53.76 54.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 116.115 -2.234 . . . . 0.0 112.197 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 1.522 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.44 129.85 41.04 Favored 'General case' 0 N--CA 1.394 -3.236 0 C-N-CA 111.82 -3.952 . . . . 0.0 111.97 -149.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 20.4 p -74.29 102.5 4.37 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 115.507 -2.477 . . . . 0.0 109.664 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.457 HG22 ' CD ' ' A' ' 77' ' ' GLU . 76.2 p -44.64 -43.11 8.01 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 114.888 -2.725 . . . . 0.0 110.877 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 . . . . . 0 N--CA 1.433 -1.301 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.027 -176.44 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 C--O 1.238 0.47 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 15.0 p -154.69 23.07 0.46 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 115.918 -2.313 . . . . 0.0 110.064 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.22 -14.52 61.36 Favored 'General case' 0 C--O 1.197 -1.674 0 C-N-CA 115.697 -2.401 . . . . 0.0 110.351 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.62 20.19 36.37 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 114.734 -3.603 . . . . 0.0 110.853 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 49.84 83.12 0.23 Allowed Pre-proline 0 C--O 1.254 1.34 0 C-N-CA 116.639 -2.024 . . . . 0.0 109.944 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -88.95 -37.53 0.06 OUTLIER 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 121.434 1.423 . . . . 0.0 110.666 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 1.003 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 56.6 m -72.94 127.19 31.83 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 115.108 -2.637 . . . . 0.0 110.43 -176.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.448 ' CD1' HD22 ' A' ' 80' ' ' ASN . 82.2 mt -83.32 175.04 10.18 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 116.137 -2.225 . . . . 0.0 109.873 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 60.9 m-80 64.94 50.81 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.986 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 51.28 22.85 1.48 Allowed 'General case' 0 C--O 1.253 1.241 0 C-N-CA 115.518 -2.473 . . . . 0.0 113.374 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.95 -142.65 0.38 Allowed Glycine 0 N--CA 1.499 2.85 1 C-N-CA 113.677 -4.106 . . . . 0.0 110.05 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -153.13 164.42 38.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 114.974 -2.69 . . . . 0.0 109.005 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 25.0 p -141.11 150.33 42.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 114.842 -2.743 . . . . 0.0 109.747 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -138.27 134.76 34.75 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 108.295 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.06 151.98 33.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 116.022 -2.271 . . . . 0.0 111.578 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -142.44 -176.28 16.44 Favored Glycine 0 CA--C 1.544 1.901 1 C-N-CA 113.743 -4.075 . . . . 0.0 109.216 178.106 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 65' ' ' ILE . 48.5 mt -84.93 29.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.278 -1.769 . . . . 0.0 109.297 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . 165.09 86.88 0.06 OUTLIER Glycine 0 C--N 1.262 -3.542 0 C-N-CA 115.417 -3.278 . . . . 0.0 109.849 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 73.13 134.62 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 116.174 -2.21 . . . . 0.0 109.306 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.494 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -77.89 -170.86 2.05 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 117.844 -1.542 . . . . 0.0 108.62 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -130.77 136.53 48.81 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 116.607 -2.037 . . . . 0.0 109.659 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 1.003 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -103.47 129.31 50.59 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 113.448 -3.301 . . . . 0.0 110.238 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 72' ' ' CYS . 55.0 m -104.28 173.11 6.44 Favored 'General case' 0 C--O 1.25 1.105 0 C-N-CA 115.814 -2.355 . . . . 0.0 107.844 168.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.801 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.8 m -123.56 -48.96 1.91 Allowed 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 115.997 -2.281 . . . . 0.0 110.007 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.801 ' CB ' ' O ' ' A' ' 72' ' ' CYS . . . 119.75 165.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.858 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -57.3 122.21 11.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 115.375 -2.53 . . . . 0.0 111.145 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 76.95 34.91 40.81 Favored Glycine 0 N--CA 1.47 0.956 0 C-N-CA 115.114 -3.422 . . . . 0.0 111.502 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 73' ' ' ALA . 82.7 m-85 -143.58 150.38 38.75 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.036 167.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 2.4 mt-10 -155.83 178.43 10.27 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 115.721 -2.391 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.1 179.09 21.39 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 114.72 -3.609 . . . . 0.0 110.036 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.86 -61.0 2.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 115.222 -2.591 . . . . 0.0 108.092 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.783 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 16.0 m-20 -78.91 -20.91 48.21 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 116.633 -2.027 . . . . 0.0 111.156 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.783 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 12.5 m 92.18 27.25 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 116.394 -2.123 . . . . 0.0 108.383 -164.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.25 -19.77 56.12 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 116.005 -2.278 . . . . 0.0 110.547 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.463 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 35.4 m-85 -81.16 177.48 9.0 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.825 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.9 m -136.24 39.85 2.68 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.503 166.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 35.2 p 43.5 30.26 0.32 Allowed 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.964 -1.894 . . . . 0.0 109.932 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' THR . 31.7 tpt180 . . . . . 0 C--N 1.298 -1.657 0 CA-C-O 115.888 -2.006 . . . . 0.0 109.254 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp . . . . . 0 N--CA 1.424 -1.757 0 CA-C-O 113.279 -3.248 . . . . 0.0 115.607 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -114.71 -45.66 2.98 Favored 'General case' 0 C--O 1.268 2.039 2 C-N-CA 111.238 -4.185 . . . . 0.0 110.433 -173.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.29 98.07 0.13 Allowed Glycine 0 CA--C 1.472 -2.606 0 C-N-CA 114.574 -3.679 . . . . 0.0 108.866 -173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.637 ' O ' ' N ' ' A' ' 50' ' ' CYS . 3.7 p-10 -104.39 -10.76 17.52 Favored 'General case' 0 CA--C 1.581 2.15 0 C-N-CA 114.294 -2.962 . . . . 0.0 109.065 176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 46.53 7.05 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.846 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 89.2 m -110.74 19.92 18.12 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 114.126 -3.03 . . . . 0.0 107.631 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.64 142.88 44.51 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 115.201 -2.599 . . . . 0.0 110.048 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.714 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 76.04 47.75 10.85 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 115.172 -3.394 . . . . 0.0 110.161 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.714 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.5 m80 9.25 91.99 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 118.161 -1.416 . . . . 0.0 111.616 173.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -91.75 -43.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 122.627 0.804 . . . . 0.0 110.65 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 77.2 m -77.76 151.88 33.86 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 115.611 -2.435 . . . . 0.0 110.349 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.601 ' CD1' HD22 ' A' ' 80' ' ' ASN . 74.0 mt -101.67 173.47 6.4 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 115.825 -2.35 . . . . 0.0 110.596 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 47.69 64.69 1.51 Allowed 'General case' 0 N--CA 1.528 3.467 0 C-N-CA 117.415 -1.714 . . . . 0.0 111.688 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 46.83 26.86 0.62 Allowed 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 118.081 -1.448 . . . . 0.0 111.497 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.36 132.49 12.69 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 113.95 -3.976 . . . . 0.0 110.155 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -77.86 167.93 20.73 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.345 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.194 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.5 p -147.62 123.61 10.71 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 115.75 -2.38 . . . . 0.0 109.718 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -90.0 -141.6 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 115.345 -2.542 . . . . 0.0 108.611 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -144.47 161.64 38.54 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 115.894 -2.322 . . . . 0.0 109.168 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -166.9 173.5 42.2 Favored Glycine 0 C--N 1.35 1.36 0 C-N-CA 115.092 -3.433 . . . . 0.0 109.917 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -88.76 30.08 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 116.274 -2.17 . . . . 0.0 108.612 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.65 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 176.16 80.7 0.05 OUTLIER Glycine 0 C--N 1.279 -2.612 0 C-N-CA 115.614 -3.184 . . . . 0.0 108.298 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.65 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 42.3 m-20 73.81 137.21 0.05 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 116.527 -2.069 . . . . 0.0 109.355 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.4 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 26.9 p90 -78.25 -165.16 0.63 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 116.501 -2.08 . . . . 0.0 109.491 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -133.68 143.8 48.77 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 115.975 -2.29 . . . . 0.0 109.67 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.181 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 44.4 m -90.03 144.14 26.16 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 115.647 -2.421 . . . . 0.0 110.001 -176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 83.6 m -123.33 107.93 12.19 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 116.789 -1.964 . . . . 0.0 108.246 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 8.2 m -79.44 141.14 37.07 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 115.836 -2.346 . . . . 0.0 109.689 -174.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.85 164.84 18.79 Favored 'General case' 0 N--CA 1.424 -1.75 0 C-N-CA 115.462 -2.495 . . . . 0.0 109.479 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -53.88 115.15 1.86 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.174 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.63 12.85 13.81 Favored Glycine 0 C--N 1.357 1.722 0 C-N-CA 115.068 -3.444 . . . . 0.0 112.08 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.4 m-85 -141.62 153.52 44.82 Favored 'General case' 0 C--N 1.371 1.502 0 C-N-CA 115.059 -2.656 . . . . 0.0 109.638 174.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.609 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -155.03 -146.31 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 115.379 -2.528 . . . . 0.0 108.914 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.918 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 87.58 168.89 45.04 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 114.285 -3.817 . . . . 0.0 107.917 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -58.32 -29.9 66.27 Favored 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 115.14 -2.624 . . . . 0.0 110.213 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.601 HD22 ' CD1' ' A' ' 56' ' ' LEU . 19.9 m-20 -108.64 19.62 19.5 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 116.225 -2.19 . . . . 0.0 111.242 -176.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.018 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 56.0 m 60.11 27.52 16.99 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 115.102 -2.639 . . . . 0.0 106.945 -162.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.692 ' N ' ' O ' ' A' ' 77' ' ' GLU . 7.7 tt0 -61.61 -47.8 83.8 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 117.595 -1.642 . . . . 0.0 112.643 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 1.609 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -98.75 134.18 42.01 Favored 'General case' 0 N--CA 1.404 -2.771 0 C-N-CA 112.533 -3.667 . . . . 0.0 113.169 -152.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.3 p -79.49 106.03 11.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 115.676 -2.409 . . . . 0.0 109.748 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.46 HG22 ' CD ' ' A' ' 77' ' ' GLU . 69.6 p -46.46 -43.53 16.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 116.269 -2.172 . . . . 0.0 110.732 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 . . . . . 0 C--O 1.21 -1.0 0 C-N-CA 115.278 -2.569 . . . . 0.0 110.775 -179.542 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 1 N--CA 1.548 4.464 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -121.01 -27.54 4.94 Favored 'General case' 0 C--O 1.274 2.374 0 C-N-CA 114.492 -2.883 . . . . 0.0 110.962 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 178.36 105.45 0.19 Allowed Glycine 0 C--O 1.265 2.078 0 C-N-CA 113.955 -3.974 . . . . 0.0 107.54 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -97.15 52.56 1.14 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 116.874 -1.93 . . . . 0.0 112.072 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -84.43 -25.72 28.79 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 115.928 -2.309 . . . . 0.0 109.517 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.9 t -143.22 19.88 1.91 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 115.681 -2.408 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -81.88 -1.96 49.5 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 115.758 -2.377 . . . . 0.0 110.912 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.13 18.67 5.53 Favored Glycine 0 CA--C 1.497 -1.061 0 C-N-CA 114.446 -3.74 . . . . 0.0 110.882 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.9 t60 51.29 90.33 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.797 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -98.92 -26.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.28 1.32 . . . . 0.0 110.041 -174.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 65.7 m -78.07 141.31 38.91 Favored 'General case' 0 N--CA 1.511 2.587 0 C-N-CA 115.663 -2.415 . . . . 0.0 110.061 -175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.6 mt -88.09 177.42 6.92 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 117.433 -1.707 . . . . 0.0 110.216 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.623 ' ND2' ' O ' ' A' ' 81' ' ' CYS . 5.4 p30 43.67 56.88 4.28 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 113.604 -1.635 . . . . 0.0 110.891 -178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 57' ' ' ASN . 6.6 tt0 49.73 29.2 3.04 Favored 'General case' 0 N--CA 1.397 -3.097 0 C-N-CA 116.503 -2.079 . . . . 0.0 112.268 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.83 -176.33 16.78 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 114.815 -3.564 . . . . 0.0 111.334 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 61.0 t-80 -109.87 147.14 33.9 Favored 'General case' 0 N--CA 1.501 2.107 0 C-N-CA 116.71 -1.996 . . . . 0.0 109.236 -176.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.2 p -128.26 107.84 10.11 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 116.057 -2.257 . . . . 0.0 108.774 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -91.97 121.76 33.85 Favored 'General case' 0 C--O 1.258 1.502 0 C-N-CA 115.553 -2.459 . . . . 0.0 109.173 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -80.0 153.14 29.06 Favored 'General case' 0 C--O 1.255 1.37 0 C-N-CA 115.773 -2.371 . . . . 0.0 109.934 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.32 -92.71 0.08 OUTLIER Glycine 0 CA--C 1.547 2.05 0 C-N-CA 116.64 -2.695 . . . . 0.0 109.405 174.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 66' ' ' GLY . 83.9 mt -65.22 173.62 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.587 0 C-N-CA 116.836 -1.946 . . . . 0.0 110.462 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.634 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.85 -22.31 11.88 Favored Glycine 0 C--O 1.255 1.446 1 C-N-CA 113.267 -4.301 . . . . 0.0 111.394 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.403 ' N ' ' C ' ' A' ' 65' ' ' ILE . 31.5 m-20 -107.18 135.58 48.46 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 115.965 -2.294 . . . . 0.0 108.991 173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.485 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -77.4 -166.19 0.71 Allowed 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 116.243 -2.183 . . . . 0.0 109.177 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.67 133.99 38.72 Favored 'General case' 0 C--O 1.255 1.36 0 C-N-CA 113.256 -3.378 . . . . 0.0 108.646 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 7.4 m -90.95 110.97 22.22 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 115.535 -2.466 . . . . 0.0 108.965 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 98.1 m -96.8 119.32 35.06 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.182 -2.607 . . . . 0.0 108.832 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.06 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 61.6 m -88.28 156.93 18.93 Favored 'General case' 0 C--O 1.276 2.457 0 C-N-CA 114.256 -2.977 . . . . 0.0 109.342 -173.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 176.11 10.0 Favored 'General case' 0 CA--C 1.488 -1.442 0 C-N-CA 115.236 -2.586 . . . . 0.0 110.392 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -59.02 134.02 56.62 Favored 'General case' 0 C--O 1.266 1.941 0 C-N-CA 115.954 -2.298 . . . . 0.0 110.047 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.814 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.59 24.67 60.12 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 115.522 -3.228 . . . . 0.0 110.39 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 95.8 m-85 -141.95 140.94 32.89 Favored 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 115.455 -2.498 . . . . 0.0 108.704 171.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -144.57 -172.42 3.81 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 116.167 -2.213 . . . . 0.0 108.728 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.72 172.56 46.55 Favored Glycine 0 C--N 1.299 -1.492 0 C-N-CA 115.638 -3.172 . . . . 0.0 110.79 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -64.89 -47.0 79.37 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 115.658 -2.417 . . . . 0.0 109.594 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.772 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 13.3 m120 -79.67 -17.26 54.1 Favored 'General case' 0 C--N 1.288 -2.104 0 C-N-CA 115.741 -2.384 . . . . 0.0 109.979 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.06 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 12.7 m 86.48 18.67 0.09 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 115.574 -2.45 . . . . 0.0 107.616 -164.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -55.95 -29.55 60.35 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 117.593 -1.643 . . . . 0.0 112.003 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 65.5 m-85 -78.92 162.56 25.92 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 115.032 -2.667 . . . . 0.0 110.066 -174.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 35.7 t -121.85 29.54 7.07 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 115.243 -2.583 . . . . 0.0 107.949 170.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 84' ' ' SER . 26.3 p 43.87 19.95 0.02 OUTLIER 'General case' 1 N--CA 1.542 4.153 0 C-N-CA 117.311 -1.755 . . . . 0.0 111.178 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.463 ' N ' ' C ' ' A' ' 84' ' ' SER . 45.2 ttt85 . . . . . 0 C--N 1.287 -2.119 0 C-N-CA 116.527 -2.069 . . . . 0.0 111.013 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.5 tttp . . . . . 0 N--CA 1.395 -3.224 0 CA-C-O 124.831 2.253 . . . . 0.0 112.725 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -154.03 108.44 3.05 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-N 110.956 -2.838 . . . . 0.0 110.732 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.46 94.33 0.62 Allowed Glycine 0 C--O 1.206 -1.646 1 C-N-CA 113.306 -4.283 . . . . 0.0 110.393 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -110.64 58.73 0.61 Allowed 'General case' 0 N--CA 1.503 2.193 0 C-N-CA 114.912 -2.715 . . . . 0.0 107.779 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.662 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -71.46 -36.2 71.13 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 115.033 -2.667 . . . . 0.0 109.645 -176.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 37.9 t -109.94 -14.33 14.28 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 114.846 -2.742 . . . . 0.0 109.967 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -74.96 144.72 43.06 Favored 'General case' 0 C--O 1.268 2.057 0 C-N-CA 114.945 -2.702 . . . . 0.0 108.965 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.762 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . 87.28 43.13 5.99 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 114.666 -3.635 . . . . 0.0 110.495 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.762 ' C ' ' O ' ' A' ' 52' ' ' GLY . 0.7 OUTLIER 10.61 92.63 0.04 OUTLIER Pre-proline 0 N--CA 1.44 -0.931 0 CA-C-N 112.46 -1.87 . . . . 0.0 110.506 175.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.78 -40.22 0.03 OUTLIER 'Trans proline' 0 C--O 1.251 1.136 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 83.8 m -74.63 150.01 39.79 Favored 'General case' 0 C--O 1.256 1.439 0 C-N-CA 113.82 -3.152 . . . . 0.0 109.762 175.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.462 ' CD1' HD22 ' A' ' 80' ' ' ASN . 17.6 mt -88.63 -178.55 5.83 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 116.118 -2.233 . . . . 0.0 109.888 -173.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.693 HD21 ' HB2' ' A' ' 81' ' ' CYS . 6.7 p30 41.72 38.97 1.06 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.879 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 54.55 26.5 7.34 Favored 'General case' 0 N--CA 1.405 -2.722 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.541 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.52 177.23 6.12 Favored Glycine 0 C--N 1.282 -2.462 0 C-N-CA 114.161 -3.876 . . . . 0.0 108.124 171.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -106.71 154.27 21.2 Favored 'General case' 0 C--N 1.278 -2.516 0 C-N-CA 116.229 -2.188 . . . . 0.0 108.492 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.178 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 31.4 p -133.53 93.72 3.19 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 115.658 -2.417 . . . . 0.0 108.48 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -76.99 147.41 36.85 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 116.133 -2.227 . . . . 0.0 110.117 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -95.58 158.53 15.41 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 116.182 -2.207 . . . . 0.0 110.025 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.4 -100.66 0.14 Allowed Glycine 0 C--O 1.24 0.517 0 C-N-CA 115.261 -3.352 . . . . 0.0 109.309 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 66' ' ' GLY . 63.2 mt -62.77 170.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 115.584 -2.447 . . . . 0.0 108.462 173.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -53.83 -19.18 9.73 Favored Glycine 0 N--CA 1.478 1.498 0 C-N-CA 114.46 -3.733 . . . . 0.0 110.401 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' N ' ' C ' ' A' ' 65' ' ' ILE . 9.1 t70 -101.95 139.45 37.57 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 117.651 -1.62 . . . . 0.0 107.222 169.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.586 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 16.4 p90 -83.98 -162.12 0.61 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 116.923 -1.911 . . . . 0.0 107.296 -176.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -141.05 141.99 34.24 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 116.265 -2.174 . . . . 0.0 108.594 173.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.089 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 95.1 m -94.7 114.44 26.36 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 116.131 -2.228 . . . . 0.0 110.274 -173.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.3 m -98.62 120.18 38.61 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 115.528 -2.469 . . . . 0.0 108.171 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 41.3 m -93.89 147.21 23.29 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 114.855 -2.738 . . . . 0.0 109.086 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.5 165.52 24.68 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 114.483 -2.887 . . . . 0.0 109.004 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -55.14 134.72 49.59 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 115.959 -2.296 . . . . 0.0 108.372 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 99.34 -13.05 61.74 Favored Glycine 0 CA--C 1.489 -1.588 0 C-N-CA 114.585 -3.674 . . . . 0.0 110.85 -173.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.698 ' HB3' ' HB3' ' A' ' 81' ' ' CYS . 85.4 m-85 -126.95 147.94 50.09 Favored 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 114.051 -3.06 . . . . 0.0 109.436 167.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.1 170.68 19.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 114.517 -2.873 . . . . 0.0 110.652 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.47 -175.67 19.02 Favored Glycine 0 N--CA 1.434 -1.474 1 C-N-CA 113.035 -4.412 . . . . 0.0 111.343 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -74.31 -61.64 1.79 Allowed 'General case' 0 CA--C 1.489 -1.392 0 C-N-CA 113.807 -3.157 . . . . 0.0 109.394 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 46.6 m-20 -76.56 -5.14 46.38 Favored 'General case' 0 C--N 1.265 -3.083 0 C-N-CA 114.776 -2.77 . . . . 0.0 111.711 175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.284 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 8.1 m 82.51 17.44 0.34 Allowed 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 116.539 -2.065 . . . . 0.0 107.698 -169.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -52.75 -22.32 5.13 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 116.281 -2.168 . . . . 0.0 112.573 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -79.27 153.2 30.08 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 114.834 -2.747 . . . . 0.0 109.597 175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 39.1 m -120.44 42.86 2.88 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 114.602 -2.839 . . . . 0.0 106.457 164.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 71.1 p 41.41 47.42 3.12 Favored 'General case' 0 N--CA 1.512 2.665 0 C-N-CA 118.478 -1.289 . . . . 0.0 110.833 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 . . . . . 0 C--N 1.277 -2.579 0 C-N-CA 115.262 -2.575 . . . . 0.0 109.099 -174.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm . . . . . 0 N--CA 1.526 3.365 0 CA-C-O 124.398 2.047 . . . . 0.0 107.345 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -67.96 170.56 8.05 Favored 'General case' 1 C--N 1.434 4.265 0 CA-C-N 111.616 -2.538 . . . . 0.0 109.035 -175.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.09 -124.35 1.43 Allowed Glycine 0 N--CA 1.499 2.855 0 C-N-CA 114.272 -3.823 . . . . 0.0 110.353 173.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -106.53 39.15 1.89 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 116.415 -2.114 . . . . 0.0 106.646 174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -94.58 -2.66 51.07 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 116.092 -2.243 . . . . 0.0 108.803 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 24.2 t -148.63 68.38 1.07 Allowed 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 113.618 -3.233 . . . . 0.0 108.606 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 53' ' ' HIS . 8.1 tt0 -65.31 179.3 0.77 Allowed 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 115.384 -2.526 . . . . 0.0 108.631 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 4.0 4.71 Favored Glycine 0 N--CA 1.497 2.748 0 C-N-CA 114.718 -3.611 . . . . 0.0 111.576 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 51' ' ' GLU . 11.0 t-160 -173.12 96.67 0.35 Allowed Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 116.14 -2.224 . . . . 0.0 109.058 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -111.92 -46.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 108.049 -1.558 . . . . 0.0 108.049 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 79.5 m -81.19 157.11 25.36 Favored 'General case' 0 C--O 1.253 1.241 0 C-N-CA 114.863 -2.735 . . . . 0.0 108.923 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' CD1' HD22 ' A' ' 80' ' ' ASN . 80.9 mt -90.25 175.95 6.93 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 115.964 -2.294 . . . . 0.0 108.682 -177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 56.37 43.13 26.71 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 113.113 -1.858 . . . . 0.0 110.174 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 45.66 33.38 1.42 Allowed 'General case' 0 N--CA 1.407 -2.616 0 C-N-CA 117.068 -1.853 . . . . 0.0 112.793 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.94 -170.03 1.74 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 114.77 -3.586 . . . . 0.0 109.635 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 24.2 t-80 -107.78 163.55 13.01 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 115.665 -2.414 . . . . 0.0 109.564 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.116 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 10.8 t -143.19 143.05 31.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 115.204 -2.598 . . . . 0.0 108.295 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -123.3 -144.35 0.33 Allowed 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 116.539 -2.065 . . . . 0.0 108.114 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -140.53 152.38 45.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 114.469 -2.892 . . . . 0.0 110.315 -177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.95 149.55 12.02 Favored Glycine 0 N--CA 1.485 1.936 0 C-N-CA 115.084 -3.436 . . . . 0.0 110.026 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 67' ' ' ASP . 39.4 mt -62.57 138.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 115.809 -2.356 . . . . 0.0 110.303 -176.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.6 -28.89 1.51 Allowed Glycine 0 N--CA 1.501 2.989 0 C-N-CA 116.299 -2.857 . . . . 0.0 111.436 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' A' ' 65' ' ' ILE . 34.3 t70 -176.58 141.14 0.38 Allowed 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 116.521 -2.072 . . . . 0.0 110.152 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.773 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 17.9 p90 -81.48 -165.6 0.99 Allowed 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 116.424 -2.111 . . . . 0.0 108.068 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 p -131.99 136.46 47.31 Favored 'General case' 0 CA--C 1.488 -1.405 0 C-N-CA 115.41 -2.516 . . . . 0.0 110.507 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.773 ' SG ' ' HE2' ' A' ' 68' ' ' TYR . 93.2 m -94.3 142.39 27.47 Favored 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 115.268 -2.573 . . . . 0.0 109.475 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 82.2 m -125.53 108.32 11.48 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 115.282 -2.567 . . . . 0.0 107.647 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.991 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.0 m -82.42 142.89 31.58 Favored 'General case' 0 C--O 1.259 1.559 0 C-N-CA 116.325 -2.15 . . . . 0.0 108.716 -176.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 165.59 24.76 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 115.806 -2.358 . . . . 0.0 109.936 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -50.36 143.13 9.23 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 115.859 -2.337 . . . . 0.0 110.185 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 80.83 12.94 82.15 Favored Glycine 0 N--CA 1.478 1.474 0 C-N-CA 114.889 -3.529 . . . . 0.0 110.426 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 98.1 m-85 -140.25 143.64 36.07 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.382 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -145.56 -174.34 4.37 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 116.128 -2.229 . . . . 0.0 109.622 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.43 173.42 48.3 Favored Glycine 0 C--O 1.236 0.261 0 C-N-CA 114.636 -3.65 . . . . 0.0 109.658 -175.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -71.15 -42.18 69.48 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 115.456 -2.498 . . . . 0.0 110.38 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.612 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 41.2 m-20 -83.65 -4.7 58.81 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 116.795 -1.962 . . . . 0.0 110.152 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.991 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 70.91 25.66 3.79 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 114.322 -2.951 . . . . 0.0 108.219 -165.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -63.58 -25.03 68.05 Favored 'General case' 0 C--N 1.368 1.394 0 C-N-CA 116.155 -2.218 . . . . 0.0 110.057 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -79.16 175.65 10.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 115.892 -2.323 . . . . 0.0 109.234 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 23.4 p -139.97 28.45 2.12 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 116.768 -1.973 . . . . 0.0 108.246 171.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.8 p 41.92 30.07 0.15 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.4 -1.72 . . . . 0.0 110.405 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' N ' ' C ' ' A' ' 84' ' ' SER . 48.1 ttp180 . . . . . 0 C--N 1.3 -1.557 0 C-N-CA 116.426 -2.11 . . . . 0.0 109.764 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt . . . . . 0 N--CA 1.419 -2.008 0 CA-C-O 123.234 1.492 . . . . 0.0 107.165 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -147.8 144.22 28.04 Favored 'General case' 0 N--CA 1.538 3.942 0 C-N-CA 113.413 -3.315 . . . . 0.0 106.196 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.07 103.13 0.13 Allowed Glycine 0 CA--C 1.556 2.614 0 C-N-CA 118.412 -1.852 . . . . 0.0 109.548 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -136.54 55.15 1.85 Allowed 'General case' 1 C--N 1.237 -4.287 0 C-N-CA 116.118 -2.233 . . . . 0.0 108.059 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.1 mp0 -97.76 -7.51 30.53 Favored 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 113.681 -3.208 . . . . 0.0 109.051 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.5 t -137.32 64.41 1.53 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 115.04 -2.664 . . . . 0.0 110.132 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' C ' ' N ' ' A' ' 53' ' ' HIS . 9.1 tt0 -57.48 164.76 1.78 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 115.668 -2.413 . . . . 0.0 109.311 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.22 -12.74 8.48 Favored Glycine 0 CA--C 1.529 0.959 1 C-N-CA 113.853 -4.022 . . . . 0.0 111.448 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.422 ' N ' ' C ' ' A' ' 51' ' ' GLU . 21.1 t-160 -172.3 94.48 0.39 Allowed Pre-proline 0 CA--C 1.577 1.989 0 C-N-CA 116.323 -2.151 . . . . 0.0 109.403 177.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -97.34 -37.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.481 0.765 0 O-C-N 123.422 1.222 . . . . 0.0 110.668 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 79.7 m -98.54 154.75 17.67 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 115.235 -2.586 . . . . 0.0 108.755 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.554 ' CD1' HD22 ' A' ' 80' ' ' ASN . 58.0 mt -73.84 176.93 5.9 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 115.483 -2.487 . . . . 0.0 111.662 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.519 HD21 ' C ' ' A' ' 81' ' ' CYS . 3.6 p30 46.2 53.44 9.39 Favored 'General case' 0 C--O 1.269 2.081 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.781 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 50.94 25.07 2.05 Favored 'General case' 0 N--CA 1.396 -3.166 0 C-N-CA 116.981 -1.888 . . . . 0.0 110.26 172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.09 130.44 38.69 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 115.666 -3.159 . . . . 0.0 108.252 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -80.03 174.64 11.39 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.348 -174.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.084 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 19.4 p -139.96 116.55 10.78 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 114.407 -2.917 . . . . 0.0 108.435 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -90.38 119.72 30.91 Favored 'General case' 0 C--O 1.209 -1.033 0 C-N-CA 115.406 -2.518 . . . . 0.0 107.338 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -79.3 157.56 27.69 Favored 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 116.524 -2.07 . . . . 0.0 110.02 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.16 -87.11 0.07 OUTLIER Glycine 0 C--O 1.198 -2.114 0 C-N-CA 114.23 -3.843 . . . . 0.0 108.226 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.751 HG22 ' N ' ' A' ' 66' ' ' GLY . 50.4 mt -71.04 -176.42 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.263 1.778 0 C-N-CA 116.533 -2.067 . . . . 0.0 110.231 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.751 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -58.65 -13.19 16.59 Favored Glycine 0 N--CA 1.486 2.002 0 C-N-CA 116.407 -2.806 . . . . 0.0 109.878 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.6 p-10 -120.62 144.88 47.91 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 115.931 -2.308 . . . . 0.0 106.118 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.425 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 21.1 p90 -84.91 -161.3 0.56 Allowed 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 115.858 -2.337 . . . . 0.0 108.94 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 p -140.14 136.94 34.02 Favored 'General case' 0 C--O 1.204 -1.314 0 C-N-CA 116.34 -2.144 . . . . 0.0 109.098 169.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.183 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.3 m -78.15 137.25 38.08 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 115.283 -2.567 . . . . 0.0 108.611 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 92.8 m -120.67 115.22 22.92 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 116.774 -1.97 . . . . 0.0 107.754 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.065 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.2 m -84.52 139.72 31.95 Favored 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 114.886 -2.726 . . . . 0.0 110.014 -174.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.9 168.89 5.76 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.367 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.08 120.0 6.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.836 -2.345 . . . . 0.0 110.166 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 98.44 23.45 12.48 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 115.016 -3.469 . . . . 0.0 111.617 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.669 ' HB3' ' O ' ' A' ' 81' ' ' CYS . 83.8 m-85 -146.37 149.71 34.29 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 115.412 -2.515 . . . . 0.0 110.554 172.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.24 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.4 OUTLIER -155.84 -146.72 0.18 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 115.314 -2.554 . . . . 0.0 109.657 173.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.847 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 86.68 168.43 44.82 Favored Glycine 1 N--CA 1.52 4.263 0 C-N-CA 114.739 -3.6 . . . . 0.0 109.165 177.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -54.7 -37.25 65.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 116.254 -2.179 . . . . 0.0 109.008 -176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.554 HD22 ' CD1' ' A' ' 56' ' ' LEU . 75.1 m-20 -102.19 29.93 4.82 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 116.105 -2.238 . . . . 0.0 111.676 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.065 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 73.6 m 50.84 25.01 1.97 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 115.232 -2.587 . . . . 0.0 106.786 -163.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.815 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.2 tp10 -55.22 -55.03 35.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.455 -1.698 . . . . 0.0 113.022 -178.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 1.24 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -90.1 139.1 30.95 Favored 'General case' 0 N--CA 1.387 -3.582 0 C-N-CA 113.445 -3.302 . . . . 0.0 112.098 -148.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 22.8 t -86.15 58.47 5.07 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 115.992 -2.283 . . . . 0.0 110.734 -171.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.468 ' C ' ' O ' ' A' ' 84' ' ' SER . 5.2 p 37.14 28.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 116.051 -2.26 . . . . 0.0 112.051 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' N ' ' C ' ' A' ' 84' ' ' SER . 71.4 mtp85 . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 115.941 -1.98 . . . . 0.0 108.762 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -95.62 126.3 40.8 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 112.452 -3.699 . . . . 0.0 107.566 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.02 113.33 0.28 Allowed Glycine 1 C--N 1.214 -6.208 0 C-N-CA 114.616 -3.659 . . . . 0.0 112.611 -175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.617 ' C ' ' H ' ' A' ' 50' ' ' CYS . 13.1 m-20 -103.85 -16.84 15.26 Favored 'General case' 0 C--O 1.26 1.628 0 C-N-CA 116.846 -1.942 . . . . 0.0 109.599 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 42.21 6.78 0.0 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.532 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 74.2 m -117.32 -0.66 11.95 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.425 -2.11 . . . . 0.0 108.98 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.76 -7.15 59.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 115.059 -2.657 . . . . 0.0 109.85 -173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -95.55 18.13 57.98 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 114.903 -3.522 . . . . 0.0 111.01 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' GLY . 16.4 t-160 44.48 84.2 0.19 Allowed Pre-proline 0 CA--C 1.555 1.147 0 C-N-CA 116.239 -2.185 . . . . 0.0 110.161 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -97.13 -38.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 O-C-N 123.667 1.351 . . . . 0.0 111.096 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.051 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 61.2 m -96.42 151.02 19.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 115.677 -2.409 . . . . 0.0 110.423 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.442 ' CD1' HD22 ' A' ' 80' ' ' ASN . 86.2 mt -103.78 176.39 5.17 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 116.128 -2.229 . . . . 0.0 110.034 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 56.75 47.77 17.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 117.218 -1.793 . . . . 0.0 111.755 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 49.52 35.12 7.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.174 173.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.75 -161.39 4.88 Favored Glycine 0 C--N 1.363 2.05 0 C-N-CA 114.051 -3.928 . . . . 0.0 110.468 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.544 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 9.0 t-160 -135.68 175.03 9.97 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 115.208 -2.597 . . . . 0.0 109.697 -176.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 14.3 p -153.13 138.14 17.24 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 114.374 -2.93 . . . . 0.0 108.702 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -115.82 133.28 56.19 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 116.124 -2.23 . . . . 0.0 109.237 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.14 159.3 29.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 116.083 -2.247 . . . . 0.0 108.607 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 66' ' ' GLY . . . -152.21 38.29 0.79 Allowed Glycine 0 N--CA 1.504 3.178 0 C-N-CA 114.471 -3.728 . . . . 0.0 110.367 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 65' ' ' ILE . 81.4 mt 36.27 36.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 116.784 -1.966 . . . . 0.0 110.037 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 162.22 85.62 0.06 OUTLIER Glycine 0 C--N 1.288 -2.101 0 C-N-CA 115.471 -3.252 . . . . 0.0 109.825 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 6.2 m-20 67.57 116.78 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 116.656 -2.017 . . . . 0.0 109.007 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.488 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 24.6 p90 -76.7 -169.9 1.4 Allowed 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.278 -2.569 . . . . 0.0 108.363 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.9 p -139.43 132.8 30.07 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 115.789 -2.364 . . . . 0.0 108.831 175.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.051 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 61.4 m -81.68 128.46 33.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 115.309 -2.556 . . . . 0.0 109.38 -173.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 88.8 m -108.04 109.65 21.15 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 114.739 -2.785 . . . . 0.0 108.435 174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.9 m -86.46 143.41 27.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 115.57 -2.452 . . . . 0.0 109.648 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.71 171.44 13.29 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 116.935 -1.906 . . . . 0.0 109.711 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -52.4 126.88 20.59 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 115.705 -2.398 . . . . 0.0 110.039 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.6 19.46 44.48 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.769 -3.586 . . . . 0.0 110.235 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 99.9 m-85 -140.49 145.99 37.61 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 115.287 -2.565 . . . . 0.0 108.538 165.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 46.2 mm-40 -146.31 -166.97 2.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 116.086 -2.245 . . . . 0.0 109.083 -175.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.54 168.27 35.96 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 114.296 -3.811 . . . . 0.0 109.261 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -68.54 -37.09 79.68 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 114.58 -2.848 . . . . 0.0 109.904 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.633 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 39.9 m-20 -80.72 -16.01 55.02 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 117.16 -1.816 . . . . 0.0 111.762 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 6.2 m 77.98 18.67 1.16 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 115.16 -2.616 . . . . 0.0 107.331 -162.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -59.74 -31.16 69.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 117.498 -1.681 . . . . 0.0 110.211 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 49.5 m-85 -78.82 160.71 27.23 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 115.362 -2.535 . . . . 0.0 110.502 -176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.569 ' C ' ' N ' ' A' ' 86' ' ' ARG . 19.2 t -123.58 38.08 4.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 115.564 -2.455 . . . . 0.0 108.221 170.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p 40.03 20.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.324 -173.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.569 ' N ' ' C ' ' A' ' 84' ' ' SER . 78.0 ttt-85 . . . . . 0 C--N 1.308 -1.231 0 C-N-CA 115.936 -2.306 . . . . 0.0 110.202 175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.5 tttp . . . . . 0 C--O 1.175 -2.838 0 CA-C-O 127.877 3.703 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -88.58 164.21 15.49 Favored 'General case' 1 C--N 1.46 5.387 0 C-N-CA 114.975 -2.69 . . . . 0.0 108.941 176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ASP . . . -179.63 -115.38 0.47 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 114.566 -3.683 . . . . 0.0 110.333 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' GLY . 13.9 t70 50.0 64.46 1.77 Allowed 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 115.734 -2.386 . . . . 0.0 109.261 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -97.92 -8.02 28.99 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 115.669 -2.412 . . . . 0.0 109.215 -174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 49.4 t -127.19 -22.8 3.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 114.906 -2.718 . . . . 0.0 111.532 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -67.3 -17.41 64.77 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 114.311 -2.956 . . . . 0.0 110.122 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.72 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -88.88 36.36 3.48 Favored Glycine 0 C--O 1.259 1.657 0 C-N-CA 115.872 -3.061 . . . . 0.0 110.993 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.72 ' C ' ' O ' ' A' ' 52' ' ' GLY . 1.7 m-70 13.98 88.47 0.05 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 117.843 -1.543 . . . . 0.0 110.678 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -89.98 -42.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.974 1.782 . . . . 0.0 109.746 -173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 38.7 m -81.97 113.42 19.86 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 116.12 -2.232 . . . . 0.0 110.969 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.445 ' CD1' HD22 ' A' ' 80' ' ' ASN . 81.2 mt -74.82 175.93 7.55 Favored 'General case' 0 CA--C 1.58 2.126 0 C-N-CA 115.023 -2.671 . . . . 0.0 110.666 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 62.11 50.44 4.0 Favored 'General case' 0 N--CA 1.502 2.152 0 C-N-CA 117.146 -1.821 . . . . 0.0 109.972 168.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 53.39 27.79 6.74 Favored 'General case' 0 C--O 1.281 2.711 0 C-N-CA 116.7 -2.0 . . . . 0.0 111.389 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.18 -150.46 3.86 Favored Glycine 1 N--CA 1.521 4.342 0 C-N-CA 114.081 -3.914 . . . . 0.0 110.44 175.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -141.07 135.13 30.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 114.606 -2.838 . . . . 0.0 108.308 -177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.279 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 26.7 p -113.93 128.11 56.26 Favored 'General case' 0 C--O 1.246 0.911 0 C-N-CA 116.051 -2.26 . . . . 0.0 110.032 176.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -97.78 -165.24 1.23 Allowed 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.599 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -151.81 138.03 18.37 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 115.945 -2.302 . . . . 0.0 109.26 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.29 -95.96 0.1 Allowed Glycine 0 C--O 1.247 0.959 0 C-N-CA 114.49 -3.719 . . . . 0.0 109.766 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.649 HG22 ' N ' ' A' ' 66' ' ' GLY . 71.6 mt -62.82 177.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 116.007 -2.277 . . . . 0.0 110.833 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.649 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -52.32 -18.76 5.22 Favored Glycine 0 CA--C 1.549 2.205 0 C-N-CA 114.772 -3.585 . . . . 0.0 111.067 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' C ' ' A' ' 65' ' ' ILE . 3.3 p-10 -112.81 146.56 38.64 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 116.005 -2.278 . . . . 0.0 108.014 174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -83.89 -166.03 1.3 Allowed 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 116.762 -1.975 . . . . 0.0 108.604 175.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.87 136.15 36.84 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 114.985 -2.686 . . . . 0.0 108.542 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.197 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 8.6 m -95.88 155.33 16.8 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 114.676 -2.81 . . . . 0.0 110.937 -174.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 78.4 m -135.49 131.04 35.61 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 115.506 -2.478 . . . . 0.0 109.0 171.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.033 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 30.6 m -107.51 142.45 37.37 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 114.697 -2.801 . . . . 0.0 108.503 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.87 172.71 10.36 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 116.233 -2.187 . . . . 0.0 109.319 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -55.85 146.21 22.46 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 116.251 -2.18 . . . . 0.0 110.863 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.746 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 79.23 8.73 87.62 Favored Glycine 0 N--CA 1.476 1.323 0 C-N-CA 114.487 -3.721 . . . . 0.0 110.994 -178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 92.4 m-85 -136.82 140.74 42.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 114.506 -2.878 . . . . 0.0 109.998 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -147.08 -166.75 2.59 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 116.197 -2.201 . . . . 0.0 107.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.56 167.06 38.06 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 114.383 -3.77 . . . . 0.0 109.501 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -67.8 -34.44 76.75 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 116.375 -2.13 . . . . 0.0 108.391 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.59 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 57.4 m-20 -89.71 -4.74 57.57 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 116.35 -2.14 . . . . 0.0 111.933 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.033 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 3.8 m 71.66 17.48 5.53 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 114.484 -2.886 . . . . 0.0 107.452 -166.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -59.28 -31.12 68.82 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 118.021 -1.472 . . . . 0.0 109.406 -176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 38.3 m-85 -79.74 165.01 23.24 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 115.517 -2.473 . . . . 0.0 111.296 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.5 t -127.29 38.67 4.04 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 115.53 -2.468 . . . . 0.0 107.898 173.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.6 p 46.1 22.95 0.16 Allowed 'General case' 0 N--CA 1.511 2.588 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.836 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.443 ' N ' ' C ' ' A' ' 84' ' ' SER . 8.8 mmm180 . . . . . 0 N--CA 1.514 2.732 0 CA-C-O 115.702 -2.094 . . . . 0.0 108.135 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -131.52 166.61 20.98 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 113.216 -3.394 . . . . 0.0 109.55 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.22 52.38 0.1 OUTLIER Glycine 0 N--CA 1.499 2.87 1 C-N-CA 113.12 -4.372 . . . . 0.0 110.815 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.717 ' C ' ' H ' ' A' ' 50' ' ' CYS . 1.3 p30 -111.6 -24.47 10.08 Favored 'General case' 0 C--O 1.254 1.333 0 C-N-CA 114.465 -2.894 . . . . 0.0 107.589 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.529 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 85.9 mm-40 43.29 4.91 0.0 OUTLIER 'General case' 0 C--N 1.375 1.689 0 CA-C-O 122.552 1.168 . . . . 0.0 111.732 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 50.1 t -112.53 54.97 0.7 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 115.101 -2.639 . . . . 0.0 109.513 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 50' ' ' CYS . 16.9 tt0 -40.61 163.93 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 115.669 -2.412 . . . . 0.0 111.204 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.6 -14.01 8.77 Favored Glycine 0 CA--C 1.559 2.832 0 C-N-CA 114.488 -3.72 . . . . 0.0 112.115 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -174.26 93.03 0.32 Allowed Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 115.191 -2.604 . . . . 0.0 109.888 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -99.74 -41.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.823 0 N-CA-C 108.863 -1.245 . . . . 0.0 108.863 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.203 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -81.72 169.39 17.01 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 115.926 -2.31 . . . . 0.0 109.122 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.474 ' CD1' HD22 ' A' ' 80' ' ' ASN . 73.8 mt -98.91 176.88 5.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 115.181 -2.608 . . . . 0.0 109.784 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 56.52 44.13 24.67 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 117.029 -1.869 . . . . 0.0 110.356 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 50.49 29.29 3.87 Favored 'General case' 0 N--CA 1.385 -3.693 0 C-N-CA 118.757 -1.177 . . . . 0.0 111.14 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.45 -166.99 7.9 Favored Glycine 0 N--CA 1.475 1.277 1 C-N-CA 113.099 -4.382 . . . . 0.0 111.48 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 13.9 t-160 -120.13 166.08 13.9 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 116.179 -2.208 . . . . 0.0 110.089 -173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.195 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 20.2 p -144.87 130.12 18.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 115.355 -2.538 . . . . 0.0 108.576 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -103.29 -132.75 0.3 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 115.241 -2.584 . . . . 0.0 108.188 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -144.84 156.04 43.81 Favored 'General case' 0 C--O 1.256 1.443 0 C-N-CA 115.227 -2.589 . . . . 0.0 110.19 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.37 141.47 4.81 Favored Glycine 0 N--CA 1.485 1.918 0 C-N-CA 114.849 -3.548 . . . . 0.0 108.804 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.45 ' C ' ' H ' ' A' ' 67' ' ' ASP . 11.1 mt -59.65 137.19 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 113.047 -3.461 . . . . 0.0 110.769 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.99 -38.32 2.97 Favored Glycine 0 CA--C 1.498 -0.99 0 C-N-CA 115.176 -3.392 . . . . 0.0 110.236 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.9 147.23 5.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 116.124 -2.23 . . . . 0.0 108.997 -174.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HD1' ' HB3' ' A' ' 49' ' ' GLN . 16.7 p90 -86.13 -166.59 1.58 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 116.237 -2.185 . . . . 0.0 108.001 174.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.4 p -134.36 142.67 47.28 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 114.297 -2.961 . . . . 0.0 108.936 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.203 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 97.3 m -90.64 145.86 24.5 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 115.182 -2.607 . . . . 0.0 110.05 -176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 60' ' ' HIS . 97.1 m -126.8 116.83 21.49 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 116.15 -2.22 . . . . 0.0 107.848 172.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 34.3 m -90.05 143.88 26.39 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 116.049 -2.26 . . . . 0.0 109.745 -176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.48 171.57 12.9 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 116.313 -2.155 . . . . 0.0 110.468 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -54.82 137.96 43.71 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 116.09 -2.244 . . . . 0.0 110.179 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.15 16.28 69.91 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 115.447 -3.263 . . . . 0.0 111.121 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.8 m-85 -144.2 145.07 31.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 115.807 -2.357 . . . . 0.0 108.878 170.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 5.0 mt-10 -147.63 -178.95 6.53 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.488 -2.085 . . . . 0.0 109.555 -176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.7 174.66 39.88 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 114.859 -3.543 . . . . 0.0 109.762 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -70.34 -48.33 56.93 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 115.577 -2.449 . . . . 0.0 109.725 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 37.7 m-20 -82.08 -5.0 58.07 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 116.741 -1.984 . . . . 0.0 110.622 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 5.0 m 74.25 27.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 115.159 -2.617 . . . . 0.0 108.922 -165.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.9 -22.59 65.7 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 117.38 -1.728 . . . . 0.0 110.076 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -85.04 165.26 17.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 114.82 -2.752 . . . . 0.0 109.177 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.8 t -128.49 35.81 4.34 Favored 'General case' 0 C--O 1.251 1.14 0 C-N-CA 115.713 -2.395 . . . . 0.0 107.695 169.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 84' ' ' SER . 20.7 p 44.29 16.15 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 117.439 -1.704 . . . . 0.0 111.39 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.549 ' N ' ' C ' ' A' ' 84' ' ' SER . 15.6 ptm180 . . . . . 0 C--O 1.196 -1.76 0 C-N-CA 114.938 -2.705 . . . . 0.0 108.949 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . 0.274 61.1 mttp . . . . . 0 C--O 1.264 1.856 0 CA-C-O 118.838 -0.601 . . . . 0.0 111.488 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -104.54 139.98 38.65 Favored 'General case' 0 C--O 1.19 -2.04 0 C-N-CA 117.157 -1.817 . . . . 0.0 106.712 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.6 -117.71 0.41 Allowed Glycine 0 C--N 1.369 2.391 0 C-N-CA 115.367 -3.301 . . . . 0.0 110.729 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -166.43 29.73 0.04 OUTLIER 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 110.1 -3.05 . . . . 0.0 106.926 173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 2.3 mp0 -89.93 -11.8 40.72 Favored 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 116.018 -2.273 . . . . 0.0 109.046 -167.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 49' ' ' GLN . 59.1 m -163.87 14.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 116.191 -2.204 . . . . 0.0 109.47 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -78.67 -14.09 59.48 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 114.965 -2.694 . . . . 0.0 108.437 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -117.04 26.0 8.53 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 114.986 -3.483 . . . . 0.0 110.327 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 52' ' ' GLY . 13.2 t-160 39.65 91.5 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.823 0 C-N-CA 116.066 -2.254 . . . . 0.0 110.788 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -91.68 -31.95 0.09 OUTLIER 'Trans proline' 0 C--O 1.253 1.261 0 C-N-CA 121.339 1.36 . . . . 0.0 109.878 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 60' ' ' HIS . 15.7 m -75.83 124.38 27.22 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 115.696 -2.401 . . . . 0.0 110.598 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD1' HD22 ' A' ' 80' ' ' ASN . 46.9 mt -77.07 176.44 8.68 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 116.476 -2.09 . . . . 0.0 109.404 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 63.36 40.33 8.6 Favored 'General case' 0 C--O 1.29 3.202 0 CA-C-N 114.001 -1.454 . . . . 0.0 108.895 173.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 46.5 35.88 3.19 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 115.266 -2.574 . . . . 0.0 110.35 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.11 -134.82 0.05 OUTLIER Glycine 0 CA--C 1.563 3.042 1 C-N-CA 113.141 -4.361 . . . . 0.0 110.2 171.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.424 ' O ' ' SG ' ' A' ' 55' ' ' CYS . 2.0 t-160 -159.17 -175.46 5.27 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 114.64 -2.824 . . . . 0.0 109.003 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 36.5 t -155.46 128.94 8.39 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 114.429 -2.908 . . . . 0.0 108.36 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.6 ' O ' ' O ' ' A' ' 87' ' ' ' OH' . 5.3 mptp? -89.43 -20.97 23.28 Favored 'General case' 0 C--O 1.256 1.418 0 C-N-CA 114.629 -2.828 . . . . 0.0 110.301 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t70 63.22 146.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 117.59 -1.644 . . . . 0.0 110.443 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.3 -100.91 0.14 Allowed Glycine 0 C--O 1.211 -1.282 0 C-N-CA 114.81 -3.567 . . . . 0.0 109.417 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.653 HG22 ' N ' ' A' ' 66' ' ' GLY . 4.6 mm -69.4 178.27 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 C-N-CA 116.081 -2.248 . . . . 0.0 110.713 172.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.653 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -49.92 -23.39 5.3 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 115.561 -3.209 . . . . 0.0 110.192 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' N ' ' C ' ' A' ' 65' ' ' ILE . 6.0 m-20 -98.27 132.05 44.09 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 116.569 -2.052 . . . . 0.0 108.669 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 17.9 p90 -90.65 -173.81 3.87 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 115.256 -2.578 . . . . 0.0 109.941 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 p -123.95 133.79 53.63 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 115.95 -2.3 . . . . 0.0 108.942 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.83 128.96 49.37 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 115.584 -2.446 . . . . 0.0 109.614 -171.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 72' ' ' CYS . 38.9 m -99.26 170.03 8.95 Favored 'General case' 0 CA--C 1.564 1.483 0 C-N-CA 115.441 -2.504 . . . . 0.0 106.636 171.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.022 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 17.0 m -122.09 -45.05 2.26 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 114.276 -2.97 . . . . 0.0 110.897 -170.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' CB ' ' O ' ' A' ' 72' ' ' CYS . . . 115.88 162.28 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.99 119.35 5.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 115.58 -2.448 . . . . 0.0 110.943 -175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 83.2 29.94 32.36 Favored Glycine 0 N--CA 1.504 3.218 0 C-N-CA 114.156 -3.878 . . . . 0.0 111.839 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.732 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 88.5 m-85 -142.96 152.1 41.63 Favored 'General case' 0 C--O 1.248 0.975 0 C-N-CA 114.088 -3.045 . . . . 0.0 108.943 170.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 6.5 mt-10 -153.32 -176.68 5.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 115.336 -2.546 . . . . 0.0 108.442 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.74 176.32 28.27 Favored Glycine 0 C--N 1.361 1.919 0 C-N-CA 114.315 -3.802 . . . . 0.0 110.568 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -58.01 -63.18 1.35 Allowed 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 116.463 -2.095 . . . . 0.0 110.568 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.825 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 22.9 m-20 -78.85 -21.0 48.23 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 116.15 -2.22 . . . . 0.0 110.713 177.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.022 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 19.5 m 94.1 26.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 116.647 -2.021 . . . . 0.0 107.671 -168.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.76 -19.91 65.34 Favored 'General case' 0 CA--C 1.6 2.897 0 C-N-CA 117.078 -1.849 . . . . 0.0 109.274 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.462 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 27.5 m-85 -78.14 176.2 9.44 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 116.077 -2.249 . . . . 0.0 110.764 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 80.5 p -133.97 28.4 3.84 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 116.12 -2.232 . . . . 0.0 108.278 172.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.628 ' OG1' ' O ' ' A' ' 84' ' ' SER . 41.0 p 47.54 5.33 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 117.54 -1.664 . . . . 0.0 111.148 -172.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.649 ' H ' ' C ' ' A' ' 84' ' ' SER . 16.1 tpt180 . . . . . 0 CA--C 1.572 1.815 0 C-N-CA 117.775 -1.57 . . . . 0.0 108.83 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . 0.6 ' O ' ' O ' ' A' ' 62' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.3 mttp . . . . . 1 N--CA 1.549 4.495 0 CA-C-O 125.637 2.637 . . . . 0.0 104.408 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -97.12 117.41 31.26 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 113.657 -3.217 . . . . 0.0 107.577 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.92 101.35 0.14 Allowed Glycine 0 N--CA 1.51 3.592 1 C-N-CA 113.358 -4.258 . . . . 0.0 109.831 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -119.44 66.67 0.8 Allowed 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 115.896 -2.322 . . . . 0.0 110.335 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -89.13 -6.84 56.71 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 115.554 -2.458 . . . . 0.0 109.097 -176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 34.0 m -145.23 -22.75 0.49 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 115.416 -2.514 . . . . 0.0 109.563 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -78.58 -15.67 58.28 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 116.349 -2.14 . . . . 0.0 108.748 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 53' ' ' HIS . . . -87.8 13.37 61.11 Favored Glycine 0 C--O 1.215 -1.057 0 C-N-CA 114.817 -3.563 . . . . 0.0 110.684 -178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 52' ' ' GLY . 11.6 t-160 44.3 82.18 0.24 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 116.485 -2.086 . . . . 0.0 110.018 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -95.69 -42.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 121.029 1.153 . . . . 0.0 110.606 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.11 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 72.4 m -77.74 160.42 28.42 Favored 'General case' 0 C--O 1.253 1.258 0 C-N-CA 115.903 -2.319 . . . . 0.0 109.713 -177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.472 ' CD1' HD22 ' A' ' 80' ' ' ASN . 82.7 mt -101.99 175.86 5.4 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 116.038 -2.265 . . . . 0.0 110.989 -176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 55.43 38.9 30.94 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 117.458 -1.697 . . . . 0.0 110.319 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 56.79 25.95 10.91 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 118.688 -1.205 . . . . 0.0 110.827 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.16 136.6 32.63 Favored Glycine 0 N--CA 1.424 -2.16 0 C-N-CA 114.723 -3.608 . . . . 0.0 108.864 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -78.47 179.37 7.08 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 111.725 -2.237 . . . . 0.0 108.725 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.196 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 11.1 p -154.61 137.49 15.39 Favored 'General case' 0 C--O 1.256 1.447 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.661 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -102.35 128.32 48.97 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 115.76 -2.376 . . . . 0.0 108.855 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.4 149.39 42.52 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 115.681 -2.407 . . . . 0.0 109.878 -173.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.55 161.99 35.79 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 115.469 -3.253 . . . . 0.0 108.356 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mt -58.74 144.0 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 116.195 -2.202 . . . . 0.0 109.16 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 67' ' ' ASP . . . 68.8 69.56 1.36 Allowed Glycine 0 CA--C 1.54 1.618 0 C-N-CA 114.728 -3.606 . . . . 0.0 111.802 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 32.4 m-20 68.08 153.51 0.09 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 117.114 -1.835 . . . . 0.0 109.95 178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -82.75 -164.47 0.86 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 118.045 -1.462 . . . . 0.0 107.239 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 61' ' ' CYS . 17.6 p -135.16 152.11 51.29 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 116.218 -2.193 . . . . 0.0 108.797 171.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.11 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 92.0 m -96.22 154.03 17.48 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 115.738 -2.385 . . . . 0.0 110.802 -174.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.2 m -142.24 113.73 7.81 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 115.27 -2.572 . . . . 0.0 108.147 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.036 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 22.2 m -89.67 140.63 29.38 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 115.141 -2.624 . . . . 0.0 108.846 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.2 169.72 15.55 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 115.795 -2.362 . . . . 0.0 110.583 177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.26 127.76 28.42 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 116.259 -2.177 . . . . 0.0 110.196 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 90.17 18.59 49.44 Favored Glycine 0 N--CA 1.48 1.57 1 C-N-CA 113.714 -4.089 . . . . 0.0 111.209 -178.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.732 ' HA ' ' HA ' ' A' ' 84' ' ' SER . 92.9 m-85 -140.63 142.15 35.03 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 115.298 -2.561 . . . . 0.0 111.322 161.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.36 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 2.1 pt-20 -143.2 -145.86 0.18 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.341 -2.544 . . . . 0.0 109.719 169.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.994 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 82.13 164.25 33.87 Favored Glycine 1 N--CA 1.519 4.207 0 C-N-CA 114.229 -3.844 . . . . 0.0 107.067 178.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -56.08 -50.74 70.18 Favored 'General case' 0 N--CA 1.511 2.625 0 C-N-CA 115.063 -2.655 . . . . 0.0 110.869 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 29.3 m-20 -90.13 29.04 1.28 Allowed 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 117.408 -1.717 . . . . 0.0 110.348 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.036 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 47.8 m 57.07 20.78 5.76 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 113.943 -3.103 . . . . 0.0 106.678 -164.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' N ' ' C ' ' A' ' 80' ' ' ASN . 9.3 tp10 -49.08 -52.47 25.56 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 117.528 -1.669 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 1.36 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -93.93 174.85 6.96 Favored 'General case' 1 N--CA 1.365 -4.683 0 C-N-CA 112.977 -3.489 . . . . 0.0 109.311 -165.768 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.926 ' O ' HG23 ' A' ' 85' ' ' THR . 22.9 p -88.69 -68.67 0.75 Allowed 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 114.886 -2.726 . . . . 0.0 108.004 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.926 HG23 ' O ' ' A' ' 84' ' ' SER . 0.9 OUTLIER -178.29 -49.08 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 CA--C 1.553 1.07 0 CA-C-O 113.404 -3.188 . . . . 0.0 108.399 -179.848 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt . . . . . 0 N--CA 1.508 2.425 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -100.2 -65.56 0.96 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 113.468 -3.293 . . . . 0.0 110.69 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -177.09 103.4 0.18 Allowed Glycine 2 N--CA 1.356 -6.669 1 C-N-CA 113.07 -4.395 . . . . 0.0 112.723 -172.947 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.39 26.44 6.04 Favored 'General case' 0 CA--C 1.598 2.804 0 C-N-CA 117.813 -1.555 . . . . 0.0 108.77 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -83.95 -17.16 41.57 Favored 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 116.163 -2.215 . . . . 0.0 109.199 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.3 t -122.98 -3.98 8.57 Favored 'General case' 0 C--O 1.256 1.426 0 C-N-CA 115.393 -2.523 . . . . 0.0 109.733 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -75.2 -21.98 58.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 C-N-CA 114.395 -2.922 . . . . 0.0 109.458 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.07 7.6 81.79 Favored Glycine 0 CA--C 1.558 2.732 0 C-N-CA 114.242 -3.837 . . . . 0.0 112.019 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.52 86.13 0.16 Allowed Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 116.478 -2.089 . . . . 0.0 110.187 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -97.95 -46.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.746 0 N-CA-C 109.88 -0.854 . . . . 0.0 109.88 -171.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 93.6 m -75.28 165.07 25.76 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 115.928 -2.309 . . . . 0.0 110.446 -170.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' A' ' 80' ' ' ASN . 58.7 mt -103.32 174.83 5.7 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 116.645 -2.022 . . . . 0.0 111.293 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 51.02 52.4 15.08 Favored 'General case' 0 N--CA 1.523 3.219 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.206 174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 53.29 26.36 5.16 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 117.999 -1.48 . . . . 0.0 110.571 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.73 127.41 25.48 Favored Glycine 0 N--CA 1.465 0.602 0 C-N-CA 115.087 -3.435 . . . . 0.0 110.514 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -81.32 102.64 10.55 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 112.005 -2.098 . . . . 0.0 109.817 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.1 p -78.71 123.3 27.02 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 115.955 -2.298 . . . . 0.0 109.909 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -92.73 152.84 19.27 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 114.92 -2.712 . . . . 0.0 108.302 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -83.45 141.76 31.46 Favored 'General case' 0 CA--C 1.561 1.396 0 C-N-CA 115.721 -2.391 . . . . 0.0 110.782 -170.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.68 161.31 28.79 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 115.166 -3.397 . . . . 0.0 108.903 173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 67' ' ' ASP . 8.6 mt -66.7 138.5 22.8 Favored 'Isoleucine or valine' 0 C--O 1.251 1.135 0 C-N-CA 114.982 -2.687 . . . . 0.0 109.327 -172.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.72 -37.74 1.89 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 114.57 -3.681 . . . . 0.0 112.135 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 65' ' ' ILE . 21.9 m-20 -162.84 139.19 7.35 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 116.53 -2.068 . . . . 0.0 109.484 -169.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 68' ' ' TYR . 27.0 p90 -78.56 -164.71 0.6 Allowed 'General case' 0 C--O 1.259 1.557 0 C-N-CA 116.153 -2.219 . . . . 0.0 108.458 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 p -137.16 140.5 41.87 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 115.399 -2.52 . . . . 0.0 109.35 171.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.077 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 99.5 m -85.67 128.47 34.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.717 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.5 m -117.35 108.75 15.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 114.608 -2.837 . . . . 0.0 107.786 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 11.6 m -80.98 140.39 35.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 115.067 -2.653 . . . . 0.0 108.994 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 74' ' ' GLU . . . -74.5 159.67 31.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 114.826 -2.75 . . . . 0.0 109.159 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 73' ' ' ALA . 41.7 tt0 -47.07 116.58 1.42 Allowed 'General case' 0 C--O 1.258 1.514 0 C-N-CA 115.671 -2.412 . . . . 0.0 111.012 -176.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 113.05 7.05 21.96 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 114.418 -3.753 . . . . 0.0 110.724 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 96.6 m-85 -139.01 152.52 47.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 C-N-CA 116.257 -2.177 . . . . 0.0 108.617 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.438 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.1 pt-20 -154.73 -151.95 0.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 115.9 -2.32 . . . . 0.0 109.234 174.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.838 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 91.76 174.28 42.78 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 115.13 -3.414 . . . . 0.0 108.754 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -61.57 -38.22 86.7 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 115.703 -2.399 . . . . 0.0 110.52 -175.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.553 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 10.8 m-20 -102.47 26.23 8.11 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 117.513 -1.675 . . . . 0.0 111.175 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 55.5 m 57.24 30.19 18.0 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 114.17 -3.012 . . . . 0.0 107.905 -165.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.3 tp10 -63.84 -50.4 69.01 Favored 'General case' 0 CA--C 1.575 1.927 0 C-N-CA 116.86 -1.936 . . . . 0.0 112.405 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 1.438 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.51 135.5 35.88 Favored 'General case' 0 N--CA 1.382 -3.832 0 C-N-CA 113.477 -3.289 . . . . 0.0 110.728 -149.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 36.2 p -76.12 94.82 3.54 Favored 'General case' 0 C--O 1.251 1.159 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.878 -177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.698 ' HB ' ' CD ' ' A' ' 77' ' ' GLU . 1.1 t -73.09 -25.78 61.01 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 115.869 -2.333 . . . . 0.0 109.47 -177.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 . . . . . 0 C--O 1.202 -1.395 0 C-N-CA 115.543 -2.463 . . . . 0.0 110.847 177.665 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.3 mttp . . . . . 0 CA--C 1.594 2.646 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -72.81 146.31 46.39 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 111.869 -3.932 . . . . 0.0 111.958 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 173.77 98.06 0.11 Allowed Glycine 0 C--N 1.352 1.425 1 C-N-CA 113.594 -4.146 . . . . 0.0 110.81 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.78 ' O ' ' N ' ' A' ' 50' ' ' CYS . 5.1 m-20 -97.29 -6.03 35.33 Favored 'General case' 0 C--O 1.264 1.858 0 C-N-CA 115.182 -2.607 . . . . 0.0 109.693 173.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.504 ' HB3' ' HD1' ' A' ' 68' ' ' TYR . 89.9 mm-40 41.99 6.58 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 117.999 -1.48 . . . . 0.0 111.885 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.78 ' N ' ' O ' ' A' ' 48' ' ' ASP . 46.2 t -116.16 4.76 13.64 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.467 -1.693 . . . . 0.0 110.473 178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -73.26 143.91 46.87 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 116.109 -2.236 . . . . 0.0 109.423 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.84 -4.68 75.67 Favored Glycine 0 CA--C 1.541 1.716 0 C-N-CA 114.072 -3.918 . . . . 0.0 111.266 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.1 t60 48.08 90.74 0.07 OUTLIER Pre-proline 0 C--N 1.36 1.045 0 C-N-CA 115.65 -2.42 . . . . 0.0 109.179 -175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -93.32 -35.31 0.04 OUTLIER 'Trans proline' 0 C--O 1.249 1.047 0 C-N-CA 121.116 1.21 . . . . 0.0 110.228 -173.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.025 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 88.7 m -81.76 146.94 29.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 114.883 -2.727 . . . . 0.0 109.19 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.601 ' CD1' HD22 ' A' ' 80' ' ' ASN . 74.2 mt -96.96 175.26 6.4 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 116.147 -2.221 . . . . 0.0 109.553 -174.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 57.46 46.81 17.41 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 113.085 -1.871 . . . . 0.0 107.02 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 50.69 33.48 8.35 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.871 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.66 -168.72 5.26 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 113.976 -3.964 . . . . 0.0 109.839 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -130.7 120.26 23.61 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 115.087 -2.645 . . . . 0.0 109.311 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.3 p -104.9 117.35 33.81 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 115.175 -2.61 . . . . 0.0 109.036 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -98.82 148.71 23.63 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 116.0 -2.28 . . . . 0.0 107.304 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -94.03 149.55 21.14 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 115.419 -2.512 . . . . 0.0 108.587 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.1 -94.67 0.1 OUTLIER Glycine 0 C--O 1.255 1.458 0 C-N-CA 114.947 -3.501 . . . . 0.0 109.671 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.811 HG22 ' H ' ' A' ' 66' ' ' GLY . 5.6 mm -70.32 -173.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.969 0 C-N-CA 115.594 -2.442 . . . . 0.0 109.288 176.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.811 ' H ' HG22 ' A' ' 65' ' ' ILE . . . -62.79 -4.95 7.89 Favored Glycine 0 N--CA 1.482 1.719 0 C-N-CA 114.244 -3.836 . . . . 0.0 110.774 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.454 ' N ' ' C ' ' A' ' 65' ' ' ILE . 1.3 p30 -123.67 146.91 47.87 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 115.667 -2.413 . . . . 0.0 106.787 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.544 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.0 p90 -84.76 -164.5 0.98 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 115.306 -2.558 . . . . 0.0 107.82 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.6 135.35 40.19 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 116.435 -2.106 . . . . 0.0 109.362 171.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.025 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 57.0 m -86.65 140.08 30.17 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 115.594 -2.442 . . . . 0.0 107.931 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -122.5 110.79 16.02 Favored 'General case' 0 C--O 1.21 -1.025 0 C-N-CA 115.963 -2.295 . . . . 0.0 110.015 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 81' ' ' CYS . 6.9 m -83.08 140.53 32.61 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 115.464 -2.495 . . . . 0.0 109.432 -175.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.66 164.23 22.03 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 115.416 -2.514 . . . . 0.0 110.191 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -50.62 109.85 0.35 Allowed 'General case' 0 C--O 1.215 -0.741 0 C-N-CA 115.277 -2.569 . . . . 0.0 109.519 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 115.88 15.13 7.5 Favored Glycine 0 CA--C 1.551 2.323 0 C-N-CA 114.984 -3.484 . . . . 0.0 112.299 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.535 ' HB2' ' HB3' ' A' ' 72' ' ' CYS . 97.0 m-85 -146.0 153.77 41.13 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 115.143 -2.623 . . . . 0.0 109.015 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.522 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.6 pt-20 -157.15 -145.52 0.15 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 114.593 -2.843 . . . . 0.0 107.846 177.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.896 ' N ' ' CE1' ' A' ' 83' ' ' PHE . . . 84.49 176.09 50.93 Favored Glycine 0 N--CA 1.475 1.238 0 C-N-CA 115.089 -3.434 . . . . 0.0 108.085 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -57.38 -36.68 71.55 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 115.342 -2.543 . . . . 0.0 111.115 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.657 ' O ' ' HB2' ' A' ' 81' ' ' CYS . 55.2 m-20 -107.56 21.61 17.2 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 116.585 -2.046 . . . . 0.0 110.436 -172.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 72' ' ' CYS . 62.3 m 62.02 24.52 14.61 Favored 'General case' 0 C--O 1.21 -1.016 0 C-N-CA 114.963 -2.695 . . . . 0.0 107.278 -160.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.736 ' N ' ' O ' ' A' ' 77' ' ' GLU . 6.8 tp10 -58.7 -53.76 54.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 116.115 -2.234 . . . . 0.0 112.197 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 1.522 ' CE1' ' HG3' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -94.44 129.85 41.04 Favored 'General case' 0 N--CA 1.394 -3.236 0 C-N-CA 111.82 -3.952 . . . . 0.0 111.97 -149.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 20.4 p -74.29 102.5 4.37 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 115.507 -2.477 . . . . 0.0 109.664 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.457 HG22 ' CD ' ' A' ' 77' ' ' GLU . 76.2 p -44.64 -43.11 8.01 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 114.888 -2.725 . . . . 0.0 110.877 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 . . . . . 0 N--CA 1.433 -1.301 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.027 -176.44 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.0 mttm . . . . . 0 CA--C 1.5 -0.947 0 CA-C-O 122.099 0.952 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -109.16 -31.56 7.55 Favored 'General case' 0 C--O 1.178 -2.659 0 CA-C-O 126.633 3.111 . . . . 0.0 112.187 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.84 118.35 0.64 Allowed Glycine 0 CA--C 1.569 3.446 0 C-N-CA 114.676 -3.63 . . . . 0.0 109.724 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -96.09 39.26 1.15 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 115.154 -2.618 . . . . 0.0 108.826 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -79.92 -24.44 41.07 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 117.039 -1.864 . . . . 0.0 107.677 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 15.0 p -154.69 23.07 0.46 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 115.918 -2.313 . . . . 0.0 110.064 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.22 -14.52 61.36 Favored 'General case' 0 C--O 1.197 -1.674 0 C-N-CA 115.697 -2.401 . . . . 0.0 110.351 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.62 20.19 36.37 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 114.734 -3.603 . . . . 0.0 110.853 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 49.84 83.12 0.23 Allowed Pre-proline 0 C--O 1.254 1.34 0 C-N-CA 116.639 -2.024 . . . . 0.0 109.944 -178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -88.95 -37.53 0.06 OUTLIER 'Trans proline' 0 C--O 1.242 0.681 0 C-N-CA 121.434 1.423 . . . . 0.0 110.666 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 1.003 ' SG ' ' SG ' ' A' ' 70' ' ' CYS . 56.6 m -72.94 127.19 31.83 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 115.108 -2.637 . . . . 0.0 110.43 -176.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.448 ' CD1' HD22 ' A' ' 80' ' ' ASN . 82.2 mt -83.32 175.04 10.18 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 116.137 -2.225 . . . . 0.0 109.873 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 60.9 m-80 64.94 50.81 1.85 Allowed 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 117.966 -1.494 . . . . 0.0 109.986 172.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 51.28 22.85 1.48 Allowed 'General case' 0 C--O 1.253 1.241 0 C-N-CA 115.518 -2.473 . . . . 0.0 113.374 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.95 -142.65 0.38 Allowed Glycine 0 N--CA 1.499 2.85 1 C-N-CA 113.677 -4.106 . . . . 0.0 110.05 176.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -153.13 164.42 38.07 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 114.974 -2.69 . . . . 0.0 109.005 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 50' ' ' CYS . 25.0 p -141.11 150.33 42.71 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 114.842 -2.743 . . . . 0.0 109.747 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -138.27 134.76 34.75 Favored 'General case' 0 C--O 1.247 0.945 0 C-N-CA 114.392 -2.923 . . . . 0.0 108.295 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.06 151.98 33.18 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 116.022 -2.271 . . . . 0.0 111.578 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 66' ' ' GLY . . . -142.44 -176.28 16.44 Favored Glycine 0 CA--C 1.544 1.901 1 C-N-CA 113.743 -4.075 . . . . 0.0 109.216 178.106 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 65' ' ' ILE . 48.5 mt -84.93 29.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 117.278 -1.769 . . . . 0.0 109.297 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . 165.09 86.88 0.06 OUTLIER Glycine 0 C--N 1.262 -3.542 0 C-N-CA 115.417 -3.278 . . . . 0.0 109.849 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.5 t70 73.13 134.62 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 116.174 -2.21 . . . . 0.0 109.306 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.494 ' HE2' ' SG ' ' A' ' 70' ' ' CYS . 22.6 p90 -77.89 -170.86 2.05 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 117.844 -1.542 . . . . 0.0 108.62 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 p -130.77 136.53 48.81 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 116.607 -2.037 . . . . 0.0 109.659 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 1.003 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -103.47 129.31 50.59 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 113.448 -3.301 . . . . 0.0 110.238 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 72' ' ' CYS . 55.0 m -104.28 173.11 6.44 Favored 'General case' 0 C--O 1.25 1.105 0 C-N-CA 115.814 -2.355 . . . . 0.0 107.844 168.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.801 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 47.8 m -123.56 -48.96 1.91 Allowed 'General case' 0 N--CA 1.504 2.268 0 C-N-CA 115.997 -2.281 . . . . 0.0 110.007 -169.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.801 ' CB ' ' O ' ' A' ' 72' ' ' CYS . . . 119.75 165.29 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.858 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -57.3 122.21 11.99 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 115.375 -2.53 . . . . 0.0 111.145 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.655 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . 76.95 34.91 40.81 Favored Glycine 0 N--CA 1.47 0.956 0 C-N-CA 115.114 -3.422 . . . . 0.0 111.502 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 73' ' ' ALA . 82.7 m-85 -143.58 150.38 38.75 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 115.43 -2.508 . . . . 0.0 109.036 167.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 2.4 mt-10 -155.83 178.43 10.27 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 115.721 -2.391 . . . . 0.0 109.824 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.1 179.09 21.39 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 114.72 -3.609 . . . . 0.0 110.036 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.86 -61.0 2.9 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 115.222 -2.591 . . . . 0.0 108.092 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.783 ' O ' ' CB ' ' A' ' 81' ' ' CYS . 16.0 m-20 -78.91 -20.91 48.21 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 116.633 -2.027 . . . . 0.0 111.156 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.783 ' CB ' ' O ' ' A' ' 80' ' ' ASN . 12.5 m 92.18 27.25 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 116.394 -2.123 . . . . 0.0 108.383 -164.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.25 -19.77 56.12 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 116.005 -2.278 . . . . 0.0 110.547 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.463 ' O ' ' HD1' ' A' ' 76' ' ' PHE . 35.4 m-85 -81.16 177.48 9.0 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 115.875 -2.33 . . . . 0.0 110.825 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.655 ' HA ' ' O ' ' A' ' 75' ' ' GLY . 31.9 m -136.24 39.85 2.68 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 115.259 -2.576 . . . . 0.0 108.503 166.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 35.2 p 43.5 30.26 0.32 Allowed 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.964 -1.894 . . . . 0.0 109.932 -173.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' THR . 31.7 tpt180 . . . . . 0 C--N 1.298 -1.657 0 CA-C-O 115.888 -2.006 . . . . 0.0 109.254 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ' OH' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_